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Abstract 
Terminal deoxynucleotidyl transferase (TdT) contributes to antigen receptor 
diversity of B and T lymphocytes of the adaptive immune system. TdT is a DNA 
polymerase catalyzing template independent addition of nucleotides during the process of 
V(D)J recombination. This thesis investigates whether the polymerase activities of 
naturally occurring single nucleotide polymorphic (SNP) forms of human TdT vary and 
the possible effects on the antigen receptor repertoire. Two SNPs (A445T/L397S) 
demonstrated significantly lower in vitro polymerization activities compared to the wild 
type enzyme, while one (R431 C) was completely inactive. In vivo extrachromosomal 
recombination assay demonstrated over 3 fold difference in the proportion of N-
containing joints and significantly lower numbers of N-nucleotides per joint for both 
L397S and R431C variants compared to WT hTdTS. Variability in enzymatic activities 
of the SNPs may affect the diversity of antigen receptors, thus potentially impact the 
downstream adaptive immune response in healthy and autoimmune-prone individuals 
possessing these SNPs. 
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Chapter 1: Introduction 
The human adaptive immune system is equipped with mechanisms to recognize 
and defend against numerous pathogens through the generation of Band T lymphocytes. 
A pathogen-specific immune response is mounted through antigen recognition via T and 
B lymphocyte receptors. The diversity of B and T antigen receptors is encoded by genes 
that are modified by recombination during the development of B and T cells. The 
recombination results in well over a million different receptors with different specificities 
and affinities for essentially any antigen. The receptors contain a variable domain region 
that constitutes the antigen-binding site through gene rearrangements and recombination 
of variable (V), diversity (D) and joining (J) gene segments. This process is known as 
V(D)J recombination and contributes to diverse repertoire of lymphocyte antigen 
receptors that are crucial for proper adaptive immune response. 
My thesis work focuses on one of the enzymes critical for V(D)J recombination 
and T cell and B cell receptor diversity, terminal deoxynucleotidyl transferase (hTdT). I 
undertook a functional characterization of a number of human naturally occurring 
polymorphic forms of hTdT. Specifically, single nucleotide polymorphisms (SNPs) that 
result in a protein amino acid change were considered. TdT plays an important role in 
antigen receptor diversification. This chapter will introduce hTdT properties, its function 
in V(D)J recombination and its role in immune-related disorders. 
Section 1.1 Biochemical properties of TdT 
Terminal deoxynucleotidyl transferase (TdT} is a 58kDa nucleus localized X-
family DNA polymerase that is able to add non-temp lated (N) nucleotides to a free 3' 
hydroxyl group of single stranded DNA during V(D)J recombination. It contributes to the 
diversity at the coding joints between V, D and J gene segments. TdT is the only member 
of X-family of DNA polymerases that is template-independent. Other family members 
including DNA polymerase ~' DNA polymerase /..., and DNA polymerase µ require a 
double-stranded DNA substrate to catalyze the phosphoryl transfer reaction, (1,2). 
1.1.1 TdT Expression and Regulation 
TdT was the first DNA polymerase to be identified and was originally purified 
from calf thymus cell lysates (3,4). It is highly conserved in vertebrates, including 
humans, mice, zebrafish and rats (5). TdT expression is confined to primary lymphoid 
tissues, namely thymus and bone marrow, and its expression is tightly controlled at 
specific stages of lymphocyte development (6,7). TdT activity is tightly regulated at the 
transcriptional level, post-translational modifications and interaction with other proteins. 
At the transcriptional level, TdT expression was shown to correlate to the expression of 
the Recombination Activating Genes (RAG) that initiate the process of V(D)J 
recombination at B and T lymphocyte receptor loci (8). In addition, activation protein- I 
(AP-1 ), a transcription factor, was found to down-regulate TdT mRNA expression via 
protein kinase C activation (9). Post-translational modifications of TdT were also 
suggested to modulate its expression. For instance, in vivo labeling studies demonstrated 
TdT phosphorylation in human lymphoblastoid cells however, the downstream effect of 
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this phosphorylation on TdT activity was not established (10, 1). TdT has been shown to 
interact with other proteins, such as the Ku proteins that participate in non-homologous 
end joining (NHEJ) processes during V(D)J recombination. Sandor et.al have shown that 
random nucleotide additions resulting from TdT activity are significantly longer (over 10 
nucleotides long) in Ku80 knockout Chinese hamster ovary cells compared to Ku80+/+ 
cells, thus demonstrating Ku80 ability to modulate TdT catalytic activity in vivo (11 ). 
1.1.2 Isoforms ofTdT 
Genomic organization of human TdT gene is complex. The TdT gene is 
composed of thirteen exons. A total of three human mRNA TdT splice variants have been 
identified. These translate into three mature protein isoforms: short (TdTS, 11 exons, 509 
amino acids) and two long (TdTLl, TdTL2). TdTLl isoform contains a 9 amino acid 
insert, while L2 isoform contains a 17 amino acid insert. Both long isoforms are found to 
possess 3' to 5' in vitro exonuclease activity that allows for nucleotide removal (as well 
as addition), while the short isoform is associated primarily with nucleotide additions 
(12). Normal B and T lymphocytes express exclusively hTdTS and hTdTL2, whereas 
hTdTLl expression appears to be restricted to transformed lymphoid cell lines (2). The 
significance of this finding has not been explored further. Thus, the length of N-
nucleotide regions during V(D)J recombination is thought to be regulated through the 
combined activity of its polymerase and exonuclease activities. 
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1.1.3 T dT protein domain structure 
Two functionally independent human TdT regions have been identified: breast 
cancer susceptibility protein BRCAl C-terminal (BRCT) domain at the N-terminus and 
the polymerase ~-like domain at the C-terminus (Figure 1.1 ). BRCT domain is involved 
in protein-protein and protein-DNA interactions during DNA repair and cell cycle check-
point pathways (13). The pol~-like domain is the catalytic core of the enzyme and 
contains the active site of the phosphoryl transfer reaction (1,2). In addition, a nuclear 
localization signal (NLS) motif is found at the N-terminus. To date no protein structure of 
hTdT has been published. However, the crystal structure of the catalytic core of murine 
TdT (mTdT) that shares 78% amino acid sequence homology with the hTdT has been 
solved by Delarue et.al (5). I used this established murine TdT structure as a model of 
human TdT structure in my thesis. 
According to the solved crystal structure of murine TdT at 2.35A resolution, TdT 
tertiary structure is largely a helical and contains a central antiparallel p sheet, where the 
active site resides, along with two unstructured regions (Loopl and 2) (5). TdT catalytic 
core is further subdivided into four domains named: 8 kDa, finger, palm, and thumb 
domains. The four domains assume a three dimensional right-handed shape (Figure 1.2). 
The four subdomains resemble the ones first described in polymerase ~' and thus are 
termed pol~-like domains (15). The phosphoryl transfer reaction takes place at the palm 
subdomain. The enzyme's active site is composed of three highly conserved aspartic acid 
residues and a divalent cation binding pocket. The finger subdomain aligns the incoming 
nucleotide and the DNA primer strand in proper orientation for phosphoryl transfer 
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reaction. The role of the thumb subdomain is to position the DNA primer strand to accept 
an incoming nucleotide prior to catalysis and to translocate TdT to next base position 
after catalysis. The 8 k.Da subdomain contacts the thumb subdomain to create TdT's ring-
like shape that allows DNA primer strand and incoming nucleotide to reach the active site 
(1-2, 5, 14). 
1 163 243 302 450 510 
COOH 
PolP.like Domains 
Figure 1.1: Domain structure of TdT protein. TdT is composed of four subdomains: 8 
k.Da (residues 163-243), finger (residues 243-302), palm (residues 302-450) and thumb 
(residues 450-510). Amino acid numbering is shown on top of the figure (coinciding with 
murine TdT). Nuclrear localization signal (NLS) located at the N-terminus. 
5 
Figure 1.2: Crystal structure of murine TdT (PDB code lKEJ). TdT is composed of four 
subdomains: 8 kD, finger, palm and thumb. The crystal structure excludes the BRCT 
domain at the N-terminus, thus only residues 148-510 are shown. Two unstructured loop 
regions have been determined (Loop 1 and Loop2) within the palm subdomain, shown in 
yellow. The incoming nucleotide substrate, ddATP, is shown in orange. Two cobalt ions 
are colored cyan. Figures generated using PyMol software. 
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1.1.4 Mechanism of polymerization 
The active site of X-family DNA polymerases is highly conserved and is found at 
the palm subdomain. It consists of catalytic aspartates that coordinate the two metals 
involved in the nucleotidyl transferase reaction (14). A detailed kinetic mechanism of 
template-independent polymerization by TdT has not been reported to date. Nevertheless, 
according to other established mechanisms of nucleotidyl transfer reaction of X-family 
DNA polymerases an aspartic acid residue abstracts a proton from the 3' hydroxyl group 
of DNA primer strand resulting in a reactive nucleophile. The nucleophile attacks the a-
phosphate of the incoming nucleotide, leading to the formation of a phosphodiester bond. 
The positively charged metal ions stabilize the reaction transition state as well as 
facilitating the release of the negatively charged pyrophosphate group (15, 16). A key 
structural difference between the template dependent DNA polymerases, such as 
polymerase~' and TdT is the presence of a 16 amino acid 'lariat-like' loop that does not 
allow TdT to interact with double stranded DNA. The lariat-like loop is believed to 
physically block the diffusion of duplex DNA primer into the active site of TdT (5, 17). 
Section 1.2: Generation of antigen receptor diversity 
1.2.1 Structure of B and T cell receptors 
The B cell receptor is a glycoprotein consisting of four polypeptide chains: two 
identical heavy chains and two identical light chains, linked to each other via disulfide 
bonds and hydrophobic interactions (6) (Figure 1.3). The gene loci of the BCR encode for 
a heavy chain and two light chains. In humans, the B cell immunoglobulin genes are 
found at three loci: the heavy chain locus (IgH) on chromosome 14, the K light chain 
7 
(IgK) locus on chromosome 2 and the /.... light chain locus (lg/....) on chromosome 22. Each 
chain loci contains a constant region with limited diversity and a variable region 
containing three hypervariable regions, also called complementary-determining regions 
(CDRs) (6, 18). The IgH variable region is further subdivided into gene segments: 51 VH 
segments, 27 DH segments and 6 JH segments (counting human fumctional genes). The 
lgK and lg/.... variable regions only contain V and J gene segments. Human lgK has 
approximately 40 V K and 5 JK functional gene segments, while lg/.... has about 31 VA and 4 
h segments (6, 20). The paired variable regions of heavy and light chain are responsible 
for the specificity and diversity of the antigen-binding site. The presence of multiple V, D 
and J gene segments and their combinatorial joining, as well as nucleotide deletions and 
additions at the joint junctions, form a distinctive DNA sequence at the variable region. 
An appropriate antigen-receptor is selected based on its recognition and binding to an 
epitope of an encountered pathogen, followed by proliferation of the antigen-activated 
lymphocytes and their differentiation into effector cells that function to eliminate the 
pathogen (19). 
The human T cell receptor (TCR) consists of the following gene loci: TCRa 
(chromosome 14), TCRP (chromosome 7), TCRy (chromosome 7) and TCR8 
(chromosome 14) chains. The TCR is a trans-membrane glycoprotein composed of either 
an a and a p chain (TCRap) or a y and a 8 chain (TCRy8) (6). Each polypeptide chain 
contains a variable and a constant region, similarly to the BCR. For instance, the variable 
region of the a chain is divided into approximately 70 Va and 61 J a gene segments while 
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the p chain consist of 52 V~, 2 D~ and 13 J~ gene segments (6, 20). The TCR loci undergo 
similar processes at the variable regions to reconstitute a distiiilctive antigen-binding site. 
1.2.2 Mechanism of V(D)J recombination 
The diversity of B and T cell antigen-receptors is achieved through gene 
rearrangements of V, D and J segments. This process contributes significantly to the 
generation of a diverse immune repertoire. V(D)J recombination involves four 
consecutive phases: the recognition of recombination signal 'sequences (RSS), followed 
by single-strand DNA nicking at these sites, coding-end modifications and re-joining of 
modified ends via DNA repair pathway (20, 21) (Figure 1.4). Nuclear proteins called 
Recombination Activating Gene products, RAG 1 and RAG2, recognize and align 
evolutionary-conserved RSS flanking V, D and J gene segments. RAG proteins are 
exclusively expressed in lymphoid tissues undergoing V(D)J recombination (23, 24). 
There are two types of RSSs, one of each flanking gene segments that can be joined 
together. Each of the two types has a heptamer consensus sequence 5' -CACAGTG, a 
non-conserved spacer, and a nanomer consensus sequence 5' -ACAAAAACC. The spacer 
lengths differ in the two types ofRSS. It is either 12±1 base pairs or a 23±1 base pairs. In 
order for two gene segments to be joined, the RSS of the gene segments must be of 
different spacer lengths. These sequences function as recognition sites for the RAG 
complex and ensure that the joining order of gene segments occurs between appropriate 
gene clusters (V-D-J or V-J, but not V-V, D-D or J-J). This is known as the '12/23 rule', 
meaning that recombination can only occur between a 12 base pair spacer RSS and a 23 
base pair spacer RSS (6, 25). The heptamer and nanomer sequences may vary from the 
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consensus sequence, however the non-consensus RSS are used less frequently than the 
consensus RSS in the recombination reaction (26-28). 
The RAGI/2 complex recognizes a pair ofRSS and cleaves at the border between 
a gene segment and a specific RSS, thus producing a DNA nick at the phosphodiester 
bond of the 5' end ofRSS. The RAG complex was shown to interact with DNA histones 
to render the gene segments accessible at RSS regions, however the specific mechanism 
remains unclear (29, 30). The DNA strand break exposes a 3' hydroxyl group at the 
coding segment end that serves as a nucleophile. The nick is converted to a covalent 
hairpin structure by a direct trans-esterification reaction, in which the 3' hydroxyl group 
attacks the 5' end of the complementary strand to form a new phosphodiester bond (20, 
31, 32). The result is the formation of two DNA hairpins at the end of gene segments 
encoding the variable segments to be joined and two blunt signal ends which are the RSS 
and downstream DNA. When the variable gene segments to be joined are in the same 
transcription orientation, the DNA region containing the RSS is thus excised, the RSS are 
ligated forming what has been termed a "diamond structure" (Figure 2.5) forming a 
circular DNA, known as the signal joint. (These signal joint circles are generally lost 
during subsequent cellular divisions.) The hairpin structures at the coding ends of the 
variable domains remain associated with the postcleavage complex. The postcleavage 
complex which includes RAGl and RAG2 proteins, is thought to keep the double 
stranded DNA breaks in close proximity to allow further coding end processing (33, 34). 
The hairpin structure is opened and processed at the coding joint via non-
homologous end joining proteins (NHEJ) that are associated with cellular (genetic) DNA 
IO 
damage responses (35, 36). NHEJ pathway joins double stranded DNA breaks in a 
homology-independent manner, however short homologous sequences of few nucleotides 
long may be used to align DNA ends prior to ligation. The importance of NHEJ process 
is evident in animal models with severe combined immunodeficiency (SCID). The SCID 
defect as a result of abnormal NHEJ components including the Ku and DNA-PKcs 
proteins (37, 38). The processing of the coding joint is mediated through the recruitment 
of Ku heterodimer (named Ku70 and Ku86) to the double stranded DNA breaks (39). Ku 
proteins recruit the DNA-dependent protein kinase catalytic subunit (DNA-PKcs) that 
then activates the nuclease Artemis, that has been implicated in hairpin opening reaction, 
via phosphorylation (40). In vitro studies have also implicated RAG proteins and Mrell 
complex as possible nucleases in the hairpin opening process ( 41, 42). Hairpin opening 
may occur off-center, generating 3' or 5' overhang, or at the tip, generating blunt ends. 
The final coding joint usually has evidence of processing of the open hairpins before or 
during the process of the final repair and ligation of these ends. Palindromic (P) 
nucleotides, which can be found (in vivo occur at about 5-10% of the coding joints) in the 
final coding joint, occur when the hairpin is opened off-center, and joined (Figure 1.4). 
The P nucleotides are also called P-additions, and they are typically 1-2 nucleotides long 
(36). Nucleotide deletions also may, and usually do, occur at the coding ends, however 
the nuclease(s) responsible remains undetermined. 
The coding joints are usually processed by other enzymes including TdT which 
adds 1-15 random nucleotides (preferentially C and G in vivo) in a template-independent 
manner to free 3' hydroxyl group ends of DNA (1, 43-45). As mentioned earlier, TdT is 
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expressed in primary lymphoid tissues, namely thymus and bone marrow (6,7). In B cells 
TdT is expressed in pro-B stage when the heavy chain genes begin to rearrange. Its 
expression ceases before the rearrangement of the light chain genes during small pre-B 
stage, thus the variable region do not contain N additions (although exceptions were 
noted) (1, 46, 47). TdT is expressed in T cells at two stages as a. and ~ chain 
rearrangements occur. The majority of BCR and TCR contain N additions in their 
variable domains. Moreover, N additions have been reported in developing human fetus 
however the number of N nucleotides is significantly lower as compared to adults ( 48). 
Fetal mouse B and T cell repertoire contains little to no N additions and TdT has been 
shown to be expressed only after birth (49). 
The final joining of the modified coding ends is somewhat unclear. It is believed 
that the modified ends (with one or more P, N, deletions modifications) align through 
microhomology-mediated NHEJ that involves annealing of a complementary stretch of 
nucleotides present at processed coding end overhangs. Unpaired nucleotides are 
believed to be excised and template-dependent DNA polymerase (Polymerase µ) adds 
templated nucleotides to the gaps at the coding joints (50-52). The final ligation step is 
catalyzed by DNA ligase IV in complex with XRCC4 (X-ray-repair cross-complementing 
protein 4) to form the complete recombined coding joint (53, 54). Combinatorial and 
junctional diversity achieved through the process of V(D)J Fecombination generates a 
large antigen receptor repertoire, in the order of 1010-1011 unique receptors (36), that is 
required for the broad adaptive immunity present in all vertebrates (other than the jaw less 
fish). 
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V gene segments D gene segments J gene segments 
Transcription and splicing 
·---AAAA Variable Constant 
region region 
Translation and 
assembly 
C gene segments 
Figure 1.3: V(D)J recombination overview of immunoglobulin heavy chain locus. 
The germline configuration of heavy chain variable region of B cell receptor consists of 
multiple V, D and J gene segments. The heavy chain locus unpergoes D-J recombination 
followed by V-DJ recombination. The final product is the B cell rec·eptor composed of 
two identical heavy chains and two identical light chains. The variable region of heavy 
and light chain is the antigen-binding site. 
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Figure 1.4: Schematic overview of a single V-J recombination event and associated 
protein factors, resulting in the generation of coding joint diversity. 
RAG complex recognize recombination signal sequences (12-RSS and 23-RSS, 
represented by triangles) and catalyze DNA nicking at those sites. Non-homologoes end 
joining components (Ku70/86, DNAPKcs, Artemis) are recruited to the site of DNA 
damage. The nick is converted to a hairpin structure that is processed. Palindromic (P) 
nucleotide additions result from off-center hairpin opening. TdT catalyzes random 
template independent N-additions at the coding end. NHEJ proceeds to align, trim and fill 
in gaps at the coding end. Ligation via DNA ligase IV in complex with XRCC4 proceeds 
to generate a unique coding joint. Circular signal joint is generated following blunt 
ligation of DNA found in between V and J gene segments. Figure adapted from (22). 
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Section 1.3: TdT and its role in autoimmunity 
TdT's connection to immune disorders has been widely investigated in mice 
animal models. Delayed onset of TdT expression during onto genesis is evident due to the 
difference in N-region diversity in B and T cell receptor repertoire among newborn 
versus adult mice (45, 55). Gavin and Bevan were among the first to demonstrate that 
TdT-knockout mice lacking N-additions resulted in significant loss of BCR specificity 
towards peptide antigens compared to TdT positive mice. Moreover, TdT positive 
animals were able to recognize a broader spectrum of antigen mimics than TdT-knockout 
mice (56). Numerous studies have been conducted in autoimmune mouse models.Band 
T cell reactivity towards self antigens results in autoimmunity. In this case, B and T cell 
receptors are activated and initiate an adaptive immune response against self molecules in 
the absence of a true pathogen. TdT deficient lupus-prone mice demonstrated prolonged 
lifespan along with decreased severity of disease symptoms, specifically reduction of 
acute liver inflammation and occurrence of skin lesions associated with lupus, suggesting 
that N addition resulted in specificities in their BCRs that in these mice, rendered them 
more susceptible to early onset lupus (57, 58). Similarly, research with TdT-deficient 
nonobese diabetic mice showed a decrease in type I diabetes incidence when compared to 
littermates with active TdT and hence N addition in their antigen receptors (59). Molano 
et.al. argue that TdT presence correlates with higher autoantibody production causing 
disease (60). Thus, there is strong evidence that TdT-deficient mice experience a milder 
course or a lower incidence of autoimmune diseases. 
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TdT expression was also shown to be linked to cancer and response to 
chemotherapy. TdT overexpression is noted in Band T cell acute lymphocytic leukemias 
(ALL) and acute myeloid leukemia (AML). More than 90% of ALL leukemic cells show 
high TdT activity. In fact, remission rates of TdT-positive patients are two-fold lower as 
compared to TdT-negative patients (2, 61, 62). The exact role of TdT in these cancers has 
not been determined, however research is being conducted to develop anti-cancer drugs 
in the form of TdT-specific inhibitors. For instance, synthetic non-nucleoside diketo 
hexenoic acid (DK.HA) derivative was shown to allosterically inhibit TdT activity and 
suppress cell proliferation of TdT-positive leukemic cells (62). Therefore, nontoxic 
selective TdT inhibitors have the potential to be employed in anti-leukemic 
chemotherapy. 
Section 1.4 Single nucleotide polymorphisms 
Genetic variations in the form of single nucleotide polymorphisms (SNPs) are 
common in the human population. These variations can be found in an appreciable (> 1 % ) 
number of individuals. In fact, SNPs have been estimated to occur in l out of every 1,000 
bases in the human genome (63, 64). SNPs can occur within gene's introns or exons. 
Those that are located within an exon may affect the protein-coding region. SNPs are 
divided into two general types: synonymous and non-synonymous. Synonymous SNPs do 
not affect the amino acid sequence of the translated protein, while non-synonymous SNPs 
result in a change in amino acid. Non-synonymous SNPs located at the protein-coding 
region have the potential to alter the structure and/or function of the encoded protein. 
SNPs have been link to disease susceptibility. One of the notable examples is sickle cell 
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anemia that results from a non-synonymous SNP in ~-globin gene. A glutamine to valine 
amino acid change (A to T base change) affects haemoglobin polymerization with itself 
to form protein aggregates under low oxygen conditions. This in tum distorts red blood 
cell shape and decreases their elasticity, leading to ischemia (65, 66). 
To date hTdT SNPs have not been studied. However, research has been conducted 
on RAG-1 single nucleotide changes. As mentioned earlier, RAG proteins are the key 
components responsible for initiation of V(D)J recombination. One type of Omenn 
Syndrome, resulting in severe immunodeficiency characterized by activated and self-
reactive T-cells along with low levels of lymphocytes in the blood, has been shown to be 
associated with RAG protein SNPs. For instance, Villa et. al. identified specific non-
synonymous RAG- I SNPs in Omenn syndrome patients causing decreased DNA binding 
activity to recombination specific signals, which lower the overall efficiency of V(D)J 
recombination ( 67, 68). 
Due to advances in genome sequencing technologies, SNP databases are 
continuously updated to include recent genotyping data. There are a number of SNP 
databases available, such as the National Center for Biotechnology Information (NCBI) 
SNP database and the international HapMap Project database. Genetic variation in the 
form of SNPs is thought to allow researchers to identify genes that may predispose 
individuals to disease, thus may be potentially used as markers in personalized medicine 
(63). 
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Section 1.5 Thesis objectives 
My thesis work aims to characterize the enzymatic activities of naturally 
occurring human TdT polymorphisms that result in single amino acid change within TdT 
short isoform. Junctional diversity generated by TdT during the process of V(D)J 
recombination is crucial in obtaining widely diverse antigen receptor repertoire of the 
adaptive immunity. It is now evident that genetic variations in the form of SNPs are able 
to contribute to individual differences in a population. Functional activity differences in 
various polymorphic forms of hTdT may affect the adaptive immune response of 
individual human carriers to foreign pathogens and susceptibility to immune-related 
disorders. Therefore, the goal of my thesis is to explore the possible effects of hTdT 
SNPs on V(D)J recombination and subsequent effects on the level of diversity within the 
adaptive immune system. My thesis includes identification of hTdT SNPs that may 
potentially alter the enzyme's activity and characterization of their in vitro polymerase 
function. In vivo V(D)J recombination assays were conducted to investigate the ability of 
hTdT variants to generate a diverse coding joint population as compared to the wild type 
polymerase and the potential effects ofhTdT SNPs on the antigen receptor diversity. 
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Chapter 2: Materials and Methods 
Section 2.1 Selecting hTdT SNPs for study 
The National Center for Biotechnology Information (NCBI) SNP database was 
used in the selection of potential hTdT short isoform SNP candidates for the study within 
the coding region of the protein (NCBI reference NP _004079.3). First, all known hTdT 
SNPs in the human population that resulted in a single amino acid change of the protein 
were identified. The identified SNPs were classified based on a number of criteria to 
select for those candidates hypothesized to affect hTdT function, namely chemical nature 
of the amino acid change and modeling of the relative proximity of the SNP to the TdT 
active site using PyMol software. In addition, TdT multi-sequence alignment of other 
species was completed. Based on the above criteria, the best hTdTS SNP candidates were 
chosen for this study. The results of SNP analysis are detailed in Chapter 3, Table 3.1. 
Section 2.2 Plasmid hTdTS DNA construction 
2.2.1 Bacterial expression vector construction via site-directed mutagenesis 
Bacterial pl5TV-L expression vector containing wild-type hTdTS cDNA in place 
of SacB gene (GenBank accession EF456736) was provided by Irakli Dzneladze, a 
previous laboratory member. The expression vector contains an N-terminal fusion tag of 
six Histidine residues ( 6xHis) and has T7 promoter driven expression of recombinant 
protein, in this case wild-type hTdTS (Figure 2.1 ). The expression of recombinant protein 
is under the regulatory response to lactose. In the absence of l1actose, the Lac repressor 
protein encoded by the lac! gene prevents the transcription of downstream gene. 
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However, when lactose or its metabolite Isopropyl ~-D-1-thiogalactopyranoside (IPTG) 
is present it binds to the Lac repressor and in turn triggers transcription of the 
downstream gene and subsequent translation to its protein product. 
SacB gene".. 
BseRI (s:BJ) 
Ndel(5300) 
p151V-L 
7746 bp 
T7promotcr 
N-tenninal tag 
N-tenniruil cloning site 
C-tenniruil cloning site 
T7 terminator 
bla coding sequence 
pBR322 qrigin 
lac/ coding sequence 
:racB coding sequence 
Figure 2.1: p15TV-L vector map (GenBank accession EF456736). 
5230-5246 
5317-5379 
5365-5379 
7395-7409 
7488-7534 
209-1066 
1827 
3764-4843 
5901-7319 
The vector contains T7 promoter region, N-terminal tag, two cloning sites, T7 terminator, 
ampicillin resistance gene, pBR322 origin of replication and lacl geme that codes for lac 
repressor. Wild type hTdTS cDNA was inserted in place of SacB gene, downstream of 
T7 promoter region. 
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Site directed mutagenesis (SDM) protocol (QuickChange® by Agilent 
Technologies) was utilized to produce point mutations in wild-type hTdTS p15TV-L 
expression vector corresponding to the chosen six hTdT SNP candidates. 
Table 2.1: Site-directed mutagenesis primers used to generate point mutations in wild-
type hTdTS cDNA, corresponding to selected hTdTS SNPs. 
Primer Primer Sequence Melting Name Temp. 
A445T F 5' CTACGAGCGTCGTGCCTTTACCCTGTTGGGATGG 70.8°C 
A445T R 5' CCATCCCAACAGGGTAAAGGCACGACGCTCGTAG 70.8°C 
L397S F 5' CCTAGCAGGAAGGTTGATGCTTCGGATCATTTTCAAAAGTGC 68.8°C 
L397S R 5' GCACTTTTGAAAATGATCCGAAGCATCAACCTTCCTGCTAGG 68.8°C 
R431C F 5' GGAAGGCCATCTGTGTGGATTTAGTTCTGTGCCCC 69.5°C 
R431C R 5' GCACAGAACTAAATCCACACAGATGGCCTTCCAGG 68.8°C 
R460Q F 5' GCAGTTTGAGAGAGACCTCCAGCGCTATGCCAC 69.8°C 
R460Q R 5' GTGGCATAGCGCTGGAGGTCTCTCTCAAACTGC 69.8°C 
T450S F 5' GCCCTGTTGGGATGGTCTGGCTCCCGGCAG 72.9°C 
T450S R 5' CTGCCGGGAGCCAGACCATCCCAACAGGGC 72.9°C 
D280H F 5' CTCTGAGTAAAGTAAGGTCGCACAAAAGCCTG 73.1°C 
D280H R 5' CGACCTTACTTTACTCAGAGAAGACTTTGG 67.5°C 
Each SDM PCR reaction was set up as follows; lx reaction buffer (lOmM KCl, 
lOmM (Nl1i)2S04, 20mM Tris-HCl (pH 8.8), 2mM MgS04, 1% Triton® X-100, 0.1 
mg/ml BSA), 0.2mM dNTP mix, lOOng WT hTdTS p15TV-L vector, 150ng specific 
primer DNA, 0.4µ1 PfuTurbo DNA polymerase (2.SU/µl) and dH20 up to 20µ1. The 
reactions were cycled according to the PCR program in Table 2.2. Each reaction was 
allowed to proceed through 6 PCR cycles, followed by combination of Forward and 
Reverse primer SDM reactions into one reaction. An extra 0.5 µl PfuTurbo DNA 
polymerase (2.5U/µl) was added to the combined reaction and total volume was adjusted 
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to 50µ1 using dH20. The combined PCR reaction was allowed to proceed for the 
remaining 20 PCR cycles. 
Table 2.2: Site-directed mutagenesis PCR program parameters. 
Step Temperature Duration 
Denaturation 95°C 5 minutes 
Denaturation 95°C 45 seconds 
26 cycles Annealing 55°C I minute 
Extension 68°C 20 minutes 
Final extension 68°C 30 minutes 
Completed SDM PCR reactions were then digested with 20U of Dpnl restriction 
enzyme (New England BioLabs) at 37°C overnight to degrade non-mutated, methylated 
parental DNA template in the reactions. The digested DNA samples were ran on 0.7% 
agarose gel followed by DNA gel extraction protocol (Qiagen's QIAEXII gel extraction). 
The DNA was eluted into 20µ1 dH20. Next, bacterial transformation of 25µ1 of E.Coli 
DH5a electrocompetent cells with 2.5µ1 of the Dpnl-digested DNA was performed at 
l 700V (Biorad's Gene Pulser electoporator). The transformation mix was plated on 
Luria Bertani (LB) agar plates (lOg/l NaCl, 5g/l yeast extract, lOg/l tryptone and 15g/l 
agar in dH20) containing I OOµg/ml ampicillin. Bacterial plates were incubated at 37°C 
overnight. Bacterial colonies were picked from each plate and inoculated in 5ml LB 
media containing I OOµg/ml ampicillin at 37°C overnight, shaking at 250rpm. The DNA 
from the pl5TV-L expression vectors carrying SNPs of hTdTS cDNA were purified from 
the overnight culture using Qiagen's QIAprep Spin Miniprep kit. The purified vector 
DNA was ran on 0.7% agarose gel and SDM was verified through sequencing of the 
recovered hTdTS cDNA pl5TV-L vectors using hTdTS-specific primer SQ-TdT-974 
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(5' CCTTGTCAGCTGTGTGACCA ) capable of binding to nucleotide position 974 of 
hTdTS cDNA (note; the selected hTdTS SNPs are positioned downstream of nucleotide 
position 974). The generated p15TV-L hTdTS SNPs expression vectors were later used 
in hTdTS protein purification. 
2.2.2 Mammalian expression vector construction via restriction site infusion based 
cloning 
In vivo functional TdT activity studies required mammalian hTdTS expression 
vector. Cloning of hTdTS cDNA into pcDNA ™4/myc-His A vector was performed via 
restriction site based infusion. This pcDNA vector is 5075 base pairs long and contains 
single Hindlll and Xhol restriction cut sites within its multiple cloning region (Figure 
2.2). Restriction endonuclease digest reactions of hTdTS wild type, A445T, L397S, 
R431C cDNA p15TV-L vectors and pcDNA ™4/myc-His A vector were set up as 
follows. Uncut p15TV-L: lµg WT hTdTS p15TV-L and lxNEB Buffer 2 adjusted to 
50µ1 with dH20. HindIII cut p15TV-L; lµg hTdTS p15TV-L, lxNEB Buffer 2, 10 units 
HindIII (NEB) adjusted to 50µ1 with dH20. Xhol cut p15TV-L; lµg hTdTS p15TV-L, 
lxNEB Buffer 4, lxBSA, 10 units Xhol (NEB) adjusted to 50µ1 with dH20. Uncut 
pcDNA; lµg pcDNA and lxNEB Buffer 2 adjusted to 50µ1 with dH20. HindIII cut 
pcDNA; lµg pcDNA, lxNEB Buffer 2, 10 units HindIII (NEB) adjusted to 50µ1 with 
dH20. Xhol cut pcDNA; 1 µg pcDNA, lxNEB Buffer 4, lxBSA, 10' units Xhol (NEB) 
adjusted to 50µ1 with dH20. HindIII and Xhol double digested pcDNA; 1 µg pcDNA, 
lxNEB Buffer 2, lxBSA, 10 units HindIII (NEB), 10 units Xhol adjusted to 50µ1 with 
dH20. All restriction digest reactions were incubated at 37°C overnight. 
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Figure 2.2: Features of pcDNA ™4/myc-His A, B, C 5.1 kb vectors (Adapted from 
Invitrogen pcDNA ™4/myc-His A, B, C User Manual, catalog no.V8'63-20). 
A. Map of pcDNA ™4/myc-His A, B, C vectors and the common functional features 
of the vectors (shown in the tabl~ 
B. Multiple cloning site of pcDNA 4/myc-His A. Hind: III and Xho I cleavage sites 
used to clone hTdTS cDNA into the mammalian vector are circled in red. hTdTS 
cDNA containing pcDNA vector is about 6.5 Kb. 
Bacterial p15TV-L expression vectors containing wild type, A445T, L397S and 
R431 C hTdTS cDNA were used to amplify the cDNA region using PCR extension 
primers designed to contain HindIII and Xhol restriction endonuclease cut sites for later 
insertion into pcDNA backbone. 
Table 2.3: PCR infusion primers used to amplify hTdTS cDNA. The forward primer 
contains Hindlll restriction cut site ( 5' AAGCTT), while the reverse primer contains Xhol 
restriction cut site (5' CTCGAG), shown in bolded font below. 
Primer name Primer Sequence Melting Temp. 
pcDNA _Infusion F 5' GTTTAAACTTAAGCTTGCCATGGATCCACCACGAGCG 68.2°C 
pcDNA Infusion R 5' GCCCTCTAGACTCGAGCTAGGCATTTCTTTCCCACGG 71.5°C 
The PCR reaction was set up as follows; O.lµg hTdTS cDNA p15TV-L vector, Ix 
Pfu buffer supplemented with MgS04 (20mM Tris-HCl (pH 8.8 at 25°C), 1 OmM 
(NHi)2S04, lOmM KCl, O.lmg/ml BSA, 1% (v/v) Triton X-100, 2mM MgS04), 0.2mM 
dNTP mix, 50pmol pcDNA_Infusion_F, 50pmol pcDNA_Infusion_R, 0.5µ1 Pfu DNA 
polymerase (2.5U/µl) and dH20 up to 50µ1. The reactions were cycled according to the 
PCR program in Table 2.4. 
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Table 2.4: PCR program parameters for amplification of hTdTS cDNA based on 
restriction site based cloning. 
Step Temperature Duration 
Denaturation 95°C 5 minutes 
30 cycles 
Denaturation 95°C 45 seconds 
Annealing 75°C 1 minute 
Extension 10°c 5 minutes 
Final extension 10°c 20 minutes 
The generated hTdTS cDNA PCR products were then double digested with 
HindIII and Xhol restriction endonucleases. The restriction digest reaction was set up as 
follows; 50µ1 of generated hTdTS cDNA PCR product, lxNEB buffer 2, lxBSA, 20 
units HindIII, 20 units Xhol and dH20 up to 60µ1. In addition, pcDNA vector was also 
set up for double digestion; pcDNA 2µg, lxNEB buffer 2, lxBSA, 20 units HindIII, 20 
units Xhol and dH20 up to 50µ1. Reactions were incubated at 37°C overnight. The 
digested reactions were purified using Qiagen's QIAquick PCR purification protocol and 
the DNA was eluted in 15µ1 dH20. 
The purified hTdTS cDNA PCR inserts digested with HindIII and Xhol 
restriction endonucleases were ligated into HindIII and Xhol digested pcDNA backbone 
at 1 :3 ratio of vector to insert. The ligation reaction was set up as follows; 0.2µg 
Hindlll/Xhol digested pcDNA, 0.6µg Hindlll/Xhol digested hTdTS cDNA PCR insert, 
Ix T4 DNA Ligase reaction buffer (50mM Tris-HCl, IOmM MgCli, lmM ATP, IOmM 
DTT, pH 7.5 at 25°C), 400 units T4 DNA Ligase (NEB) and dH20 up to 20µ1. The 
ligation reactions were incubated at l 6°C overnight. 
Bacterial transformation of 5µ1 of the ligation reaction was transformed into 50µ1 
of DH5a. electrocompetent cells at 1700V. The transformation mixture was plated on LB 
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agar plates containing lOOµg/ml ampicillin. Bacterial plates were incubated at 37°C 
overnight. Bacterial colonies were picked from the plates and colony PCR was performed 
to identify the presence of the hTdTS cDNA insert in the pcDNA backbone. A single 
colony was picked and resuspended in 20µ1 dH20. PCR reaction was set up as follows; 
2µ1 template bacterial colony, 10µ1 Fermentas 2xPCR Master mix (Ix reaction buffer, 
0.05U/µl Taq DNA polymerase, 4mM MgCb, 0.4mM dNTP mix), 50pmol pcDNA_ 
lnfusion_F primer, 50pmol pcDNA_ Infusion_R primer and dH20 up to 20µ1. Colony 
PCR reactions were cycled according to parameters in Table 2.4. The generated PCR 
products were ran on 0.7% agarose gel to check for the purity and size of the DNA 
product. Verified bacterial colonies were inoculated in 5ml LB containing I OOµg/ml 
ampicillin at 3 7°C overnight, shaking at 250rpm. Mammalian pcDNA vectors containing 
wild type, A445T, L397S, R43 l C hTdTS cDNA were purified from the overnight culture 
using Qiagen's QIAprep Spin Miniprep kit. The purified vector DNA was ran on 0.7% 
agarose gel and its size was verified though restriction digest with either HindIII or Xhol 
restriction endonucleases, as previously described. Single point mutations in hTdTS 
cDNA were verified through sequencing using SQ-TdT-974 primer. The correct hTdTS 
pcDNA clones were then amplified as according to Qiagen plasmid Maxi purification 
protocol. 
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Section 2.3 hTdT His-tag protein purification 
Bacterial p15TV-L hTdTS SNPs expression vectors were tramsformed into E.coli 
BL21 cells to express the different protein variants. hTdT protein variants containing N-
terminal His-tag were purified through nickel affinity chromatography and used for in 
vitro functional studies. 
2.3 .1 Heat-shock transformation of competent BL21 cells 
BL21 competent cells were thawed on ice. hTdTs p15TV-L vector (50ng) was 
mixed with 25 µl BL21 cells and incubated for 45 seconds at 42°C water bath. The 
transformation mix was then immediately placed on ice for 10 minutes followed by the 
addition of 200µ1 LB media to the transformation mix. The reaction was then incubated 
for 1 hour at 37°C, shaking at 250rpm. The reaction content was then transferred to 
bacterial 15ml conical tube containing 5ml LB with lOOµg/ml ampicillin and incubated at 
37°C overnight, shaking at 250rpm. Glycerol stock of overnight BL21 cultures were 
prepared by mixing 500µ1 bacterial culture with 500µ1 50% (v/v) glycerol and stored at 
-80°C. 
2.3.2 Induction of hTdT protein expression 
Transformed BL21 overnight cultures (5ml culture) were transferred into 1 litre 
LB medium containing lOOµg/ml ampicillin and grown at 37°C, shaking at 200rpm, for 
about 4 hours until the absorbance reading at 600nm (00600) reached 1.0. Protein 
expression was induced with the addition of 1 ml of 1 M IPTG to the 1 litre bacterial 
culture. The culture was then incubated at l 6°C overnight, shaking at 200 rpm. 
28 
2.3.3 hTdT protein purification via nickel affinity chromatography 
Note: the following purification protocol was performed at 4°C and all buffers were kept 
on ice. 
IPTG-induced overnight BL21 culture was centrifuged at 1,500xg for 30 minutes 
at 4°C. The bacterial pellet was resuspended in freshly prepared Lysis buffer (50mM Tris 
pH 7.5, 500mM NaCl, lOmM imidazole, lmM benzamidine, 0.5mM 
phenylmethylsulfonyl fluoride (PMSF), lmM ~-mercaptoethanol (BME)) (about 1 Oml 
Lysis buffer per lg bacterial pellet). The bacterial cells were further lysed by sonication 
for 8 minutes (0.5 seconds pulse on, 2 seconds pulse off at 30% amplitude) on ice. A 
sample of the crude lysate (50µ1) was taken for analysis using sodium dodecyl sulfate 
polyacrylamide (SDS-PAGE) gel electrophoresis. The lysed cells were centrifuged at 
25,000xg for 30 minutes at 4°C. Nickel-nitrilotriacetic acid (Ni-NTA) metal-affinity 
chromatography resin was equilibrated with freshly prepared Wash buffer (50mM Tris 
pH 7.5, 500mM NaCl, 20mM imidazole, lmM benzamidine, 0.5mM PMSF, lmM 
BME). This was done by adding 50ml Wash buffer to the resin, centrifuging at 500xg for 
5 minutes at 4°C and discarding the Wash buffer. The supernatant was then incubated 
with equilibrated Ni-NTA resin (3.5ml resin per 5g bacterial pellet) in a chromatography 
column for 1 hour at 4 °C, slowly rocking, to allow for binding of the resin with His-
tagged hTdT protein. The flow-through was decanted from the column (50µ1 of flow-
through sample was taken for analysis on SDS-PAGE gel). The column was washed 3 
times with 50ml of Wash buffer. The wash fractions were checked for protein absence by 
mixing 10µ1 of each wash fraction with 100µ1 Bradford reagent (Biorad). The wash 
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fraction samples were also collected for SDS-PAGE analysis. Elution of His-tagged 
hTdT protein was done by adding 500µ1 aliquots of freshly prepared Elution buffer 
(50mM Tris pH 7.5, 500mM NaCl, 500mM imidazole, lmM benzamidine, 0.5mM 
PMSF, lmM BME) to the column at and checking for protein presence using Biorad's 
Bradford reagent. The elution fractions that showed deep blue color using Bradford 
protein assay were collected in al 5ml falcon tube on ice. The final elution sample was 
collected for analysis on SDS-P AGE gel. 
2.3.4 hTdT protein dialysis into storage buffer 
Eluted hTdT protein collected in Elution buffer was transferred into a dialysis bag 
and submerged into 500ml of TdT storage buffer (50mM K.P04, 1 OOmM NaCl, 1.43mM 
BME, 50% glycerol, 0.1% Triton X-100 pH 7.3 at 25°C). The storage buffer recipe was 
prepared as according to commercial recombinant TdT protein (NEB #M0315S) storage 
buffer. Dialysis proceeded at 4 °C overnight with gentle stirring. The dialysis buffer was 
changed the next day followed by additional 3 hour dialysis. The dialyzed hTdT protein 
was aliquot on ice and stored as 100µ1 aliquots at -80°C. In vitro functional activity 
assays were carried out using freshly thawed hTdT protein aliquots. 
2.3.5 Analytical SDS-PAGE electrophoresis of hTdT protein purification 
Following protein purification, SDS-P AGE gel electrophoresis was performed as 
follows. The collected 50µ1 samples of crude lysate, flow-through, wash and elution were 
mixed with 10µ1of6x SDS-PAGE loading dye (0.03% bromophenol blue, 0.03% xylene 
cyanol FF, 60% glycerol, 1% SDS, lOOmM EDTA (pH 7.6)). The samples were boiled at 
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95°C for 5 minutes and span down. A total of 1 Oµl of each sample was loaded onto 12% 
SDS-PAGE gel along with 6µ1 of protein standard ladder (PageRuler Unstained Broad 
Range- Thermo Scientific #26630). The gel was ran for 1 hour at l 80V followed by gel 
staining using Coomassie staining solution (50% methanol, 10% glacial acetic acid, 3g/l 
Coomassie Brilliant Blue dye in dH20) for 1 hour. The gel was destained overnight in 
Destain solution ( 40% methanol, 10% acetic acid in dH20). 
Section 2.4 In vitro hTdT functional activity assays 
2.4.1 General polymerase activity assay setup 
The in vitro polymerization activity of purified wild type hTdTS was tested and 
compared to commercially available recombinant TdT from calf thymus (NEB 
#M0315S). TdT protein was incubated at 37°C with a single stranded oligonucleotide 
that is fluorescently labeled at the 5' DNA end with a Cy3 label (Cy3 oligo 
5' Cy3-CTACTGGTACTTCGATCTCTGGGGCCGTGACGC) along with dNTP mix in 
lxTdT reaction buffer (50mM potassium acetate, 20mM Tris-acetate, lOmM magnesium 
acetate at pH 7.9 at 25°C), supplemented with 0.25mM CoC}i. A typical TdT 
polymerization reaction included; 0.3nM Cy3 oligo, O. l 5mM dNTP mix, 0.25mM CoCh, 
lxTdT reaction buffer, 3.4µM purified wild type hTdT protein for a total reaction volume 
of 30µ1 with dH20. Reaction with recombinant calf TdT was set up in the same manner 
using 20 units of polymerase. Reaction master mix was incubated at 37°C to allow TdT 
to add nucleotides to substrate oligo and 30µ1 aliquots were taken at various time points. 
The reactions were stopped by the addition of 30µ1 TdT stopping buffer (95% 
formamide, 50mM EDTA, 0.05% bromophenol blue),' thus inactivating the polymerase 
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via chelating its metal ion. All reactions were carried out using standardized amount of 
protein using Biorad's Bradford protein assay. The completed TdT reactions were then 
boiled for 5 minutes and placed on ice to denature any duplex DNA. The samples were 
then loaded onto 10% denaturing TBE-urea gel ( 40% acrylamide, 7M urea, 1 xTBE 
(89mM Tris, 89mM boric acid, 2mM EDTA pH 8.0), 10% ammonium persulfate, 
Tetramethylethylenediamine). A total of 10µ1 of each TdT reaction was loaded on a gel 
along with 6µ1 of DNA ladder (GeneRuler™ DNA Ladder, Ultra Low Range, Fermentas 
#SM1213). The denaturing TBE-urea gel was ran at 180V for 1.5 hours at 4°C. In order 
to visualize the DNA ladder, the gel was stained for 15 minutes in 1: 10,000 dilution of 
SYBR® Green I Nucleic Acid Gel Stain (Invitrogen #87567). The gel was then scanned 
by the Typhoon Imager to visualize Cy3-labelled DNA (scanning done at excitation 
wavelength of 532nm, emission wavelength of 580nm). 
Note; preliminary purified hTdTS titration and dNTPs titration experiments were 
performed to determine the optimal amount of polymerase for in vitro functional assays. 
2.4.2 dNTP substrate preference polymerase activity assay 
The utilization of deoxyribonucleotide triphosphates (dNTPs) by hTdTS variants 
was tested. The assay was set-up as described in section 2.4.1, however instead of dNTP 
mix the reactions were supplemented with either of the single dNTPs; namely dATPs, 
dTTPs, dCTPs or dGTPs. 
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2.4.3 DNA substrate preference polymerase activity assay 
The type of DNA substrate was varied under the same reaction condition (section 
2.4.1). Purified hTdTS variants were supplied with either 0.3nM of single stranded 33 
nucleotide long Cy3 oligo, a double stranded 33 nucleotide long Cy3 oligo having a blunt 
ends or a double stranded 33 nucleotide long Cy3 oligo having a 3' end overhang of 6 
nucleotides (Table 2.5). 
The double stranded Cy3 oligo substrates were obtained by annealing the single 
stranded Cy3-labelled oligo to unlabelled sequence complementary DNA oligo. The 
annealing reactions were performed by first boiling I :3 equimolar ratio of single stranded 
Cy3 labelled oligo to single stranded unlabelled complementary oligo for I 0 minutes. 
This reaction mix was allowed to slow-cool for about an hour. The annealed DNA 
product was then ready for use. 
Table 2.5: DNA sequences of DNA substrates used for in vitro DNA substrate 
preference polymerase assay. 
Single stranded Cy3 oligo 5' Cy3-CTACTGGTACTTCGATCTCTGGGGCCGTGACGC 
Double stranded blunt end Cy3 5' Cy3-CTACTGGTACTTCGATCTCTGGGGCCGTGACGC 
oligo GATGACCATGAAGCTAGAGACCCCGGCACTGCG 
Double stranded 3' overhang end 5' Cy3-CTACTGGTACTTCGATCTCTGGGGCCGTGACGC 
Cy3 oligo GATGACCATGAAGCTAGAGACCCCGGC 
2.4.4 DNA substrate sequence preference polymerase activity assay 
The polymerase activity of purified wild type hTdTS was investigated using two 
single stranded Cy3-labelled oligos with different base sequences. Oligo I sequence of 33 
bases is found at the beginning of the human immunoglobulin heavy chain J2 region 
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(IGHJ2); whereas oligo 2 sequence of 33 bases is complementary to the oligo 1 sequence 
(Figure 2.3). The assay was set-up as described in section 2.4.1 supplemented with either 
0.3nM Oligo 1 or Oligo 2. 
Note; all of the in vitro polymerase activity assays were performed using single stranded 
Cy3-labelled oligo 1 sequence unless otherwise stated. 
Substrate oligo 1 5' Cy3-cta ctg gta ctt cga tct ctg ggg ccg tga cgc 33nt long 
Substrate oligo 2 5' Cy3-gtg cca egg ccc cag aga tcg aag tac cag tag 33nt long 
Nanomer 23-bp heptamer IGHJ2 
5' gtg ttt ttg tat ggg aga age agg agg gca gag get gtg1•ct."ctg gta ctt cqa tct ct9 ggg ccg tgg cac J•_ 
3' cac aaa aac ata ccc tct tcg tee tee cgt etc cga cac gat gac cat gaa get aga gac ccc ggc ace gtg*5' ... 
Figure 2.3: Sequences of Cy3-labelled oligo 1 and 2 used for in vitro DNA substrate 
sequence preference polymerase activity assay. Germline sequence of human 
immunoglobulin heavy chain 12 region flanked by 23-RSS region (adapted from NCBI 
database) shown at the bottom. Star (*) indicates Cy3 fluorescent label. 
2.4.5 Cofactor preference polymerase activity assay 
The type of divalent cofactor supplemented m the TdT reaction, specifically 
cobalt and magnesium was investigated. The assay was set-up as described in section 
2.4.1, supplemented with either 0.25mM CoCh or 0.25mM MgCb. 
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Section 2.5 In vivo V(D)J recombination assay 
2.5.1 Assay overview 
Analysis of in vivo functional activity differences between wild type hTdT and its 
polymorphic forms was carried out using an extrachromosomal V(D)J recombination 
substrate assay in human mammalian cells that lack endogenous TdT expression (Figure 
2.4). The set up of the assay involved transfection of mammalian hTdTS expression 
vector (pcDNA ™4/myc-His A), vectors expressing human RAGl and RAG2 proteins 
(pEBG-hRAG 1 and pEBG-hRAG2) along with recombination substrate plasmid 
(pGG51) into human mammalian cells not expressing TdT (human embryonic kidney 
cells; HEK293T). HEK293T cells were chosen for the assay due to their relative fast 
proliferation and transfection efficiency. The cells were tested for hTdT expression at the 
RNA and protein level (see below in section 2.5.2 and 2.5.3). 
Human RAG 1 and RAG2 expression vectors (pEBG-hRAG 1 and hRAG2) were 
obtained from Dr. Patricia Q. Cortes, Mount Sinai Medical School, New York. These are 
mammalian expression vectors that contain human RAG I core and C-terminus cDNA 
(amino acid 384-1040) and human RAG2 full length cDNA (amino acid 1-527). pEBG 
vector contains human elongation factor 1 alpha (EF-1 a) promoter. It is a glutathione-S-
transferase (GST) fusion vector, thus hRAGI and hRAG2 proteins contain a GST tag. 
The presence of the tag was previously shown not to affect recombination efficiency (69). 
Once RAG proteins and hTdT are expressed in the mammalian cells following 
transfection, the recombination substrate plasmid is able to undergo recombination 
similarly to V(D)J recombination process in T and B lymphocytes (Figure 2.5). The 
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substrate plasmid pGG5 l was generously supplied by Dr. Patricia Q. Cortes at the Mt 
Sinai School of Medicine, New· York and Dr. Michael R. Lieber at the University of 
Southern California, USA (70, 71) (Figure 2.6). The substrate is 6284 base pairs long, 
containing two recombination signal sequences (RSSs ); RSS with a 12 base pair spacer 
(12-RSS) and a second RSS with a 23 base pair spacer (23-RSS). A prokaryotic 
transcriptional termination sequence is found in between 12-RSS and 23-RSS regions 
which causes transcription elongation complex to pause and fall off the DNA template 
due to a stem-loop structure generated by its GC-rich sequence. The pGG51 plasmid 
contains a gene encoding for chloramphenicol acetyltransferase (cat) located downstream 
of the transcriptional stop, which confers chloramphenicol-resistance in bacteria. 
Expression of chloramphenicol acetyltransferase is driven by the prokaryotic trp 
promoter generally responsible for tryptophan biosynthesis. In addition, the plasmid 
contains a gene encoding for ~-lactamase (amp) which confers ampicillin-resistance in 
bacteria, located upstream of the RSS region. Additional features of pGG51 substrate 
plasmid include simian virus 40 (SV 40) eukaryotic replication origin and prokaryotic Col 
El replication origin that allow the plasmid to replicate in both mammalian and bacterial 
cells. 
As RAG-mediated recombination occurs, RSS region along with the 
transcriptional stop signal are excised out and form a signal joint. The recombined 
substrate plasmid forms a coding joint, thus allowing for expression of chloramphenicol-
resistance gene. The newly recombined substrate plasmid confers both ampicillin and 
chloramphenicol resistance in bacteria. Its coding joint sequence may then be analyzed. 
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Figure 2.4: Overview of the in vivo extrachromosomal recombination assay. Human 
mammalian cells are first transfected with three mammalian expression vectors (hTdTS, 
hRAGl and hRAG2) along with substrate plasmid (pGG51). After a 48 hour incubation, 
the DNA is harvested and transformed into bacterial cells for later selection on ampicillin 
and chloramphenicol containing bacterial plates for recombined substrate plasmid. In the 
last stage, ampicillin and chloramphenicol resistant colonies are picked and the 
recombined substrate plasmid is purified. The coding joint of the recombined substrate 
plasmid is analyzed through sequencing. 
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Figure 2.5: General design of the recombination substrate plasmid for in vivo assay. The 
unrecombined plasmid shown in top left contains a transcriptional terminator sequence 
flanked by a pair of recombination signal sequences (RSS). If the substrate does not 
undergo recombination, transcription of chloramphenicol-resistant gene is prevented by 
the transcriptional terminator. However, if recombination occurs, the RSS region along 
with the transcriptional terminator is excised out and a coding joint forms in its place. 
The transcription of the chloramphenicol-resistance gene is allowed to proceed. Thus, the 
recombined substrate plasmid, shown in bottom left, confers both ampicillin and 
chloramphenicol resistance. 
38 
I' 
trp Promoter 
--~~~~--...A.....--~~~~~-
F or ward Primer t:°35 BOX -10 BOX°' 
TTGTCGATGAATTCCCCTG ATTAATCATCGAACTAGlllllllllllilATACGCAGCTTGGCTG 64 
12-RSS 
CAGGTCGAC~~CTACAGACTGGl\f@~~CTGCAGTCGACTCTCA~CGATGGGGGA 128 
TCAACGACCCCCCATTCAAGAACAGCAAGCAGCATTGAGAACTTTGilllllllllllllllllltl 192 
Prokaryotic Transcriptiona1 Stop 
256 
lllllllllllllllllllllllllllA'TTGGTGAGAATCGCAGCAACTTGTCGCGCCAATCGA 320 
23-RSS 
GCCATGTCGTCGTCGATCCTCTCATCGATGAGAGGATCCCGA~Tirliir(@iAQAGCCAGACAG 384 
Reverse Primer 
TGGAGTACTAC~~GGATCCCCGGGGATCAGCTTGGCGAGATTTTCAGGAGCTAAGGAAG 448 
Chloramphenicol Resistance Gene: 
CT 512 
Figure 2.6: Substrate recombination plasmid pGG51 sequence features. pGG51 is a 
recombination substrate plasmid (6284 bp). It contains a trp promoter region consisting 
of -35 and -10 box (highlighted in green). It also contains a 12-RSS region consisting of a 
heptamer (7 bp, highlighted in yellow), followed by a 12 bp spacer and a nanomer (9 hp, 
highlighted in yellow). A 23-RSS region also consist of a nanomer (highlighted in 
yellow), followed by a 23 bp spacer and a heptamer (highlighted in yellow). Prokaryotic 
transcriptional stop sequence (highlighted in red) is found between the RSS pair region. 
Chloramphenicol-resistance gene (highlighted in pink) is downstream of the 23-RSS 
region and its expression is driven by the trp promoter. pGG51 forward and reverse 
primers (undersigned in blue) are used to identify recombined plasmid. 
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2.5.2 Reverse transcriptase PCR 
Reverse transcriptase PCR (RT-PCR) was performed ito test :«or endogenous TdT 
production in HEK293T cells. The cells were passaged ~or at !~east a week prior 
transfection in DMEM/high glucose media (Sigma Aldrieh's Duilibecco's Modified 
Eagle's Medium - high glucose with 4500 mg/I glucose,'L-glut~mine, and sodium 
bicarbonate) supplemented with 10% fetal bovine serum (FIBS) at 37°C and 5% C02• 
Cells were seeded for transfection in 60mm tissue culture dislies at ,...;:80-90% confluency 
in a total volume of 2.5ml culture media. One hour prior to transfection, cells were 
washed with warm lxPBS (137mM NaCl, 2.7mM KCI, 10mM:Na2HP;Q4, 2mM KH2P04) 
and fresh culture media was added for a total volume of2.5ml per 60mm dish. HEK293T 
cells were transfected with either substrate recombination. plasmid pGG5 l, empty 
pcDNA ™4/myc-His A vector, wild type hTdTS pcDNA Thf4/myc-His A expression 
vector or co-transfected with pGG5 l plasmid, wild type hTdTS pcDNA, pEBG-hRAG 1 
and hRAG2 expression vectors. 
Per transfection, 2.5 µg DNA was gently resuspended in 100µ1 serum-free culture 
media in an eppendorf tube. In a different eppendorf tube, 7.5µ1 Poly-Jet™ DNA 
transfection reagent (FroggaBio #SL100688.l) was resuspended in 100µ1 serum-free 
culture media. Diluted Poly-Jet™ reagent was immediately added to diluted DNA and 
pipetted up and down few times to mix. The transfection mix was incubated for 15 
minutes at room temperature to allow Poly-Jet™/DNA complexes to form. The 
transfection mix was then added drop-wise to the media in the culture dish and gently 
swirled to mix. The transfected cells were incubated at 3 7°C and 5% C02 for 6 hours. Six 
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hours post-transfection, cells were washed with warm 1 xPBS and fresh culture media 
was added for a total volume of 2.5ml per 60mm dish. 
HEK293T cells were then harvested 48 hours post-transfection and total RNA 
was extracted using TRizol® Reagent (lnvitrogen by Life Technologies #15596-026). 
Appropriate precautions were taken to avoid RNase contamination. As control, RNA 
from non-transfected HEK293T cells was also harvested. First, culture media was 
removed from the culture dish and lml of TRizol® Reagent was added to each 60mm 
dish. The cells were lysed through pipetting up and down few times to homogenize the 
samples and transferred to a clean tube. The homogenized samples were then incubated 
for 5 minutes at room temperature. To each sample 0.2ml of chloroform was added 
followed by vigorous hand shaking for 15 seconds. The samples were incubated for 2-3 
minutes at room temperature and centrifuged at 12,000xg for 15 minutes at 4°C. The 
aqueous upper layer of the mixture was removed after the spin and placed in a clean tube. 
Total RNA was precipitated after the addition of 0.5ml 100% isopropanol to the aqueous 
layer, followed by incubation for 10 minutes at room temperature. The samples were then 
centrifuged at 12,000xg for 10 minutes at 4°C. The supernatant was removed and the 
RNA pellet was washed with lml of 75% ethanol (in DEPC-treated water), vortexed 
briefly and centrifuged at 7,500xg for 5 minutes at 4°C. The supernatant was discarded 
and the centrifugation step was repeated to remove any residual ethanol. The RNA pellet 
was then air dried for 5-10 minutes and resuspended in 20µ1 of RNase-free water. The 
resuspended RNA was then incubated on a heat block set at 55-60°C for 10-15 minutes. 
The recovered RNA sample was immediately used in a downstream RT-PCR protocol. 
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Reverse transcription reaction was set up using ThermoScript™ RT-PCR system 
(Invitrogen by Life Technologies #11146-024). First cDNA synthesis reaction was set up 
in a PCR tube containing 150ng of RNA sample, 50µM 01ligo (dT)2o primer, 1.5mM 
dNTP mix and DEPC-treated water for a total volume of 12µ1. The reaction was 
incubated at 65°C for 5 minutes in a thermocycler to denature the sample and then placed 
on ice. Next, cDNA synthesis mix was added to the reaction (4µ1of5xcDNA synthesis 
buffer, lµl of 0.lM DTT, 40 units of RNaseOUT™, 15 units of ThermoScript™ RT, 
DEPC-treated water up for a total volume of 8µ1). The 20µ1 cDNA reaction was 
incubated in a thermocycler for 50 minutes at 50°C, followed by reaction termination for 
5 minutes at 85°C. 
PCR amplification reaction of target cDNA was set up using hTdTS gene-specific 
primers that were designed to span an intron-exon boundry (DNTT_F and DNTT_R 
5'CACCAGCTTGTTGTGAGAAGAGAC, S'CTCTCTCAAACTGCCGGGAGCCAGT, 
respectively). A single PCR reaction included 2µ1 cDNA, lxreaction buffer (1 OmM Tris-
HCl (pH 9.0), 50 mM KCl, 1% Triton X-100, l.5mM MgC}i), 50pmol DNTT_F and 
DNTT_R primers, 0.2mM dNTP mix, 2.5 units EconoTaq® DNA Polymerase (Lucigen 
#30031-1) and dH20 for a total reaction volume of 50µ1. Negative PCR control reaction 
did not include cDNA template, while the positive PCR control reaction included 0.25 µg 
wild type hTdTS pcDNA expression vector as template DNA. The PCR reactions were 
cycled according to parameters in Table 2.6. Following PCR amplification, the reaction 
products were ran on 0. 7% agarose gel stained with ethidium bromide and visualized 
under UV light. 
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Table 2.6: PCR program parameters for amplification of hTdTS cDNA following cDNA 
synthesis via Reverse transcriptase. 
Step Temperature Duration 
Denaturation 95°C 2 minutes 
Denaturation 95°C 45 seconds 
30 cycles Annealing 75°C 1 minute 
Extension 70°C 3 minutes 
Final extension 70°C 15 minutes 
2.5.3 Western blotting procedures 
Endogenous hTdT expression was also tested at the protein level by Western blot 
using rabbit polyclonal TdT specific antibody (Novus Biologicals #NBPl-58254) raised 
against N-terminal peptide sequence of TdT gene (FQDLVVFILEKKMGTTRRAFLMEL 
ARRKGFRVENELSDSVTHIVAENNSG). HEK293T cells were transfected with either 
wild type hTdTS pcDNA ™4/myc-His A expression vector or co-transfected with 
substrate recombination pGG51 plasmid, wild type hTdTS pcDNA, pEBG-hRAG 1 and 
hRAG2 expression vectors. The transfections were performed with Poly-Jet™ DNA 
transfection reagent in 60mm culture dishes as described in section 2.5.2. Note, culture 
media was supplemented with caffeine for a final concentration of 1 mM 6 hours post-
transfection. 
HEK293T cells were harvested 48 hours post-transfection. As experimental 
control, non-transfected HEK293T cells were also harvested. First, cells were washed 
with warm lxPBS. Cells were then resuspended in 2.5ml lxPBS and transferred to a 
clean 15ml falcon tube. The cells were spun at 500xg for 5 minutes at room temperature 
and the supernatant was removed. The cell pellet was resuspended in 75µ1 RIPA Lysis 
buffer (150mM NaCl, 50mM Tris pH 8.0, 0.5% NP-40, Ix protease inhibitor) and 
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transferred to a clean eppendorf tube. The samples were incubated for 20 minutes at 4 °C 
on a rotator. The cells were then further lysed by sonication (0.5 second pulse on, 2 
seconds pulse off, at 10% amplitude for a total pulse time of 3 seconds). The lysed 
samples were centrifuged at 22,500xg for 5 minutes at 4 °C. The supernatant was 
transferred to a clean eppendorf tube and total protein concentration was measured using 
Bradford reagent. A total of 85 µg of protein per sample was measured and boiled for 5 
minutes prior to loading onto freshly prepared 12% SDS-PAGE gel. 
The protein samples were loaded onto 12% SDS-PAGE gel along with pre-
stained protein marker (Thermo Scientific PageRuler #26616). The gel was ran for 150V 
until the dye front reached the bottom of the gel. The proteins were then set up for a 
transfer onto a nitrocellulose membrane that was activated in 100% methanol. The 
transfer was conducted overnight at 30V at 4 °C. After the transfer, the membrane was 
blocked in lxPBST (137mM NaCl, 2.7mM KCl, lOmM Na2HP04, 2mM KH2P04, 0.1% 
Tween-20 pH 7.4) containing 5% milk (w/v) for 2 hours, on a rocker, at room temperate. 
The membrane was then cut in half and the top portion was probed with 1: 1,000 dilution 
of rabbit polyclonal TdT specific antibody (Novus Biologicals #NBPl-58254) in milk, 
while the bottom portion was probed with 1 :5,000 dilution of mouse monoclonal IgG 
GAPDH specific antibody (Santa Cruz Biotech #SC-47724) in milk. The membrane was 
incubated in primary antibody for 1 hour, on a rocker, at room temperature. The 
membrane was then washed for 5 minutes with lxPBST. The wash was repeated twice 
more. The top portion of the membrane was probed with 1: 10,,000 dib1tion of anti-rabbit 
horseradish peroxidase (HRP)- conjugated antibody (Promega #W4011) in milk. The 
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bottom portion of the membrane was probed with 1: 10,000 dilution of anti-mouse IgG 
HRP-conjugated antibody (Promega #W 4021) in milk. The secondary antibody 
incubation proceeded for 1 hour, on a rocker, at room temperature. The membrane was 
then washed for 20 minutes with lxPBST. The wash was repeated twice more. The 
membrane was then washed with Clarity™ Western ECL substrate (Biorad #170-5060) 
and transferred into a western blot cassette to be kept in the dark. The membrane was 
then developed in the dark by exposing western blotting film directly onto a membrane, 
followed by film development. 
2.5.4 Mammalian cell transfection for the V(D)J recombination assay 
HEK293T cells were transfected with Poly-Jet™ DNA transfection reagent in 
60mm culture dishes as described in section 2.5.2. Each transfection was composed of 
0.62µg substrate recombination pGG51 plasmid, 0.62µg pEBG-hRAG 1 expression 
vector, 0.62µg pEBG-hRAG2 expression vector and 0.62µg wild type hTdTS (or other 
hTdTS variant) pcDNA ™4/myc-His A expression vector for a total of 2.5µg DNA per 
transfection. Note, culture media was supplemented with caffeine for a final 
concentration of lmM 6 hours post-transfection. A total of 8 independent HEK293T cell 
transfection sets were performed. Culture media supplemented with 1 mM caffeine post 
transfection was shown to increase recombination frequency, at least five fold, by 
increasing expression levels of RAG proteins (72, 73). 
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2.5 .5 Harvesting plasmid DNA via alkaline lysis 
Substrate plasmid DNA was harvested 48 hours post-transfection via alkaline 
lysis methods. The cells were washed with warm lxPBS, resuspended in 2.5ml lxPBS 
and transferred to a clean l 5ml falcon tube. The cells were spun at 500xg for 5 minutes at 
room temperature and the supernatant was removed. The pellet was then washed with 
cold I xPBS and cells were centrifuged at 500xg for 5 minutes at room temperature. The 
supernatant was removed and pellet was gently resuspended in 400µ1 of Lysis buffer (50 
mM glucose, 25 mM Tris-HCl pH 8.0, I 0 mM EDTA in dH20) and transferred into a 
clean tube. Freshly prepared 800µ1 of alkaline solution (0.2 M NaOH, 0.6% SDS in 
dH20) was added to the cell lysate. The solution was gently inverted 6 times and left on 
ice for 4 minutes. To the solution, 600µ1of7.5M ammonium acetate was added and the 
tube were gently inverted to mix and left on ice for I 0 minutes to precipitate protein and 
chromosomal DNA. Next, the solution was centrifuged at 20,000xg for 15 minutes at 
4 °C. The supernatant was transferred to a tube containing I OQ% ethanol at about twice 
the volume of supernatant and incubated at -80°C for 45 minutes to precipitate plasmid 
DNA. Next, the solution was centrifuged at 20,000xg for 25 minutes at 4°C. The 
precipitated DNA pellet was washed twice with I ml of ice cold 70% ethanol and 
centrifuged at 20,000xg for 5 minutes at 4 °C. The supernatant was removed and the 
pellet was air dried for I 0 minutes and resuspended in 44µ1 of water. 
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2.5 .6 Dpnl digest of harvested plasmid DNA 
Dpnl digest was carried out in order to remove any unreplicated DNA plasmid 
from the harvested DNA samples. Dpnl restriction enzyme cleaves methylated adenines 
in 5' GATC base pair sequence, thus digesting unreplicated DNA plasmid in transfected 
HEK293T cells. To each of the resuspended plasmid DNA samples, 20 units of Dpnl 
restriction enzyme (New England BioLabs #R0176S) and lxNEBuffer 4 (20mM Tris-
acetate, 50mM potassium acetate, lOmM magnesium acetate, and lmM DTT, pH 7.9 at 
25°C) were added for a total volume of 50µ1. The restriction digest reaction was 
incubated at 37°C for two hours. To each sample 200µ1 of 100% ethanol and 40µ1 of 
7 .SM ammonium acetate were added. The samples were incubated at -80°C for 30 
minutes followed by centrifugation at 20,000xg for 15 minutes at 4 °C. The DNA pellet 
was washed with 500µ1of70% ethanol and centrifuged at 20,000xg for 5 minutes at 4°C. 
The wash was repeated twice more and the DNA pellet was allowed to air dry for 10 
minutes. The plasmid DNA was resuspended in 6µ1 of dH20 and used in subsequent 
bacterial transformation. 
2.5.7 Transformation of harvested plasmid DNA via electroporation 
The harvested pGG5 l substrate plasmid from each transfection was transformed 
into E.coli ElectroMAX™ DHIOB™ Cells (lnvitrogen #18290-015). Competent cells 
were thawed on ice and 25 µI of cells were aliquot to a pre-chilled eppendorf tube and 
mixed with 2.5 µI of freshly harvested plasmid DNA for each transformation reaction. 
The mixture was transferred into a dry pre-chilled 0.1 cm BioRad electroporation cuvette 
and pulsed at l 700V using Gene Pulser electoporator. Immediately, lml of pre-warmed 
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SOC medium (20g/l tryptone, 5g/l yeast extract, 0.5g/l NaCl, 2.5mM KCl, 1 OmM MgCb, 
and 20mM glucose) was added to the cells and mixed gently. The mixture from was 
transferred to a clean 15ml falcon tube and incubated 1 hour at 37°C, shaking at 200rpm. 
After incubation, each of the electroporation samples was used to plate onto pre-warmed 
LB agar plates containing either lOOµg/ml ampicillin (AMP pfates) or 33µg/ml 
chloramphenicol and lOOµg/ml ampicillin (CAM/AMP plates). Per each transformation, 
300µ1 of transformation reaction was plated per every CAM/ AMP for a total of 3 plates. 
In addition, 100µ1 of 1: 100 and 1 :500 dilution of transformation reaction were plated on 
AMP plates. All plates were incubated at 37°C overnight or for one full day, as needed, 
to allow colony growth. The number of colonies on each plate was counted and recorded. 
2.5.8 Colony PCR 
Bacterial colonies from CAM/ AMP plates were picked and colony PCR was 
performed in order to select for true recombined substrate pGG51 plasmids. A single 
colony was picked and resuspended in 20µ1 dH20. A PCR reaction was set up using 
pGG51 forward and reverse primers (shown in Figure 2.6) were used to identify 
recombined plasmid. Recombined substrate plasmid was expected to produce PCR 
product of about 100 base pairs, while the non-recombined plasmid produced PCR 
product of about 400 base pairs. A single PCR reaction included 2µ1 bacterial colony 
DNA template, 10µ1 PCR master mix (Thermo Scientific #KOl 71), 0.25µg of each of 
pGG51 forward and reverse primers and dH20 for a total reaction volume of 20µ1. The 
PCR reaction was cycled as per program in Table 2.7. The PCR products were ran on 2% 
agarose gel, stained with ethidium bromide and visualized under UV light. Only the 
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recombined bacterial colonies were inoculated overnight in 5ml LB containing 1 OOµg/ml 
ampicillin. The recombined pGG5 l substrate plasmid was purified from the overnight 
culture via QIAprep® Miniprep kit (Qiagen #27106). 
Table 2.7: PCR program parameters for colony PCR of recombination pGG51 substrate 
plasmid. 
Step Temperature Duration 
Denaturation 95°C 5 minutes 
Denaturation 95°C 45 seconds 
30 cycles Annealing 53°C 1 minute 
Extension 72°C 2 minutes 
Final extension 72°C 15 minutes 
2.5.9 Recombination data analysis 
The analysis of V(D)J recombination assay included calculating recombination 
frequency (also known as R-value) and sequencing recombined substrate plasmid to 
analyze the arbitrary complementary-determining region (CDR). The R-value represents 
the ratio of the total number of double-resistant (ampicillin and chloramphenicol 
resistance) colonies post transformation and the total number of ampicillin resistant 
colonies. The ampicillin resistant colonies represent the total number of bacterial cells 
that have been transformed with the substrate pGG5 l plasmid, while the double-resistant 
colonies represent the total number of substrate plasmids that undergone RAG-mediated 
recombination. The equation for calculation ofR-value is shown below. 
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R-value (%) = 
The total number of AMP + CAM resistant colornies in a 
specific volume of undiluted transformation sample 
The total number of AMP resistant colonies in the same 
volume of undiluted transformation sample 
x 100% 
The harvested recombined pGG51 substrate plasmid was sequenced using pGGS 1 
forward primer (5' TTGTCGATGAATTCCCCTGT) (Shown in Figure 2.6) in order to 
examine the recombined coding joint. Analysis was performed on the following 
parameters: number of nucleotide deletions and additions (palindromic and random 
nucleotide additions), frequency of nucleotide additions, AT versus GC base content, the 
distribution of number of N-nucleotide additions per recombined joint and the length of 
arbitrary complementary determining region (CDR). The analysis was performed to 
determine if there was a statistical difference between different populations of wild-type 
and hTdTS variant generated joints. The difference between two groups was considered 
statistically significant if the p-value obtained was less than 0.05. The analysis was 
performed using SPSS statistical analysis and data management system. In this study, 
repeated recombined pGG51 substrate sequences within the same mammalian 
transfection were excluded from the analysis due to the possibility of plasmid replication 
in mammalian cells after recombination. 
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Chapter 3: Results 
The objective of my research is to determine whether naturaUy occurring variants 
of a human polymerase, TdT, have differences in their activity, and hence function. TdT 
is a non-template dependent polymerase that is needed to generate the high level of 
diversity found in the receptors that recognize pathogens, specifically, the diversity 
generated in the CDR3 regions during the process of V(D)J recombination of the B cell 
and T cell receptor genes. I investigated the functions of the identified variant hTdTS 
using two different approaches, namely, biochemical kinetic analyses and in vivo 
functional V(D)J recombination assays. This chapter details my characterization of 
potential functional variants, including their cloning and expression, their function in 
biochemical assays, and finally their in vivo functions in generating diversity in the 
Immune System. 
Section 3.1 hTdT SNPs 
The NCBI SNP database was used to map a total of 62 SNPs of hTdTS isoform 
(1530 base pairs long, 509 amino acid residues) (Appendix A). Among these, 24 SNPs 
were not considered in the study since they all localized in the BRCA 1-C terminus of the 
protein not associated with TdT polymerase activity (Appendix A, first 24 SNPs). 
Another 12 synonymous SNPs were discarded since they did not result in an amino acid 
change. Thus, a total of 26 missense SNPs were screened based 0n a number of criteria to 
identify the top hTdTS variants I would use for activity studies. First, the TdT protein 
sequence homology across species was considered. A total of 20 TdT protein sequences 
from 18 different species including mouse, zebrafish and rat were multi-aligned using 
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BioEdit software (Figure 3.1). The residues that were highly conserved at the SNP 
positions across all species were hypothesized to be significant for TdT structure and 
possibly its function. Secondly, the chemical nature of the amino acid change was 
considered. 
SNPs resulting in significant changes in amino acid chemical property, such as 
negatively to positively charged amino acid residue were hypothesized to have a greater 
effect on the protein and its function as compared to less significant changes, such as 
substituting one polar residue for a different polar residue. The third screening process 
included modeling of the SNP residue change using the available crystal structure of 
murine TdT via PyMol Mutagenesis wizard software (note, the human TdT structure has 
not been determined to date). This provides structural information of the SNP residue and 
the proximity of the mutation to the polymerase active site, composed of three highly 
conserved aspartic acid residues, D343, D345 and D434, and two cation metal binding 
sites (Figure 3.2). 
A total of six hTdTS SNPs were identified for further characterization of their 
effects on the polymerase activity (Table 3.1 ). R431 C, R460Q and T450S SNPs are 
localized in close proximity to the active site of the polymerase (Figure 3 .2, Panel C). 
T450S SNP is part of the polymerase dNTP-binding site. In addition, A445T SNP is 
within 8A of the incoming ddA TP substrate, is also located within the same dNTP-
binding site (Figure 3.2, Panel C). L397S SNP is positioned within the loop region shown 
to associate with template independent polymerase activity (Figure 3.2, Panel B). D280H 
SNP was chosen as an experimental control due to its location at the periphery of the 
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protein, away from the active site, and thus was hypothesized not to affect TdT activity 
(Figure 3.2, Panel B). Next, in vitro and in vivo functional activity assays were carried 
out to compare activity of these SNPs to the wild-type TdT protein. 
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SCLTFMRAAS VLRSLPFTII SMRDIEGIPC LEDKAKCVIE EIIEDGESSE VRTVLNDERY QSFRLFTSVF GVGLKTSEKW FRMGFRTLSK IRSDKTLRFT 
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RLRLPSRRVD ALDHFQRCFL IFRLPRQRVD ------SDQS SWQEGRTWRA IRVOLVLCPY ERRAFALLGW TGSR-FERD·L RRYATHERRM ILDNHALYDR 
RFRQPSRRVD ALDHFQRCFL ILRLDHGRVH ------SERS GQQEGRGWRA IRVDLVMCPY DRRAFALLGW TGSRQFERD'L RRYATHERRM MLDNHALYDR 
RFRQPSRRVO ALDHFQRCFL ILRLDHGRVH ------SERS GQQEGKGWRA IRVOLVMCPY DRRAFALLGW TGSRQFERD'L RRYATHERRM MLDNHALYOR 
RFRLPSRQVD TLDHFQRCFL ILRLHHQRVD ------SSRS NQQEGKTWRA IRVDLVMCPY ENRAFALL1)W TGSRQFERDI RRYATHERRM MLDNHALYDl'I: 
LRQLPNHRFE AMDRFSRCFL LVKLQMQ--- ---------- ESRTGRNWRA VRVOLVAPPL ERFPYALLGW TGSTLFERDL RRFARLERGR LLDNHTLYDl'I: 
RFRLPSRRVD ALDHFQRCFL ILRLHRGLVR ------SEES GQQEGRDWRA IRVDLVMCPY ERRAFALLf)W TGSRQFERDL RRYATHERRM MLDNHALYDR 
REQIPSRHVD AMDHFQRCFA ILRLYQPRVD NSSYNMSRRC DMAEVRDWl'l:A IRVOLVITPF EQYAYALLl3W TGSRQFGROL RRYATHERRM MLDNHALYDR 
DLRLPSRRID ALOHFQRCFL ILRLYHBRED RRRWEMPTGS NESEARSWRA IRVOLVVCPY DRYAFALLpW SGSRQFERDL RRYATHERRM MLDNHALYDR 
ETRLPSRHVO ALDHFQRCFT ILRLPRRQMD IG---NIIDP HECERRNWl'l:A VRLDLVITPY EQYPYALLGW TGSRQFIERDL RRYATHEKRM MLDNHGLYDR 
VSRLPSCRFE DMDCFQRCFL ILRLEQGQVE GE---RGLQR DPGDSRGWRA VRVDLVAPPV DRYAFALLGW TGS-RFGRl>L RTFAQRERQM LLONHALYDK 
RLRLPSRRVD ALOBFQRCFL IFRLPRQRVD ------SDQS SWQEGRTWRA IRVDLVLCPY ERRAFALLtW TGSRQFEROL RRYATHERRM ILDNHALYDR 
RLRLPSRRVO ALDHFQRCFL IFRLPLQRVD ------SDQS SWQEGRTWRA IRVOLVMCPY ERRAFALLGW TGSRQFEROL RRYATHERRM ILONHALYDR 
RLRLPSRRVO ALDHFQRCFL IFRLPRQRVO ------GDQS SWQEGRTWRA IRVDLVLCPY ERRAFALLCIW TGSRQFERDL RRYATHERRM ILDNHALYDl'I: 
RLRLPSRRVD ALDHFQRCFL IFRLPRQRVD ------SDQS SWQEGRTWRA IRVOLVLCPY ECRAFALL$W TGSRQF!!Rli>L RRYATHERRM ILDNHALYDR 
RLRLPSRRVD ALDHFQRCFL ILRLHHQRVD ------GGRC SQQEGRTWRA IRVDLVMCPY ERRAFALLc&W TGSR-FERDL RRYASHERRM ILDNHALYDR 
RFRLPSRRVD ALDHFQRCFL ILRLYHQRVG ------SDES SQQEGRGWRA IRVDLVMCPY DRRAFALLGW TGSRQFERDL RRYATHERRM MLDNHALYDK 
RLRLPSRRVD ALDHFQRCFL IFRLPRQRLD ------SDQP SWQBGRTWRA IRVDLVMCPY ERRAFALLGW TGSRQF!Jq\)L RRYATHERRM ILONHALYDR 
RLRQPSRRVO ALDHFQRCFL ILRLPHERVD ------SDRP SQQEGRNWRA IRVDLVMCPY ECHAFALLGW TGSRQFERli>L RRYATHERRM ILONHALYDR 
RSRLPSRRVO ALDHFQRCFL ILRLHHQRVD ------SGRS SQQBGRTWRA IRVDLVVCPY ENHAFALLGW TGSR-FERDL RRYATHERRM ILDNHALYDl'I: 
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.... l····I .... 1 .... 1 ····1 .... 1 ····l .. ··I ····l····I 
TR-------- ---------- --RIFLRAES EBBIFAHLGL DYIEPWBRNA 
TR-------- ---------- --RIFLRAES E!BIFAHLGL DYIKPWBRNA 
TRGRTVTISP LDGRVSRLQR ALRVFLEAES EEEIFAHLGL DYIBPWERNA 
TR--------
TR--------
TT--------
TR--------
RR--------
TR--------
TR--------
TR--------
TR--------
TR--------
TR--------
TR--------
TR--------
TR--------
TR--------
TR--------
TR--------
--RVFLEAES BBS:IFAHLGL DYIEPWERNA 
--RVFLRAES EBBIFABLGL DYIBPWERNA 
--RTFLPANT EEDIFQHLGL EYIEPWQRNA 
--RVFLEABS EBEIFABLGL DYIEPWERNA 
--RVFLRAGS EBBIFABLGL DYVEPWERNA 
--RIFLRARS BBEIFAHLGL EYIQPSBRNA 
--NNFLRANN EBDIFRQLGL DYLEPWERNA 
--RLCLLATT BEDIFTHLGL EYVEPWQRNA 
--RIFLRAES EEEIFABLGL DYIBPWERNA 
--RIFLRAES BBBIFAHLGL DYIEPWERNA 
--RIFLRAES BBBIFAHLGL DYIEPWERNA 
--RIFLRAES EEEIFAHLGL DYIBPWERNA 
--RIFLRAES EEBIFABLGL DYIEPWERNA 
--RVFLEADS EEBIFABLGL DYIEPWERNA 
--RIFLRABS EEEIFTHLGL DYIEPWERNA 
--RMFLQAES EEEIFABLGL DYIEPWERNA 
--RIFLRAES EEEIFABLGL DYIEPWERNA 
54 
Figure 3.1: Multi-sequence alignment of TdT amino acid sequences from 18 different 
species available at NCBI database using BioEdit software.1. Black errors represent the 
location of amino acid change in hTdT isoform 1 caused by the identified SNPs. Red 
errors represent the top six candidates picked for the study. 
The species used in the multi-alignment, in order, are: gil630548501 TdT isoform 1 
[Homo sapiens], gil630548521 TdT isoform 2 [Homo sapiens], gill 127348471 TdT 
isoform 1 [Mus musculus], gill 127348411 TdT isoform 2 [Mus musculus], gil291352891 
TdT [Bos taurus], gil62414130l TdT [Danio rerio], g1il60223©471 TdT [Rattus 
norvegicus], gil4538238ll TdT [Gallus gallus], gil741365091 l'dT [Monodelphis 
domestica], gil1478997621 TdT [Xenopus laevis], gil1851321291 TdT [Oncorhynchus 
mykiss], gil55634423l TdT isoform 3 [Pan troglodytes], gill!09090095l TdT isoform 2 
[Macaca mulatta], gil332212412l TdT [Nomascus leucogenys], gil297687123l TdT 
[Pongo abelii], gil7399810ll TdT isoform 2 [Canis lupus familiaris], gil3544711271 TdT 
[Cricetulus griseus], gil296220892l TdT [Callithrix jacchus], gil29140455ll TdT 
[Oryctolagus cuniculus], gil338716705l TdT [Equus caballus]. 
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Table 3.1: Human TdT variant 1 Sl'TP candidates for functional activity assays, characterized based on mRNA position, base change, 
amino acid position and change, the chemical nature of the amino acid change, amino acid homology across species and their 
respective significance. 
SNPID mRNA position 
Base 
change 
Amino 
acid 
position 
Amino acid 
change 
Chemical nature 
of amino acid 
change 
Amino acid 
homology 
across species* 
Significance 
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*Amino acid homology across species is based on TdT amino acid sequence multi-alignment (Figure 3.1 ), shown as percentage of 
amino acid identity across 20 TdT protein sequences analyzed. 
**The genotype frequencies of abov~ SNPs do not exceed 2% of assayed cohort populations (according to the NCBI). 
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Figure 3.2: Crystal structure of murine TdT (PDB ID: lKEJ) and the relative positions of 
hTdTS SNPs. Figures generated using PyMol software. 
A. TdT secondary structure elements (alpha helices and ibeta strands) are shown. 
Three conserved aspartic acid residues are highlighted in green (D343, D435 and 
D434). The incoming nucleotide substrate, ddATP, is shown in orange. Two 
cobalt ions are colored cyan. 
B. TdT structure showing the relative positions of D280H and L397S. The positions 
of SNPs are superimposed on the wild type amino acid residues, shown in 
magenta. 
C. Active site of TdT showing the relative positions of R431 C, T450S, A445T and 
R460Q SNPs within 8A of incoming nucleotide substrate, ddATP. The positions 
of SNPs are superimposed on the wild type amino acid residues, shown in 
magenta. 
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Section 3.2 Plasmid hTdTS DNA construction 
The chosen six hTdTS SNPs candidates for the study were generated via site-
directed mutagenesis hTdTS cDNA in bacterial p15TV-L expression vector. Figure 3.3 
indicates the base change and position of the point mutations. Figure 3.4 shows the 
corresponding protein multi-sequence alignment of all six hTdTS variants. The generated 
p15TV-L hTdTS SNPs expression vectors were later used in hTdTS protein purification. 
Mammalian hTdTS pcDNA ™4/myc-His A expression vectors carrying specific 
point mutations were generated via restriction site infusion based cloning. Specifically, 
HindIII and Xhol restriction cut sites were used to insert hTdTS PCR product generated 
fro_m hTdTS cDNA p15TV-L vector into multiple cloning site of pcDNA ™4/myc-His A 
vector. Restriction digest DNA products shown in Figure 3.5 were used in mammalian 
expression vector construction. Bacterial p15TV-L vector contains a single HindIII and 
Xhol restriction cut site, thus upon digestion a single predominant band of about 7Kb is 
produced (note; the smaller size bands of the digestion represent, I believe, non-specific 
cutting by the restriction enzymes). Mammalian pcDNA vector also contains a single 
HindIII and Xhol cut site at its multiple cloning region separated by 7 4 base pairs from 
one another (Figure 2.2). Thus, upon Hindlll/Xhol double digest a single predominant 
band is seen around 5Kb. 
The final successfully cloned wild-type, L397S, R431 C and A445T hTdTS cDNA 
pcDNA expression vector were verified through sequencing (Figure 3.6) and used in 
subsequent functional activity assays. 
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1 ACACTTTGGC AGGAAGCTGT TGCCAGGGCA GCACCTGTGA AGCCCTGGCC 
51 TGGCTTCAGA GTCTGCTGGT GAGATGACAT CAAAACCCTT CGTGTAGGAG 
101 GGTGGCAGTC TCCCTCCCTT CTGGAGACAC CACCAGATGG GCCAGCCAGA 
151 GGCAGCAGCA GCCTCTTCCC ATGGATCCAC CACGAGCGTC CCACTTGAGC 
201 CCTCGGAAGA AGAGACCCCG GCAGACGGGT GCCTTGATGG CCTCCTCTCC 
251 TCAAGACATC AAATTTCAAG ATTTGGTCGT CTTCATTTTG GAGAAGAAAA 
301 TGGGAACCAC CCGCAGAGCG TTCCTCATGG AGCTGGCCCG CAGGAAAGGG 
351 TTCAGGGTTG AAAATGAGCT CAGTGATTCT GTCACCCACA TCGTAGCAGA 
401 GAACAACTCG GGTTCGGATG TTCTGGAGTG GCTTCAAGCA CAGAAAGTAC 
451 AAGTCAGCTC ACAACCAGAG CTCCTCGATG TCTCCTGGCT GATCGAATGC 
501 ATAAGAGCAG GGAAACCGGT GGAAATGACA GGAAAACACC AGCTTGTTGT 
551 GAGAAGAGAC TATTCAGATA GCACCAACCC AGGCCCCCCG AAGACTCCAC 
601 .CAATTGCTGT ACAAAAGATC TCCCAGTATG CGTGTCAGAG AAGAACCACT 
651 TTAAACAACT GTAACCAGAT ATTCACGGAT GCCTTTGATA TACTGGCTGA 
701 AAACTGTGAG TTTAGAGAAA ATGAAGACTC CTGTGTGACA TTTATGAGAG 
751 CAGCTTCTGT ATTGAAATCT CTGCCATTCA CAATCATCAG TATGAAGGAC 
801 ACAGAAGGAA TTCCCTGCCT GGGGTCCAAG GTGAAGGGTA TCATAGAGGA 
851 GATTATTGAA GATGGAGAAA GTTCTGAAGT TAAAGCTGTG TTAAATGATG 
901 AACGATATCA ATCCTTCAAA CTCTTTACTT CTGTATTTGG AGTGGGGCTG 
951 AAGACTTCTG AGAAGTGGTT CAGGATGGGT TTCAGAACTC TGAGTAAAGT 
1001 AAGGTCGGAC AAAAGCCTGA AATTTACACG AATGCAGAAA GCAGGATTTC 
1051 TGTATTATGA AGACCTTGTC AGCTGTGTGA CCAGGGCAGA AGCAGAGGCC 
1101 GTCAGTGTGC TGGTTAAAGA GGCTGTCTGG GCATTTCTTC CGGATGCTTT 
1151 CGTCACCATG ACAGGAGGGT TCCGGAGGGG TAAGAAGATG GGGCATGATG 
1201 TAGATTTTTT AATTACCAGC CCAGGATCAA CAGAGGATGA AGAGCAACTT 
1251 TTACAGAAAG TGATGAACTT ATGGGAAAAG AAGGGATTAC TTTTATATTA 
1301 TGACCTTGTG GAGTCAACAT TTGAAAAGCT CAGGTTGCCT AGCAGGAAGG 
1351 TTGATGCTTT GGATCATTTT CAAAAGTGCT TTCTGATTTT CAAATTGCCT 
1401 CGTCAAAGAG TGGACAGTGA CCAGTCCAGC TGGCAGGAAG GAAAGACCTG 
1451 GAAGGCCATC CGTGTGGATT TAGTTCTGTG CCCCTACGAG CGTCGTGCCT 
1501 TTGCCCTGTT GGGATGGACT GGCTCCCGGC AGTTTGAGAG AGACCTCCGG 
1551 CGCTATGCCA CACATGAGCG GAAGATGATT CTGGATAACC ATGCTTTATA 
1601 TGACAAGACC AAGAGGATAT TCCTCAAAGC AGAAAGTGAA GAAGAAATTT 
1651 TTGCGCATCT GGGATTGGAT TATATTGAAC CGTGGGAAAG AAATGCCTAG 
1701 GAAAGTGTTG TCAACATTTT TTTCCTATTC TTTTCAAGTT AAATAAATTA 
1751 TGCTTCATAT TAGTAAAAGA TGCCATAGGA GAGTTTGGGG TTATTTAGGT 
1801 CTTATTGAAA TGCAGATTGC TACTAGAAAT AAATAACTTT GGAAACATGG 
1851 GAAGGTGCCA CTGGTAATGG GTAAGGTTCT AATAGGCCAT GTTTATGACT 
1901 GTTGCATAGA ATTCACAATG CATTTTTCAA GAGAAATGAT GTTGTCACTG 
1951 GTGGCTCATT CAGGGAAGCT CATCAAAGCC CACTT'TGTTC GCAGTGTAGC 
2001 TGAAATACTG TCTATCTCTA ATAAAAACAG GAGGAAACAA AAAAAAAAAA 
2051 AAAAAAAAAA AAAAAAAAAA A 
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Figure 3.3: Homo sapiens deoxynucleotidyl transferase, terminal (DNTT), transcript 
variant 1, mRNA. NCBI Reference Sequence: NM_004088.3, GI:G3054849. Adapted 
from the NCBI database. 
hTdTS mRNA sequence is 2071 base pairs long. The coding region of hTdT is between 
171-1700 base pairs. The start (ATG) and stop (TAG) codons are shown in bolded font. 
The chosen hTdTS SNPs positions are shown in bolded font; 
• D280H; G to C point mutation at position 1008 
• L397S; T to C point mutation at mRNA position 1360 
• R431C; C to T point mutation at mRNA position 1461 
• A445T; G to A point mutation at mRNA position 1503 
• T450S; A to T point mutation at mRNA position 1518 
• R460Q; G to A.point mutation at mRNA position 1549 
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WT MDPPRASHLSPRKKRPRQTGALMASSPQDIKFQDLVVFILEKKMGTTRRAFLMELARRKG 60 
D280H MDPPRASHLSPRKKRPRQTGALMASSPQDIKFQDLVVFILEKKMGTTRRAFLMELARRKG 60 
L397S MDPPRASHLSPRKKRPRQTGALMASSPQDIKFQDLVVFILEKKMGTTRR:AFLMELARRKG 60 
R431C MDPPRASHLSPRKKRPRQTGALMASSPQDIKFQDLVVFILEKKMGTTRRAFLMELARRKG 60 
A445T MDPPRASHLSPRKKRPRQTGALMASSPQDIKFQDLVVFILEKKMGTTRRAFLMELARRKG 60 
T450S MDPPRASHLS PRKKRPRQTGALMAS S PQD I KFQDL VVFI LEKiKMGTTRRAFLMELARRKG 60 
R460Q MDPPRASHLSPRKKRPRQTGALMASSPQDIKFQDLVVFILEK'.KMGTTRRAFLMELARRKG 60 
************************************************************ 
WT FRVENELSDSVTHIVAENNSGSDVLEWLQAQKVQVSSQPELLDVSWLIECIRAGKPVEMT 120 
D280H FRVENELSDSVTHIVAENNSGSDVLEWLQAQKVQVSSQPELLDVSWLIECIRAGKPVEMT 120 
L397S FRVENELSDSVTHIVAENNSGSDVLEWLQAQKVQVSSQPELLDVSWLIECIRAGKPVEMT 120 
R431C FRVENELSDSVTHIVAENNSGSDVLEWLQAQKVQVSSQPELLDVSWLIECIRAGKPVEMT 120 
A445T FRVENELSDSVTHIVAENNSGSDVLEWLQAQKVQVSSQPELLDVSWLIECIRAGKPVEMT 120 
T450S FRVENELSDSVTHIVAENNSGSDVLEWLQAQKVQVSSQPELLDVSWLIECIRAGKPVEMT 120 
R460Q FRVENELSDSVTHIVAENNSGSDVLEWLQAQKVQVSSQPELLDVSWLIECIRAGKPVEMT 120 
************************************************************ 
WT GKHQLVVRRDYSDSTNPGPPKTPPIAVQKISQYACQRRTTLNNCNQIFTDAFDILAENCE 180 
D280H GKHQLVVRRDYSDSTNPGPPKTPPIAVQKISQYACQRRTTLNNCNQIFTDAFDILAENCE 180 
L397S GKHQLVVRRDYSDSTNPGPPKTPPIAVQKISQYACQRRTTLNNCNQIFTDAFDILAENCE 180 
R431C GKHQLVVRRDYSDSTNPGPPKTPPIAVQKISQYACQRRTTLNNCNQIFTDAFDILAENCE 180 
A445T GKHQLVVRRDYSDSTNPGPPKTPPIAVQKISQYACQRRTTLNNCNQIFTDAFDILAENCE 180 
T450S GKHQLVVRRDYSDSTNPGPPKTPPIAVQKISQYACQRRTTLNNCNQIFTDAFDILAENCE 180 
R460Q GKHQLVVRRDYSDSTNPGPPKTPPIAVQKISQYACQRRTTLNNCNQIFTDAFDILAENCE 180 
************************************************************ 
WT FRENEDSCVTFMRAASVLKSLPFTIISMKDTEGIPCLGSKVKGIIEEIIEDGESSEVKAV 240 
D280H FRENEDSCVTFMRAASVLKSLPFTIISMKDTEGIPCLGSKVKGIIEEIIEDGESSEVKAV 240 
L397S FRENEDSCVTFMRAASVLKSLPFTIISMKDTEGIPCLGSKVKGIIEEIIEDGESSEVKAV 240 
R431C FRENEDSCVTFMRAASVLKSLPFTIISMKDTEGIPCLGSKVKGIIEEIIEDGESSEVKAV 240 
A445T FRENEDSCVTFMRAASVLKSLPFTIISMKDTEGIPCLGSKVKGIIEEIIEDGESSEVKAV 240 
T450S FRENEDSCVTFMRAASVLKSLPFTIISMKDTEGIPCLGSKVKGIIEEIIEDGESSEVKAV 240 
R460Q FRENEDSCVTFMRAASVLKSLPFTIISMKDTEGIPCLGSKVKGIIEEIIEDGESSEVKAV 240 
************************************************************ 
WT LNDERYQSFKLFTSVFGVGLKTSEKWFRMGFRTLSKVRSDKSLKFTRMQKAGFLYYEDLV 300 
D280H LNDERYQSFKLFTSVFGVGLKTSEKWFRMGFRTLSKVRSHKSLKFTRMQKAGFLYYEDLV 300 
L397S LNDERYQSFKLFTSVFGVGLKTSEKWFRMGFRTLSKVRSDKSLKFTRMQKAGFLYYEDLV 300 
R431C LNDERYQSFKLFTSVFGVGLKTSEKWFRMGFRTLSKVRSDKSLKFTRMQKAGFLYYEDLV 300 
A445T LNDERYQSFKLFTSVFGVGLKTSEKWFRMGFRTLSKVRSDKSLKFTRMQKAGFLYYEDLV 300 
T450S LNDERYQSFKLFTSVFGVGLKTSEKWFRMGFRTLSKVRSDKSLKFTRMQKAGFLYYEDLV 300 
R460Q LNDERYQSFKLFTSVFGVGLKTSEKWFRMGFRTLSKVRSDKSLKFTRMQKAGFLYYEDLV 300 
***************************************.******************** 
WT SCVTRAEAEAVSVLVKEAVWAFLPDAFVTMTGGFRRGKKMGHDVDFLITSPGSTEDEEQL 360 
D280H SCVTRAEAEAVSVLVKEAVWAFLPDAFVTMTGGFRRGKKMGHDVDFLITSPGSTEDEEQL 360 
L397S SCVTRAEAEAVSVLVKEAVWAFLPDAFVTMTGGFRRGKKMGHDVDFLITSPGSTEDEEQL 360 
R431C SCVTRAEAEAVSVLVKEAVWAFLPDAFVTMTGGFRRGKKMGHDVDFLITSPGSTEDEEQL 360 
A445T SCVTRAEAEAVSVLVKEAVWAFLPDAFVTMTGGFRRGKKMGHDVDFLITSPGSTEDEEQL 360 
T450S SCVTRAEAEAVSVLVKEAVWAFLPDAFVTMTGGFRRGKKMGHDVDFLITSPGSTEDEEQL 360 
R460Q SCVTRAEAEAVSVLVKEAVWAFLPDAFVTMTGGFRRGKKMGHDVDFLITSPGSTEDEEQL 360 
************************************************************ 
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WT 
D280H 
L397S 
R431C 
A445T 
T450S 
R460Q 
WT 
D280H 
L397S 
R431C 
A445T 
T450S 
R460Q 
WT 
D280H 
L397S 
R431C 
A445T 
T450S 
R460Q 
LQKVMNLWEKKGLLLYYDLVESTFEKLRLPSRKVDALDHFQKCFLIFKLPRQRVDSDQSS 420 
LQKVMNLWEKKGLLLYYDLVESTFEKLRLPSRKVDALDHFQKCFLIFKLPRQRVDSDQSS 420 
LQKVMNLWEKKGLLLYYDLVESTFEKLRLPSRKVDASDHFQKCFLIFKLPRQRVDSDQSS 420 
LQKVMNLWEKKGLLLYYDLVESTFEKLRLPSRKVDALDHFQKCFLIFKLPRQRVDSDQSS 420 
LQKVMNLWEKKGLLLYYDLVESTFEKLRL"PSRKVDALDHFQKCFLIFKLPRQRVDSDQSS 420 
LQKVMNLWEKKGLLLYYDLVESTFEKLRLPSRKVDALDHFQKCFLIFKLPRQRVDSDQSS 420 
LQKVMNLWEKKGLLLYYDLVESTFEKLRLPSRKVDALDHFQKCFLIFKLPRQRVDSDQSS 420 
************************************ *********************** 
WQEGKTWKAIRVDLVLCPYERRAFALLGWTGSRQFERDLRRYATHERKMILDNHALYDKT 480 
WQEGKTWKAIRVDLVLCPYERRAFALLGWTGSRQFERDLRRYATHERKMILDNHALYDKT 480 
WQEGKTWKAIRVDLVLCPYERRAFALLGWTGSRQFERDLRRYATHERKMILDNHALYDKT 480 
WQEGKTWKAICVDLVLCPYERRAFALLGWTGSRQFERDLRRYATHERKMILDNHALYDKT 480 
WQEGKTWKAIRVDLVLCPYERRAFTLLGWTGSRQFERDLRRYATHERKMILDNHALYDKT 480 
WQEGKTWKAIRVDLVLCPYERRAFALLGWSGSRQFERDLRRYATHERKMILDNHALYDKT 480 
WQEGKTWKAIRVDLVLCPYERRAFALLGWTGSRQFERDLQRYATHERKMILDNHALYDKT 480 
********** *************:****:*********:******************** 
KRIFLKAESEEEIFAHLGLDYIEPWERNA 509 
KRIFLKAESEEEIFAHLGLDYIEPWERNA 509 
KRIFLKAESEEEIFAHLGLDYIEPWERNA 509 
KRIFLKAESEEEIFAHLGLDYIEPWERNA 509 
KRIFLKAESEEEIFAHLGLDYIEPWERNA 509 
KRIFLKAESEEEIFAHLGLDYIEPWERNA 509 
KRIFLKAESEEEIFAHLGLDYIEPWERNA 509 
***************************** 
Figure 3.4: Protein multi-sequence alignment of DNA nucleotidylexotransferase isoform 
1 [Homo sapiens] (NCBI Reference Sequence: NP _004079.3) with six chosen hTdTS 
SNPs. The positions of the point mutations are shown in bold; 
• D280H; Asp to His mutation at protein position 280 
• L397S; Leu to Ser mutation at protein position 397 
• R431 C; Arg to Cys mutation at protein position 431 
• A445T; Ala to Thr mutation at protein position 445 
• T450S; Thr to Ser mutation at protein position 450 
• R460Q; Arg to Gin mutation at protein position 460 
Star (*) represents fully conserved residues. 
Colon (:) represents strong conservation between residues. 
Gap ( ) represents non-conserved residues in the sequence alignment. 
Multi-sequence alignment generated using Clusta/W software. 
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Figure 3.5: Restriction digest of hTdTS wild type, A445T, L397S, R43 l C cDNA 
pl5TV-L vectors and pcDNA ™4/myc-His A vector. A total of 10µ1 of each 50µ1 
restriction digest reaction was ran on 0.7% agarose gel electrophoresis, stained with 
ethidium bromide and visualized under ultra-violet light. 
• Uncut WT pl5TV-L: lµg WT hTdTS pl5TV-L and lxNEB Buffer 2 adjusted to 
50µ1 with dH20. 
• HindIII cut pl5TV-L: lµg hTdTS pl5TV-L, lxNEB Buffer 2, 10 units HindIII 
(NEB) adjusted to 50µ1 with dH20. 
• Xhol cut p15TV-L: lµg hTdTS p15TV-L, lxNEB Buffer 4, lxBSA, 10 units 
Xhol (NEB) adjusted to 50µ1 with dH20. 
• Uncut pcDNA: lµg pcDNA and lxNEB Buffer 2 adjusted to 50µ1 with dH20. 
• HindIII cut pcDNA: I µg pcDNA, lxNEB Buffer 2, 10 units HindIII (NEB) 
adjusted to 50µ1 with dH20. 
• Xhol cut pcDNA: lµg pcDNA, lxNEB Buffer 4, lxBSA, 10 units Xhol (NEB) 
adjusted to 50µ1 with dH20. 
• HindIII+Xhol cut pcDNA: lµg pcDNA, lxNEB Buffer 2, lxBSA, 10 units 
HindIII (NEB), 10 units Xhol adjusted to 50µ1 with dH20. 
All restriction digest reactions were incubated at 3 7°C overnight. 
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R431C pcDNA 
ttillttdl0ttGttilill0GtGGlticJ0irubrctl!°~~o~Gicd0 
TCll.lTI'GCC TCGTCll.AGA GTGGACAGTG ACCAGTCCAG CI\'GGCAGGU GGllAGAOCf 
TCll.lTIGCC TCGTC.l.lAGA GTGGACAGTG ACCAGTCCAG CijGGCAGGll, GGllAGAOCf 
TCll.lTI'GCC TCGTCll.AGA GTGGACAGTG ACCAGTCCAG CliGGCAGGM\ GGllAGAOCf 
~fo~+ott~oim:h;.do~o~o 
GGllGGCCAT CCGTGTGGAT TIAGTICTGT GCCCCTACGA Gd;ra;n;cC TTioo::cTGT 
GGllGGCCAT CCGTGTGGAT TIAGTICTGT GCCCCTACGA GCGTcGrGa: TTIAa:cTGT 
GGllGGCCAT CTGTGTGGAT TIAGTICTGT GCCCCTACGA GCGTCG'l1D: TTI"oo::cTGT 
Figure 3.6: DNA multi-sequence alignment of cloned wild-type, L397S, R431 C and 
A445T hTdTS cDNA in the pcDNA ™4/myc-His A expression vector. Sequencing was 
carried out using SQ-TdT-974 primer. The positions of the single point mutations are 
represented by black arrows; L397S (T to C base change), A445T (G to A base change), 
R431 C (C to T base change). Generated using Bio Edit software. 
Section 3.3 hTdT His-tag protein purification 
Wild type hTdTS protein along with six selected hTdTS SNP candidate proteins 
were expressed in E.Coli BL21 and purified using nickel affinity chromatography. Figure 
3.7 depicts His-tag wild type hTdTS purification. A 58kDa predominant protein band is 
seen in the elution sample, corresponding to purified wild type hTdTS. The remaining six 
purified hTdTS protein variant SDS-PAGE gels can be found in supplementary figures of 
Appendix B. All of the seven purified hTdTS protein variants were visualized on an 
SDS-PAGE gel in Figure 3.8. 
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Figure 3.7: Coomassie stained 12% SDS-PAGE gel contammg His-tag purification 
samples of wild type hTdTS. Crude lysate (CL) fraction was collected after cell lysis. 
Flow-through (FT) fraction was collected after incubation of crude lysate with the nickel 
resin. The wash (W) fractions were collected to test for removal of non-specific nickel 
resin binding. The elution (E) fraction depicts single protein band at around 58kDa, the 
expected size ofhTdT. 
58k.Da 
hTdT 
Figure 3.8: His-tag purified hTdTS protein variants resolved on 10% denaturing SDS-
PAGE gel stained with Coomassie blue dye. A total of 8µg of protein was loaded in each 
lane. 
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Section 3.4 In vitro hTdT functional activity assays 
3.4.l Activity of commercial recombinant TdT versus purified wild type hTdTS 
In order to determine whether the purified polymerase was functionally active, the 
polymerase activity of recombinant calf TdT was examined and compared to that of 
purified wild type hTdTS. The results are shown in Figure 3.9. In the absence of TdT, the 
Cy3-labelled oligo substrate was not extended even though the reaction contained 
available dNTPs. The same outcome was observed in the absence of free dNTPs, using 
either calf TdT or purified wild type hTdTS, as dNTPs are required by the polymerase 
reaction. When both TdT and dNTPs were present, the Cy3-labelled oligo substrate was 
extended by calf TdT or the purified wild type hTdTS. The activity was shown by the 
presence of a smear above the control band reaction as well as the disappearance of the 
Cy3-labelled oligo starting material in these reactions. As the TdT reaction was allowed 
to proceed for 1, 5 and 10 minutes the length of the reaction product was increased, 
indicative of increasing numbers of dNTPs polymerizing to the DNA substrate oligo with 
time. In addition, wild type hTdTS polymerase reactions resulted in longer 
polymerization products that appeared as darker smears as compared to recombinant calf 
TdT reactions. 
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Figure 3.9: In vitro polymerase activity of commercial recombinant TdT versus purified 
wild type hTdTS. Reactions were set up as follows; 
Control: 0.3nM Cy3 oligo, lxTdT reaction buffer, 0.25mM CoCh, dH20 up to 30µ1. 
-TdT: 0.3nM Cy3 oligo, lxTdT reaction buffer, 0.25nM CoCh, 0.15mM dNTP 
mix, dH20 up to 30µ1. Reactions were incubated at 3 7°C for 0, 1, 5 and 10 minutes. 
Calf TdT/-dNTPs: 0.3nM Cy3 oligo, lxTdT reaction buffer, 0.25mM CoCh, 20 
units recombinant calf TdT, dH20 up to 30µ1. Reactions were incubated at 37°C for 0, 1, 
5 and 10 minutes. 
Calf TdTl+dNTPs: 0.3nM Cy3 oligo, lxTdT reaction buffer, 0.25mM CoCh, 0.15mM 
dNTP mix, 20 units recombinant calfTdT, dH20 up to 30µ1. Reactions were incubated at 
37°C for 0, 1, 5 and 10 minutes. 
WT hTdT/-dNTPs: 0.3nM Cy3 oligo, lxTdT reaction buffer, 0.25mM CoCh, 3.4µM 
purified wild type hTdT protein, dH20 up to 30µ1. Reactions were incubated at 37°C for 
0, 1, 5 and 10 minutes. 
WT hTdTl+dNTPs: 0.3nM Cy3 oligo, lxTdT reaction buffer, 0.25mM CoCh, 0.15mM 
dNTP mix, 3.4µM purified wild type hTdT protein, dH20 up to 30µ1. Reactions were 
incubated at 37°C for 0, 1, 5 and 10 minutes. 
The reactions were stopped by the addition of 30µ1 TdT stopping buffer and resolved on 
denaturing 10% TBE-urea gel. Image obtained by Typhoon Imager scanning. 
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3 .4.2 Polymerase time course activity assay 
In order to assess the differences between wild type hTdTS and the six purified 
hTdTS variants, time course of polymerase activity was performed (Figure 3.10). All of 
the six assayed hTdTS variants demonstrated different polymerase activities under the 
assay conditions. Based on the length of TdT reaction products as well as the banding 
patterns observed. Five out of six assayed hTdTS variants were functionally active, while 
R431 C hTdTS was unable to extend DNA oligo substrate (Figure 3.10, panel B). Thus, 
R431 C variant was termed a 'dead' mutant in the biochemical assays. 
The graph in Figure 3.11 plots the change in maximum size of hTdTS oligo 
product with respect to time. The initial polymerization rate within the first minute of 
reaction differs among hTdTS variants. Wild type, D280H and T450S hTdTS reactions 
all resulted in polymerization product of about 300 bases, while R460Q, A445T and 
L397S hTdTS reaction resulted in products of 160, 75 and 50 bases respectively. 
Another key difference among the five hTdTS variants as compared to wild type 
hTdTS is the banding pattern of the polymerization products, specifically broadness 
versus tightness of the smears. For instance, wild type hTdTS reactions produce tight 
smears as compared to A445T variant which results in overall broader smears 
(highlighted by a red box in Figure 3.10, panel A). 
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Figure 3.10: In vitro polymerase time course activity of purified hTdTS SNP variants. 
Panel A assays the activity of wild type, D280H, A445T and T450S hTdTS. Red boxes 
highlight the banding pattern difference between the polymerization products of wild 
type and A445T variants. Panel B assays the activity of wild type, L397S, R460Q and 
R431 C hTdTS. 
Control reaction contained 0.3nM Cy3 oligo, 1 xTdT reaction buffer, 0.25mM CoCb, 
O. l 5mM dNTP mix, dH20 up to 30µ1. Time course reactions were set up as a master mix. 
Each polymerase reaction contained 0.3nM Cy3 oligo, lxTdT reaction buffer, 0.25mM 
CoCh, 0.15mM dNTP mix, 3.4µM purified hTdTS protein, dH20 up to 30µ1. Reactions 
were set up as a master mix and incubated at 37°C. Aliquots of 30µ1 were taken at 1, 3, 6, 
9 and 12 minutes and added to 30µ1 TdT stopping buffer. The completed reactions were 
resolved on a denaturing 10% TBE-urea gel and the image obtained by Typhoon Imager 
scanning. 
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Figure 3.11: Change in maximum size of hTdTS oligo product with respect to time of in 
vitro reaction. The graph plotted based on time course polymerase activity assay of wild 
type hTdTS and all six purified hTdTS SNP variants. The size of hTdT oligonucleotide 
product was extrapolated based on known sizes of DNA ladder that were resolved along 
with TdT reactions. The assays were independently repeated 3 times and the standard 
error was calculated and plotted on the graph. 
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3.4.3 dNTP substrate preference polymerase activity assay 
Once the polymerase activities of hTdTS variants were deteFmined through the 
time course assays, the usage of a single type of dNTP was tested to observe if there is 
any preference of hTdTS variants to use certain nucleotide for the polymerization 
reaction. Figure 3.12 shows the TdT polymerization reactions supplemented with a dNTP 
mix, dA TPs, dTTPs, dCTPs or dGTPs. The dNTPs generated by far the best reactions, 
each single deoxy-nucleotide resulted in some change in activity of the polymerases, with 
dCTP and dGTP causing the most variation. When comparing the activity of either of 
hTdTS variants to wild type protein, few key points can be made. First, five hTdTS 
variants supplemented with dCTPs produce short oligo products as compared to wild type 
hTdTS. In addition, dCTPs reactions with all hTdTS variants, including wild type 
protein, result in lower size band than the control Cy3-labelled oligo substrate. Second, 
all dGTPs supplemented reactions with all six hTdTS variants show a predominant band 
at around 50 bases. Lastly, dNTPs and dATPs supplemented reactions result in relatively 
long TdT oligo products as compared to dTTPs, dCTPs and dGTPs reactions by all six 
hTdTS variants. R43 l C hTdTS showed no polymerase activity with either of the 
supplemented dNTPs. 
To investigate dGTPs supplemented reactions, an additional time course assay 
was performed in Figure 3.13. As the wild type hTdTS reaction was allowed to proceed, 
no extension of the Cy3-labelled oligo substrate was observed beyond the predominant 
band at around 50 bases. 
73 
A hTdT 
----- + dATPs + Co2+ ____ ., *5' ----- AAAAAA 
WThTdT A445T hTdT L397S hTdT 
dN dA dT dC dG dN dA dT dC dG dN dA dT dC dG 
Bases C l' 3' l' 3' l' 3' l' 3' l' 3' C l' 3' l' 3' l' 3' l' 3' l' 3' C l' 3' l' 3' l' 3' l' 3' l' 3' 
300 
200 
150 
100 
75 
50 
35 
B 
Bases 
300 
200 
150 
100 
75 
50 
35 
i'. ~ "~ ~ :.: ~> ··,· .. ~ .. ~ .. I . ·,. ·1 . 
:· ~ : ; '\.. 
... 
--· .. ·. ~ .. 
WThTdT T450S hTdT D280H hTdT 
dN dA dT dC dG dN dA dT dC dG dN dA dT dC dG 
c l' 3' l' 3' l' 3' l' 3' l' 3' c l' 3' l' 3' l' 3' l' 3' l' 3' c l' 3' l' 3' l' 3' l' 3' l' 3' 
74 
c 
WT hTdT R460Q hTdT R431C hTdT 
dN dA dT dC dG dN dA dT dC dG d!N dA dT dC dG 
Bases C 1' 3' 1' 3' 1' 3' 1' 3' 1' 3' C 1' 3' 1' 3' 1' 3' 1' 3' 1' 3' C ll' 3' 1' 3' 1' 3' 1' 3' 1' 3' 
300 
200 
150 
100 
75 
50 
35 
••• • 
Figure 3.12: In vitro dNTPs preference polymerase activity of purified hTdTS SNP 
variants. Panel A assays the activity of wild type, A445T and L397S hTdTS. Panel B 
assays the activity of wild type, T450S and D280H hTdTS. Panel C assays the activity of 
wild type, R460Q and R431 C hTdTS. 
Control reaction contained 0.3nM Cy3 oligo, lxTdT reaction buffer, 0.25mM CoCh, 
0.15mM dNTP mix, dH20 up to 30µ1. Time course reactions were set up as a master mix. 
Each polymerase reaction contained 0.3nM Cy3 oligo, lxTdT reaction buffer, 0.25mM 
CoCh, 0.15mM dNTPs (either dNTP mix, dATPs, dTTPs, dCTPs or dGTPs), 3.4µM 
purified hTdTS protein, dH20 up to 30µ1. Reactions were set up as a master mix and 
incubated at 37°C. Aliquots of 30µ1 were taken at 1 and 3 minutes and added to 30µ1 TdT 
stopping buffer. The completed reactions were resolved on a denaturing 10% TBE-urea 
gel and the image obtained by Typhoon Imager scanning. 
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Figure 3.13: In vitro polymerase activity of purified wild type hTdTS supplemented with 
dGTPs. Control reaction contained 0.3nM Cy3 oligo, lxTdT reaction buffer, 0.25mM 
CoCh, O. l 5mM dNTP mix, dH20 up to 30µ1. Time course reactions were set up as a 
master mix. Each polymerase reaction contained 0.3nM Cy3 oligo, lxTdT reaction 
buffer, 0.25mM CoCh, 0.15mM dGTPs, 3.4µM purified wild ttype hTdTS protein, dH20 
up to 30µ1. Reactions were set up as a master mix and incubated at 3 7°C. Aliquots of 
30µ1 were taken at 1, 3, 6, 9 and 12 minutes and added to 30µ1 TdT stopping buffer. The 
completed reactions were resolved on a denaturing 10% TBE-urea gel and the image 
obtained by Typhoon Imager scanning. 
3.4.4 DNA substrate preference polymerase activity assays 
The activity of hTdTS variants was tested in terms of their preference to utilize 
different types of Cy3-labelled DNA substrate, specifically single stranded oligo, a 
double stranded oligo having a blunt end or a double stranded oligo having a 3' end 
overhang (Figure 3.14). The DNA substrate assay shows a clear preference by all hTdTS 
variants to utilize double stranded 3' overhang oligo (panel C) due to the absence of any 
residual starting DNA substrate oligo within the first minute of reaction, as compared to 
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single stranded and double stranded blunt end oligos that show the presence of the 
starting material DNA substrate (panels A and B). The double stranded blunt end DNA 
substrate is the least preferred by all hTdTS variants when looking at the left-over starting 
DNA substrate after 1 and 3 minutes. In addition, R431 C hTdTS demonstrated no 
polymerase activity with either of the DNA substrate oligos. 
A 
300 
200 
150 
100 
75 
50 
35 
25 
hTdT 
*
5
' ----- + dNTPs + Co2+ ---• 
-----NNNNNN 
WT D280H A44ST T4SOS L397S R460Q R431 C 
77 
hTdT 
B 
*5' ____ _ 
+ dNTPs + Co2+ 
WT D280H A445T T450S L397S R460Q R43 l C 
Bases C l' 3' C l' 3' C l' 3' C 1' 3' C l' 3' C l' 3' C l' 3' 
300 
200 
150 
100 
75 
50 
35 
25 
78 
hTdT 
c 
*5' ____ _ 
+ dNTPs + Co2+ 
WT D280H A445T T450S L397S R460Q R431C 
Bases C 1' 3' C 1' 3' C 1' 3' C 1' 3' C 1' 3' C 1' 3' C 1' 3' 
··: '; ..... ~_,_, 
. ) . '~. 
. . . :~. 
~·. . 
300 
Figure 3.14: In vitro DNA substrate preference polymerase activity of purified hTdTS 
SNP variants. Panel A assays the activity using single stranded Cy3-labelled 
oligonucleotide. Panel B assays the activity using double stranded Cy3-labelled blunt end 
oligonucleotide. Panel C assays the activity using double stranded Cy3-labelled 3' 
overhang oligonucleotide. 
Control reaction contained 0.3nM Cy3 oligo, lxTdT reaction buffer, 0.25mM CoCii, 
0.15mM dNTP mix, dH20 up to 30µ1. Time course reactions were set up as a master mix. 
Each polymerase reaction contained 0.3nM DNA oligo substrate (single stranded, double 
stranded blunt end or double stranded 3' overhang), lxTdT reaction buffer, 0.25mM 
CoCli, 0.1 SmM dNTP mix, 3.4µM purified hTdTS protein, dH20 up to 30µ1. Reactions 
were set up as a master mix and incubated at 37°C. Aliquots of 30µ1 were taken at 1 and 
3 minutes and added to 30µ1 TdT stopping buffer. The completed reactions were resolved 
on a denaturing 10% TBE-urea gel and the image obtained by Typhoon Imager scanning. 
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3.4.5 DNA substrate sequence preference polymerase assays 
In order to observe whether TdT polymerase activity may be affected by the 
specific nucleotide sequence of the DNA substrate oligo, a time course assay was 
undertaken using two Cy3-labelled 33 nucleotide long DNA substrate oligos that are 
complementary to one another in their base sequence. Figure 3 .. 15 pane1l A shows the base 
sequence of the two tested oligos. No difference in terms of the length of TdT reaction 
products or the banding pattern was observed between the two tested oligos in the 
presence of wild type hTdTS (Figure 3. I 5, panel B). In addition, the usage of both DNA 
substrate oligos in the polymerization reaction in the presence of dGTPs resulted in the 
production of a predominant band (Figure 3.15, panel C). This was similarly seen in 
dNTP substrate preference assay depicted in Figure 3.12. 
A 
Substrate oligo 1 5' cy3-cta ctg gta ctt cga tct ctg ggg ccg tga cgc 33nt long 
Substrate oligo 2 5' Cy3-gtg cca egg ccc cag aga tcg aag tac cag tag 33nt long 
Nanomer 23-bp heptamer IGHJ2 
5' gtg ttt ttg tat ggg aga age agg agg gca gag get gtg1•ct."ctg gta ctt cga tct ctg ggg ccg tgg cac 3'-
3' cac aaa aac ata ccc tct tcg tee tee cgt etc cga cac gat gac cat gaa get aga gac ccc ggc ace gtg*5' ... 
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Figure 3.15: In vitro DNA substrate sequence preference polymerase activity assay. 
A. Sequences of Cy3-labelled oligo I and 2 used for in vitro DNA substrate 
sequence preference polymerase activity assay. Germ line sequence of human 
immunoglobulin heavy chain J2 region flanked by 23-RSS region (adapted from 
NCBI database) shown at the bottom. 
B. Utilization of oligo I versus oligo 2 by purified wild type hTdTS. 
Control reaction contained 0.3nM Cy3-labelled oligo l or 2, lxTdT reaction 
buffer, 0.25mM CoCh, O. l 5mM dNTP mix, dH20 up to 30µ1. Time course 
reactions were set up as a master mix. Each polymerase reaction contained 0.3nM 
Cy3-labelled oligo 1 or 2, lxTdT reaction buffer, 0.25mM CoCh, 0.15mM dNTP 
mix, 3.4µM purified wild type hTdTS protein, dH20 up to 30µ1. Reactions were 
set up as a master mix and incubated at 37°C. Aliquots of 30µ1 were taken at 1, 3, 
6, 9 and 12 minutes and added to 30µ1 TdT stopping buffer. The completed 
reactions were resolved on a denaturing 10% TBE-urea gel and the image 
obtained by Typhoon Imager scanning. 
C. Utilization of oligo 1 versus oligo 2 by purified wild type hTdTS in the presence 
of dGTPs. Reactions were carried out as described in caption to panel B. The 
reactions were supplemented with O. l 5mM dGTPs instead of dNTP mix. 
81 
3.4.6 Cofactor preference polymerase activity assays 
TdT requires a divalent cofactor for function in vitro. Therefore, TdT dependency 
of the divalent metal cofactors (Co2+ and Mg2+) was examined. Figure 3.16 shows 
cofactor preference assay of wild type hTdTS and R431 C hTdTS variants. No differences 
in the lengths of wild type hTdTS reaction products were observed between the three 
conditions (with Co2\ without Co2+ and with Mg2+). However, the banding pattern of the 
reactions supplemented with cobalt (Co2+) resulted in tighter smears as compared to 
reactions in the absence of cobalt or the presence of magnesium (Mg2l. R431 C hTdTS 
reactions in any of the three tested conditions did not result in polymerization products, 
however smearing was observed below the control band in the absence of cobalt (Co2+) 
or the presence of magnesium (Mg2+). 
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Figure 3.16: In vitro cofactor polymerase activity assay. 
Control reaction contained 0.3nM Cy3 oligo, lxTdT reaction buffer, 0.15mM dNTP mix, 
dH20 up to 30µ1. Time course reactions were set up as a master mix. Each polymerase 
reaction contained 0.3nM Cy3 oligo, lxTdT reaction buffer, 0.25mM cofactor (either 
CoCh, no CoCh or MgCh), 0.15mM dNTP mix, 3.4µM purified wild type or R431C 
hTdTS, dH20 up to 30µ1. Reactions were set up as a master mix and incubated at 37°C. 
Aliquots of 30µ1 were taken at 1, 3 and 6 minutes and added to 30µ1 TdT stopping buffer. 
The completed reactions were resolved on a denaturing 10% TBE-urea gel and the image 
obtained by Typhoon Imager scanning. 
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Section 3.3 In vivo V(D)J recombination assays 
To investigate the functional differences between polymorphic hTdTS variants, in 
vivo V(D)J extrachromosomal recombination assays were performed. The assay focused 
on A445T, L397S and R431 C hTdTS from the six hTdTS SNP candidates, since these 
three demonstrated marked differences in in vitro functional assays as compared to wild 
type hTdTS. 
3.3.1 HEK.293T cell line testing 
Endogenous hTdT expression was tested in HEK293T cells prior to performing 
recombination assay. This test was important since the differences among transfected 
polymorphic forms of hTdT were assayed and any background hTdT expression would 
otherwise interfere with the assay. The cell line was tested at the RNA level through RT -
PCR and also at the protein level through Western blotting. 
The results of the RT-PCR experiment are depicted in Figure 3.17. Total RNA 
isolated from HEK.293T cells that were transfected with either substrate pGG51 plasmid, 
empty pcDNA expression vector, hTdTS pcDNA expression vector or co-transfected 
with substrate pGG51 plasmid, hRAGl and hRAG2 expression vectors along with 
hTdTS pcDNA expression vector. RAGl and RAG2 expression vectors were co-
transected since HEK293T cells do not express endogenous RAG proteins that are 
required at the first stage of V(D)J recombination. Reverse transcription reaction was 
performed using total RNA as template along with hTdTS gene-specific primers either in 
the presence or absence of reverse transcriptase to test for possible genomic DNA 
contamination. The presence of a DNA band around 1 Kb following the PCR reaction 
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indicates the presence of hTdTS RNA. Non-transfected HEK293T ceUs did not produce 
hTdTS PCR product either in the absence or presence of reverse transcriptase. The same 
results were observed in HEK293T cell transfection with substrate pGG5 l plasmid and 
empty pcDNA expression vector. The RT-PCR reaction of HEK293T cells transfected 
with wild type hTdTS pcDNA expression vector resulted in a single predominant band 
around lKb in the presence of reverse transcriptase. In the absence of reverse 
transcriptase the DNA band was not present, suggesting that no genomic DNA 
contamination occurred in the reaction. Lastly, HEK293T cell co-transfection of four 
plasmids required for recombination assay resulted in hTdTS PCR product in the 
presence of reverse transcriptase. In the absence of reverse transcriptase, no PCR product 
was observed. 
Human TdT Western blot results are shown in Figure 3.18. Endogenous hTdT 
protein was not detected in non-transfected HEK293T cells as shown in the far left lane. 
However, upon transfection of hTdTS pcDNA expression vector hTdTS protein was 
detected using rabbit polyclonal TdT specific antibody. The protein expression level of 
the four plasmid co-transfection was lower as compared to the single hTdTS pcDNA 
expression vector transfection, as shown by the fainter protein signal. In addition, TdT 
specific antibody detected purified His-tagged wild type hTdTS prote.in used in the in 
vitro functional assays. This result is shown in the far right lane and served as a positive 
control for the activity of the TdT specific antibody. 
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Figure 3.17: Reverse transcriptase PCR products using hTdTS gene-specific primers, 
separated on 0.7% agarose gel. 
HEK.293T cells were transfected with the indicated vectors; substrate recombination 
plasmid pGG5 l, empty pcDNA ™4/myc-His A vector, wild type hTdTS 
pcDNA ™4/myc-His A expression vector or co-transfection of pGG5 l plasmid, wild type 
hTdTS pcDNA, pEBG-hRAGl and hRAG2 expression vectors. Non-transfected 
HEK.293T cells were used as experimental control. 
Total RNA was extracted 48 hours post transfection using TRizol® Reagent. Total 
isolated RNA was reverse transcribed (either+ or - RT) to generate cDNA using oligo 
(dT)20, as per ThermoScript™ RT-PCR system. Generated cDNA was PCR amplified 
using hTdTS gene-specific primers (DNTT _F and DNTT _ R). 
PCR negative control included no cDNA template. PCR positive control reaction 
included wild type hTdT pcDNA ™4/myc-His A expression vector as DNA template. 
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Figure 3.18: Western blot image of total HEK293T cell lysates probed with rabbit 
polyclonal TdT specific antibody and mouse monoclonal IgG GAPDH specific antibody. 
Total HEK293T cell lysate (85µg of total protein) harvested 48 hours post-transfection 
(wild type hTdTS pcDNA expression vector or co-transfection of wild type hTdTS 
pcDNA expression vector, substrate pGG51 plasmid, pEBG-hRAG 1 and hRAG2 
expression vectors) ran on 12% SDS-PAGE gel and transferred onto activated protein 
membrane. Cell lysate of non-transfected HEK293T cells was also loaded onto SDS-
PAGE gel. The membrane was then blocked and probed with primary antibodies (rabbit 
polyclonal TdT specific antibody and mouse monoclonal IgG GAPDH specific antibody) 
followed by probing with secondary antibody (anti-rabbit HRP-conjugated antibody and 
anti-mouse lgG HRP-conjugated antibody). The signal on the membrane was developed 
using HRP substrate for either 5 or 10 minute exposure. GAPDH utilized as loading 
control. Bacterial purified His-tagged wild type hTdTS served as hTdTS antibody 
control. 
87 
3.3.2 Recombination frequencies of the substrate pGG51 plasmid 
The recombination frequencies (R-values, detailed in Chapter 2, Materials and 
Methods) for every HEK293T cell transfection were computed based on the number of 
ampicillin resistant versus chloramphenicol and ampicillin resistant bacterial colonies 
detected. The ampicillin resistant colonies represent the total number of bacterial cells 
that have been transformed with the substrate pGG51 plasmid, while the double-resistant 
colonies represent the total number of substrate plasmids that undergone RAG-mediated 
recombination. The raw data from the recombination assay are summarized in Appendix 
C. The graph in Figure 3.19 plots individual R-values and the mean R-value calculated 
based on eight independent HEK293T cell transfections. The mean R-value for L398S 
hTdTS experimental condition is 1.5 fold higher when compared to wild type hTdTS 
experimental condition (0.00498% versus 0.00318%). No marked differences were 
observed among A445T and R431 C hTdTS and wild type hTdTS. The mean R-value for 
control experimental conditions (no hTdTS expression plasmid added) is two fold higher 
compared to wild type hTdTS experimental condition (0.00662% versus 0.00318%). 
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Figure 3.19: Recombination frequencies of in vivo V(D)J recombination assay. The 
individual R-values computed based on 8 independent HEK293T cell transfections per 
single experimental condition. The mean R-values are shown along with the standard 
error, represented by error bars. 
The mean R-values are as follows; 
Control= 0.00662±0.00169 % 
WT hTdTS= 0.00318 ± 0.00106 % 
A445T hTdTS= 0.00357 ± 0.00094 % 
L397S hTdTS= 0.00498±0.00104 % 
R431 C hTdTS= 0.00315 ± 0.00054 % 
Experimental conditions are as follows; 
Control = transfection with substrate pGG51 plasmid + pEBG-hRAG 1 + pEBG-hRAG2 
expressing vectors 
WT= transfection with wild type hTdTS pcDNA expressing vector+ substrate pGG51 
plasmid + pEBG-hRAG 1 + pEBG-hRAG2 expressing vectors 
A445T = transfection with A445T hTdTS pcDNA expressing vector + substrate pGG51 
plasmid + pEBG-hRAG 1 + pEBG-hRAG2 expressing vectors 
L397S = transfection with L397S hTdTS pcDNA expressing vector + substrate pGG51 
plasmid + pEBG-hRAG 1 + pEBG-hRAG2 expressing vectors 
R431 C = transfection with R431 C hTdTS pcDNA expressing vector + substrate pGG51 
plasmid + pEBG-hRAG 1 + pEBG-hRAG2 expressing vectors 
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3.3.3 Analysis of recombined substrate pGG5 l sequences 
Analysis of in vivo functional activity differences between wild type hTdTS and 
its polymorphic forms was carried out using the extrachromosomal V(D~J recombination 
substrate assay in HEK293T cells. Recombination substrate pGG51 plasmid was allowed 
to undergo RAG-mediated recombination in mammalian cells either in the presence of 
hTdTS (wild type, A445T, L397S or R43 l C) or its absence. The substrate plasmid was 
harvested from the mammalian cells and sequenced to analyze the junctional region 
where recombination occurred. A total of 276 unique recombined substrate plasmid 
sequences were obtained from the tested experimental conditions (Appendix D). 
Repeated recombined sequences within the same mammalian transfection were excluded 
from the analysis due to the possibility of plasmid replication in mammalian cells after 
recombination (Appendix C, Table 3). 
The sequences were subjected to analysis in terms of number of nucleotide 
deletions, palindromic nucleotide additions (P-additions) and random nucleotide 
additions (N-additions). In addition, the frequency of N-additions as well as their AT 
versus GC base content was investigated. The distribution of N-nucleotide additions per 
recombined joint was examined. Finally, the length of the arbitrary complementary-
determining region (CDR) was compared amongst the experimental conditions. 
Nucleotide deletions 
Nucleotide deletions at the recombined joints were analyzed as experimental 
control, since hTdTS is known to catalyze nucleotide additions ,and not deletions. The 
summary of the nucleotide deletions observed is shown in Table 3.2. There was no 
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marked difference between the control experiment, lacking hTdTS, and other tested 
conditions including those with hTdTS variants. The average number of nucleotide 
deletions in L397S hTdTS transfection was determined to be 5.17 nudeotides, which is 
higher than 4.53 nucleotides as compared to WT hTdTS. However, this difference is not 
statistically significant (p-value ~ 0.05). 
Table 3.2: Recombined substrate pGG51 plasmid nucleotide deletions. 
148 
-P-value 0.6608 
* Average number of deletions = total number of nucleotide deletions I total number of 
unique sequences 
** P-value for nucleotide deletions for WT hTdTS experimental condition computed 
using comparison to the control condition. All other p-values computed through 
comparison to WT hTdTS experimental condition. 
***The statistical analysis was performed using a standard T-test. 
P-nucleotide additions 
Palindromic nucleotide additions (P-additions) result from off-center hairpin 
opening of DNA during the process of V(D)J recombination. P-additions at the 
recombined joints were analyzed as experimental control, since hTdTS does not play a 
role in hairpin openining in vivo. Table 3.3 summarizes the experimental results of P-
nucleotide additions. The proportions of P-addition range from 17.54% in WT hTdTS 
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transfection to 25% in control transfection. The average number of P-additions per 
recombined joint range from 1.38 to 1.8 nucleotides. No significant differences were 
observed between A445T and R431C hTdTS transfections when compared to WT 
hTdTS. However, average number of P-additions observed in L397S hTdTS transfection 
is significantly different, as compared to control transfection (p-value 0.0487). 
Table 3.3: Recombined substrate pGG51 plasmid P-nucleotide additions. 
25 17.54 
--P-value 0.2996** 
*Proportion of sequences containing P-additions (%)=(number of sequences containing 
P-additions I total number of unique sequences) * I 00% 
Average number of P-additions = total number of P-additions I number of sequences 
containing P-additions 
** P-value for P-additions for WT hTdTS experimental condition computed using 
comparison to the control condition. All other p-values computed through comparison to 
WT hTdTS experimental condition. 
*** The statistical analysis was performed using a standard T-test. P-values shown in 
bold are <0.05, thus found to be statistically significant. 
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N-nucleotide additions 
The addition of random non-templated nucleotides (N-additions) at the 
recombined joints is catalyzed by TdT. Therefore, the average number and type of N-
additions observed at the joints provides a direct measure to the activity of the 
polymerase. The analysis of random nucleotide additions (N-additions) is summarized in 
Table 3.4 and all computed statistical p-values are shown in Figure 3.20. Average number 
of N-additions observed in control transfection is 1 nucleotide (only 3 out of 48 
sequences contained a single N-nucleotide ). The WT hTdTS transfection resulted in the 
highest average number of N-additions as compared to other three hTdTS variants 
(average of 3 nucleotides per joint). Thus, the number of N-additions was different for 
WT hTdTS transfection as compared to control experiment (p-value 0.0336). Another 
significant difference was observed in R431 C hTdTS transfection. Only 1.38 N-
nucleotides were observed on average in that transfeciton compared to 3 N-nucleotides in 
WT hTdTS transfection (p-value 0.0062). 
The proportion of sequences containing N-additions was also computed (Table 3.4). 
For control transfection only 6.25% of all recovered recombined sequences contained N-
additions, compared to 73.68% of sequences recovered from WT hTdTS transfection (p-
value <0.0001). A445T hTdTS transfection did not result in a differenent frequency ofN-
containing joints, as compared to WT hTdTS transfection (78.46% versus 73.68%). 
However, both L397S and R431 C hTdTS transfections generated a significantly lower 
number ofN-containingjoints as compared to WT hTdTS transfection (about 23% versus 
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73.68%, p-values <0.0001). Therefore, there is over a 3 fold difference among these 
frequencies ofN-containing recombined sequences. 
The recombined pGG51 sequences containing N-additions were further investigated 
in terms of their AT versus GC base content (Table 3.4). In WT ln.TdTS transfection, over 
60% ofN-nucleotides were G or C bases. A445T hTdTS transfeciton also shows a clear 
preference for GC content over AT of N-additions (72% GC content). L397S hTdTS 
transfection 4 7% of N-additions were GC bases, which was determined not to be 
significant when compared to WT hTdTS transfection (p-value 0.1691). The major 
difference was observed in R43 l C hTdT transfection. Only 27% of all the recovered N-
containing joints contained GC bases. This indicated a significant shift towards the 
preference for AT bases, compared to WT hTdTS transfection (p-value 0.0164). 
Note; the statistical analysis performed using numbers of bases counted and not 
percentages. 
The distribution of N-nucleotide additions per single recombined joint was 
characterized (Figure 3 .21 ). The frequencies of N-nucleotide occurrence were computed 
as a ratio of the number of joints having a certain number ofN-nucleotides, for instance 2 
N-nucleotide additions per joint, to the number of joints containing N-additions. WT 
hTdTS transfection resulted in even distribution between 2, 3 and 4 N-nucleotides per 
joint. Lower frequencies were observed for longer N-nucleotides (for example 5, 6 and 8 
N-nucleotides per joint). A445T hTdTS transfection showed an even distribution for 1-4 
N-nucleotides per joint. There were no N-additions longer than 4 nucleotides. L397S 
hTdT transfection showed a preference for 1 or 2 N-nucleotide additions per joint (over 
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30% of joints had 1 N-nucleotide and over 40% of joints contained 2 N-nucleotides per 
joint). A clear preference was observed in R431 C hTdTS transfection in which about 
75% of all N-containing joints were in fact 1 N-nucleotide additions. 
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Table 3.4: Recombined substrate pGG5 l plasmid N-nucleotide additions, their frequency 
and AT versus GC base content. 
Control WT A445T L397S R431C hTdTS hTdTS hTdTS hTdTS 
Total number of unique 48 57 65 72 34 
se uences obtained 
Total number of 3 126 122 34 11 N-additions 
Number of sequences 3 42 51 17 8 
containin N-additions 
Average number of 1 3 2.39 2 1.38 N-additions * 
P-value 0.0336° 0.0335 0.0218 0.0062 
Number of sequences 3 42 51 17 8 
containin N-additions 
Number of sequences not 45 15 14 55 26 
containin N-additions 
Proportion of sequences 6.25 73.68 78.46 23.61 23.53 
containin N-additions % * 
Number of GC bases in N- 3 77 88 16 3 
additions (percentage of total (100%) (61.11%) (72.13%) (47.06%) (27.27%) N-additions * 
Number of AT bases in N- 49 34 18 8 
additions (percentage of total 0 (38.89%) (27.87%) (52.94%) (72.73%) N-additions * 
P-value 0.2913 0.0814 0.1691 0.0164 
*Average number ofN-additions =total number of N-additions I number of sequences 
containing N-additions. Proportion of sequences containing N-additions (%) = (number 
of sequences containing N-additions I total number of unique sequences) * 100% 
Percentage of AT or GC bases in N-additions (%)=(total number of AT or GC bases I 
total number ofN-additions) * 100% 
** P-value for N-additions for WT hTdTS experimental condition computed using 
comparison to the control condition. All other p-values computed through comparison to 
WT hTdTS experimental condition. 
* * * The statistical analysis was performed using a standard T-test for the number of N-
additions. A chi-square test was used to analyze frequency of N-additions and frequency 
of AT versus GC bases in N-additions. P-values shown in bold are <0.05, thus found to 
be statistically significant. 
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Figure 3.20: P-values obtained from standard T-test or chi-square test. The p-values, 
labeled above each bar, are subdivided to few categories; nillcleotide deletions, P-
additions, N- additions, frequency of N-additions and frequency of AT versus GC bases 
in N-additions. The p-values were acquired from Table 3.4. 
* P-value for N-additions for WT hTdTS experimental condition computed using 
comparison to the control condition. All other p-values computed through comparison to 
WT hTdTS experimental condition. P-values below 0.05 were :found to be statistically 
significant. 
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Figure 3.21: Distribution ofN-nucleotide additions per single recombined joint. 
The frequencies of N-nucleotide occurrence were computed as a ratio of the number of 
joints having a certain number of N-nucleotides to the number of joints containing N-
additions. 
Length of arbitrary complementary-determining region (CDR) 
The length of arbitrary complementary-determining region (CDR) was chosen to 
include 15 bases flanking the RSS-region of recombination substrate pGG51 plasmid on 
the 5' and the 3' end. Therefore, the length of a non-recombined germline arbitrary CDR 
region is 30 bases. Figure 3.22 shows the mean length of arbitrary CDR for every 
experimental condition tested. The mean length was computed by summing up all the 
lengths of arbitrary CDRs per experimental condition (include nucleotide deletions and 
additions) and dividing those by the total number of unique sequences. WT hTdTS 
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transfection generated significantly longer arbitrary CDRs as compared to control 
transfection (28 versus 25.67 bases, p-value <0.0001). In addition, L397S and R431C 
hTdTS transfections resulted in lower arbitrary CDRs as c0mpared to WT hTdTS 
transfection (25.56 and 26.32 bases versus 28 bases, p-values <0;0001). 
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Figure 3.22: Mean length of arbitrary complementary-determining region. 
The mean values are shown at the bottom of the bars. The error bars represent the 
standard deviation. 
The mean length of CD Rs are as follows; 
Control= 25.67 ± 2.55 bases 
WT hTdTS= 28 ± 2.69 bases (p-value <0.0001)* 
A445T hTdTS= 27.68 ± 2.26 bases (p-value 0.4719) 
L397S hTdTS= 25.56 ± 2.49 bases (p-value <0.0001) * 
R431C hTdTS= 26.63 ± 2.28 bases (p-value <0.0001) * 
* P-value for mean length of CDR for WT hTdTS experimental condition computed 
using comparison to the control condition. All other p-valiues computed through 
comparison to WT hTdTS experimental condition. The statistical analysi•s was performed 
using a standard T-test. P-values shown in bold are <0.05, thus found to be statistically 
significant. 
99 
Chapter 4: Discussion 
V(D)J recombination is an essential process in the generation of the wide range of 
diverse antigen receptors needed to recognize pathogens and activate the adaptive 
immune response to fight infection. The process requires a number of protein players, 
including TdT. TdT is a template-independent DNA polymerase responsible for the 
addition of random nucleotides to Band T cell receptors during V(D)J recombination. In 
its role, TdT contributes to junctional diversity of antigen receptors. 
I identified a number of naturally occurring polymorphic variants of the hTdT 
short isoform that potentially may alter TdT's polymerase activity. The criteria for 
selection were based on amino acid residue conservation among species, the chemical 
nature of the amino acid change and the position of the SNP relative to TdT's catalytic 
site. The activity differences of selected hTdTS SNPs compared to wild type hTdTS were 
tested using an in vitro polymerase assays and substrate preferences. Specifically, dNTPs 
usage and DNA substrate primer preferences were examined. The activity of hTdTS 
variants was also evaluated using an in vivo extrachromosomal V(D)J recombination 
assay. The implications for the development of a broad antigen receptor repertoire in 
homozygous individuals with hTdTS SNPs are elaborated in this chapter. 
4.1 Selection ofhTdTS SNPs 
The NCBI SNP database was used to identify a total of six non-synonymous 
hTdTS SNPs that, by my criteria, were predicted to be the best candidates to have altered 
polymerase activity compared to wild type hTdTS (Table 3.1). The active site of hTdT 
contains three highly conserved aspartic acid residues (D343, D345 and D434) and a 
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cation binding site that aids in stabilizing the negative charge associated with a 
triphosphate group of an incoming dNTP (Figure 3.2). As described in Chapter 1, hTdTS 
structure has not been solved to date. It would be beneficial to investigate the structure-
function relationship of the identified SNPs utilizing the solved structure of the 
polymerase rather than that of murine TdT. 
The threonine to serine amino acid change at position 450 does not result in an 
amino acid chemical property change since both residues are polar (they contain an 
hydroxyl group -OH). Therefore, the new residue, serine, is expected to maintain polar 
contacts in the same manner as the original amino acid residue, threonine. Threonine 
contains an extra methyl side chain group (-CH3) as compared to serine, thus this SNP 
results in a substitution for a smaller residue with no change to the chemical nature of the 
residue. An amino acid change from a big to relatively small mol1ecule is not expected to 
create steric hindrance at the structural protein level. However, T450 is located within 
one of two incoming dNTP-binding sites as identified by Delarue et. al. (5). The dNTP-
binding site conserved consensus sequence ALLGWTGSR (residues 445-453) is part of a 
hinge region first identified in polymerase ~ that is involved in open-closed conformation 
transition of the enzyme (5, 15) (Figure 4.1 ). A445T SNP is also found within the 
incoming dNTP-binding sites (ALLGWTGSR, residues 445-453). This SNP substitutes a 
small non-polar alanine residue for a bigger polar threonine amino acid residue. This 
mutation might create new polar interactions with surrounding residues that were 
otherwise absent. 
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A second SNP (R460Q), is also in close proximity to the active site of TdT. This 
substitution results in a change of a basic amino acid residue to a polar uncharged 
residue. This substitution may disrupt original side chain interactions with surrounding 
amino acid residues, thus potentially affecting the microenviromment in the vicinity of 
this SNP. 
Arginine at position 431 (R431) participates in a salt bridge between D343 and 
cobalt cation (Co2+). Specifically, positively charged amine group of arginine non-
covalently interacts with the negatively charged oxygen atom of carboxyl group (oxygen 
at position 82) of aspartate, while positively charged cobalt cation interacts with 
negatively charged oxygen (position 81) of the same catalytic aspartate residue. The 
amine group of R431 also interacts with negatively charged oxygen of D434 (oxygen at 
position 81) (Figure 4.1). Thus, the salt bridges created contribute to the overall stability 
of TdT at the active site. Loss of positive charge at R431 will therefore disrupt this salt 
bridge, as in the case of R431 C variant, rendering TdT's catalytic site less stable. 
L397S SNP is located at the unstructured lariant-like Loop 1 region 
(ESTFEQPSRVKDALDH, residues 382-401) (Figure 4.3) that has been shown to 
associate with template independent polymerase activity. Romain et. al. demonstrated 
that a 13 residue deletion of Loopl, including L397, managed to switch the template 
independent activity of TdT to template dependent activity comparable to polymerase /.... 
that lacks the loop region (17). Thus, it is though that TdT's Loopl region sterically 
excludes double stranded template DNA from the active site and promotes template 
independent polymerase activity. 
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Lastly, D280H SNP is located at the periphery of TdT, away from the active site. 
Thus, it served as an experimental control that was hypothesized not to affect the 
polymerase activity. 
Figure 4.1: Crystal structure of murine TdT (PDB ID: IKEJ) and location of A445 and 
T450 residues within incoming dNTP-binding site. Alpha helical structure highlighted in 
green represents incoming dNTP-binding site (ALLGWTGSR, residues 445-453). The 
locations of A445 and T450 are shown in magenta. The second incoming dNTP-binding 
site is highlighted in red (TGGFRRG, residues 331-337). Three iConserved aspartic acid 
residues are highlighted in blue (D343, D345 and D434). The incoming nucleotide 
substrate, ddATP, is shown in yellow. Two cobalt ions are colored cyan. Figure 
generated using PyMol software. 
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Figure 4.2: Crystal structure of murine TdT (PDB ID: IKEJ) an~ salt bridge interactions 
of R431 with catalytic aspartate residues. Three conserved aspartic acid residues are 
highlighted in blue (D343, D345 and D434). Salt bridge interactions between R431 
amine group and carboxyl group of D434 and D343 are shown in dashed lines (atomic 
distances of 3.0A and 3.2A are labeled). The incoming nucleotide substrate, ddATP, is 
shown in yellow. Two cobalt ions are colored cyan. Figure 1generated using PyMol 
software. 
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Figure 4.3: Crystal structure ofmurine TdT in complex with ddATP (PDB ID: IKEJ) is 
superimposed onto the murine TdT structure in complex with primer single stranded 
DNA (PDB ID: IKDH). Unstructured Loopl is shown in yellow 
(ESTFEQPSRVKDALDH, residues 382-401) and L397 position is highlighted in 
magenta. Three conserved aspartic acid residues are highlighted in blue (D343, D345 and 
D434). The incoming nucleotide substrate, ddATP, is shown in yellow. Two cobalt ions 
are colored cyan. The primer single stranded DNA represents three nucleotides at the 
active site, specifically 5-bromo-2' -deoxyuridine-5 '-monophosphate, shown in green. 
Figure generated using PyMol software. 
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4.2 hTdTS SNPs demonstrate varied polymerization activities in vitro 
Following the identification of six hTdTS SNP candidates, in vitro polymerase 
activity assays were conducted utilizing purified bacterial His-tagged hTdTS protein 
variants. Figure 3.10 depicts the results of the time course polymerization assay 
comparing WT hTdTS activity versus all six hTdTS SNPs. Five out of siix hTdTS SNPs 
are active in the biochemical assay, while R431 C hTdTS is a dead mutant under the 
assayed conditions. The polymerase activity of all assayed hTdTS variants varied based 
on the maximum length of oligo products produced and the banding pattern of the 
products. The graph in Figure 3.11 plots the change in maximum size of hTdTS oligo 
product versus time of reaction. D280H and T450S polymerization curve overlaps that of 
WT hTdTS, especially within the first 3 minutes of reaction. As detailed earlier, neither 
D280H nor T450S were expected to alter hTdTS activity. D280H SNP is located outside 
the catalytic core, at the periphery of the enzyme, and T450S because the change did not 
result in a notable amino acid change since both the original and the changed residues are 
polar. The banding pattern of D280H and T450S was similar to that of WT protein, 
meaning that most of the DNA signal concentrated at the top of the smear. The broadness 
or tightness of bands demonstrates the heterogeneity in the lengths of the oligo products. 
This heterogeneity may be interpreted as differences in processivity of the polymerase, 
meaning the ability to carry out continuous nucleotide polymerization per single 
association/dissociation event. A broad banding pattern suggests a great heterogeneity of 
oligo product lengths and frequent association/dissociation events of TdT from the DNA 
primer. On the other hand, tight banding pattern implies less heterogtmeity of oligo 
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lengths and thus a processive mode of polymerization. Figure 3.10 iUustrates a tight 
banding pattern for WT hTdTS, D280H and T450S SNPs (observed in three independent 
assays), suggesting the processive mechanism. 
It is important to note that the kinetic mechanism of polymerization by TdT has 
not been conclusively established (1, 2). In 2001, Boule et. al. concluded that it is highly 
probable that DNA synthesis catalyzed by TdT proceeds in a strictly distributive fashion, 
meaning that the oligo product dissociates from TdT following a single nucleotide 
addition (74). They observed that the size of TdT oligo product decreased as lower TdT 
concentrations were used in the in vitro reaction (all reactions carried out under excess 
primer (dA)10 initiator and dATP substrate conditions) (74). The distributive 
polymerization mode has not been agreed upon by researchers in the field. 
The initial polymerization rate of R460Q SNP is slower as compared to WT 
protein, however the most significant difference was observed for A445T and L397S 
SNPs. In fact, A445T initial rate is 3 fold lower and L397S initial rate is 5 fold lower as 
compared to WT hTdTS (comparing the slopes of polymerization curves in Figure 3.11). 
Therefore, A445T and L397S variants are least active out of six SNPs tested. In addition, 
broad banding pattern is observed for these two variants and is distinctive from the tight 
banding pattern of WT hTdTS oligo products. Based on these results I conclude that the 
polymerase mechanism of A445T and L397T appears non-processive under the assayed 
in vitro conditions. 
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4.3 hTdTS activity differs according to dCTPs and dGTPs usage 
A single type of free deoxynucleotide triphosphate was added to the in vitro 
polymerization reaction to observe whether the hTdTS SNPs have a substrate preference 
in utalizing substrate dNTPs (Figure 3.12). The dNTP mix (all four nucleotides) always 
resulted in longest polymerization products by all assayed hTdTS variants. With each 
SNP the dNTP supplement always resulted in the most active polymerase reactions. 
Interestingly, usage of dCTPs or of dGTPs in the reactions resulted in the greatest 
variation among all hTdTS variants when compared to WT hTdTS usage of dNTP, dATP 
and dTTP. Specifically, dCTP polymerization reactions resulted in shorter oligo products 
compared to the starting Cy3-labelled oligo by all assayed hTdTS variants. This 
phenomenon was observed in repeated assays and may be attributed to a 3' to 5' 
exonuclease activity by the polymerase. In spite of this observation, in vitro 3' to 5' 
exonuclease activity has only been shown to associate with long isoforms of hTdT 
(hTdTLl and hTdTL2) (12). Thus, this result is the first report of potential hTdTS in 
vitro 3' to 5' exonculease activity and this activity is only seen in dCTPs supplemented 
reactions. Due to the fact that the short isoform of hTdT is primarily responsible for 
nucleotide additions at coding joints, it is difficult to speculate the origin of this 
phenomenon. Further experiments are required to understand these results. For example, 
performing in vitro polymerization reactions with purified hTdT long isoforms in 
presence of dCTPs and comparing oligo products to hTdT short isoform reactions would 
be informative. 
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Polymerization reactions supplemented with dGTPs result in a predominant band 
of about 50 bases long in all assayed hTdTS variants (Figure 3.12). Even extending the 
reaction times of WT hTdTS in presence of dGTPs did not allow polymerization beyond 
75 base oligo products (Figure 3.13). In order to investigate whether this phenomenon is 
DNA sequence dependent, a complementary nucleotide sequence to the Cy3-labelled 
oligo DNA primer was supplemented in the reaction (Figure 3 .15). The usage of either of 
the Cy3-labelled oligo sequences resulted in the· production of aborted products in the 
presence of dGTPs. Thus, the assay ruled out my initial hypothesis that the aborted dGTP 
reaction product was caused by the sequence of the DNA primer. It is important to note 
that in vivo studies have shown a clear preference for the incorporation of dGTPs and 
dCTPs by TdT versus dA TPs and dTTPs (1, 2). Lieber et. al. have demonstrated that as 
much as two thirds of base composition is G+C at coding joints isolated from V(D)J 
recombination products and only about one third is A+T (75). A plausible explanation for 
the clear G+C preference by TdT has not been established. However, favorable base 
stacking interactions between purine-purine and pyrimidine-pyrimidine bases were 
suggested to explain the observed trend of T dT to add purines or pyrimidines in 
succession to promote DNA stability (71). 
4.4 Usage of double stranded 3' overhang DNA substrate primer is preferred by hTdTS 
Three different DNA substrate primers were used in the in vitro polymerase 
reaction; single stranded DNA, blunt ended double stranded DNA and double stranded 
DNA with a 3' nucleotide overhang. Five of the assayed hTdTS variants (R43 l C, the 
"dead" mutant, remained inactive) were able to polymerize all three DNA substrates 
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__ l__ 
(Figure 3.14). This result supports the mechanism of hairpin opening process in vivo 
during V(D)J recombination. TdT requires a free 3' hydroxyl end group of a DNA primer 
in order to catalyze the formation of a new phosphodiester bond with an incoming dNTP. 
Off-center hairpin opening of double stranded DNA results in generation of short 
nucleotide overhangs, known as P nucleotides. A blunt ended DNA results if the hairpin 
opening occurs at the tip. Thus, both types of double stranded DNA primers may be 
utilized by TdT in a lymphoid cell. 
A clear preference for double stranded 3' overhang DNA primer by all hTdTS 
variants is demonstrated in Figure 3.14. The blunt end double stranded DNA primer is the 
least preferred substrate of hTdTS. Therefore, 3' overhang DNA primer is the more 
efficient substrate for TdT within the in vitro setting. Overall, the data lead to the 
conclusion that there are no marked difference between hTdTS SNPs and WT hTdTS to 
polymerize the three DNA primer substrates. It is important to note that in vivo TdT may 
only add up to 15 nucleotides at the coding joint between recombined gene segments in 
order to properly maintain the shape and size of newly formed antigen receptor. Excess 
nucleotide additions between V(D)J segments would result in a misfolded and non-
functional receptor that would be degraded in the cell. A fact that has found a viable and 
advantageous market for biotech companies marketing TdT. On the other hand, the in 
vitro polymerization reaction is able to promote hundreds of nucleotide additions in the 
presence of excess amounts of substrate dNTPs. Therefore, although the in vitro activity 
does not reflect the in vivo ability of hTdT to carry its function the assay does reveal the 
fundamental polymerase activity of the enzyme. 
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4.5 Cobalt versus magnesium cofactor use 
TdT has been shown to use a variety of divalent cations for in vitro 
polymerization reactions, including cobalt, magnesium, zmc and manganese. At 
physiological conditions it is thought that magnesium is the primary divalent cation 
promoting TdT's activity (1, 2). Based on these considerations the polymerization 
activity in the presence of cobalt or magnesium was investigated (Figure 3 .16). Wild type 
hTdTS and R431 C variant reactions are shown. R431 C hTdTS remained a dead mutant, 
as shown previously, in presence of either cofactors. However, smears were observed 
below the control Cy3-labelled oligo band in the absence of cobalt or the presence of 
magnesium that have not been seen previously. As detailed earlier, this activity may be 
interpreted at 3' to 5' exonuclease activity that is related to the cobalt cofactor in the 
reaction. These smears were not present in the WT hTdTS reactions, suggesting that this 
observation is unique to the inactive R431 C variant. Structurally, R431 C mutant was 
implicated in coordination of the negative charge associated with triphosphate group of 
incoming dNTP (Figure 4.2). Thus, the effect of R43 l C mutant to drive depolymerization 
reaction in absence of cobalt remains unknown. 
No marked difference was observed between the sizes of WT hTdTS oligo 
products under the different conditions (Figure 3.16). The banding pattern differs when 
comparing WT hTdTS reactions in presence versus absence of cobalt cofactor. Broad 
smears reveal great heterogeneity in lengths of oligo products, such as those reactions in 
absence of cobalt or magnesium supplemented reactions. Tight smears imply less 
heterogeneity of reaction products in presence of cobalt. These observations may point to 
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greater efficiency of WT hTdTS to utilize cobalt versus magnesium in the in vitro 
polymerization reactions. Differences in metal utilization have been investigated in the 
past. In fact, cobalt was shown to increase the catalytic polymerization efficiency of 
pyrimidines, while magnesium facilitates preferential addition of purines (76-78). 
4.6 Examining R-values in V(D)J recombination assay 
Following in vitro polymerization assays of six hTdTS SNP candidates, V(D)J 
recombination assay was employed. The assay models RAG-mediated V(D)J 
recombination process on a substrate plasmid and the ability of TdT to contribute to 
junctional diversity (Figures 2.4, 2.5, 2.6). Three hTdTS SNPs were investigated, namely 
A445T, L397S and R43 l C, since they demonstrated significant functional differences as 
compared to WT hTdTS in in vitro polymerization assays. Recombination efficiency was 
examined through calculating R-values from in vivo recombination assay. R-value 
represents the ratio of recombined substrate plasmid over all recombination substrate 
plasmids, which indirectly represents the efficiency of recombination during transfection. 
As R-values are ratios, the efficiencies from multiple transfections can be compared 
(Appendix C). Figure 3.19 plots the calculated R-values from of eight independent 
HEK293T cell transfections. No marked difference in mean R-values was observed 
between WT hTdTS, A445T and R431C variants. The mean R-value for L397S variant 
was the 1.5 fold higher than that of WT hTdTS, suggesting highest recombination 
efficiency of these transfections. In addition, L397S variant generated the highest number 
of ampicillin and chloramphenicol resistant colonies in repeated transfections, which 
supports favorable recombination. Recombination efficiency has been shown to correlate 
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to changes in RSS DNA sequence (25, 27), such that RAG proteins showed preference to 
utilize certain RSSs more than others. As TdT is known to catalyze nucleotide additions 
to already cleaved double stranded DNA breaks in vivo, its role in recombination 
efficiency has not been established to date. Thus, the direct effect of L397S mutation of 
TdT is difficult to point. In addition, control transfections resulted in a 2 fold higher mean 
R-value compared to WT hTdTS transfections. The presence of TdT decreases 
recombination efficiency, suggesting that TdT may interfere with initiation of V(D)J 
recombination process in the cell. 
4. 7 Analysis of recombined joints 
In vivo recombination assay included co-transfection of recombination substrate 
plasmid, RAG proteins and hTdTS variants into HEK293T cells lacking endogenous TdT 
expression. The recombined substrate plasmids were harvested from each independent 
transfection and the junction region was sequenced (Appendix D) to examine nucleotide 
deletions, P-additions and N-additions. Statistical analysis was performed on the 
generated data. First, on average 4-5 nucleotide deletions were observed for all 
experimental conditions and no significant difference was noted among them (Table 3.2). 
Thus, the presence of TdT does not affect nucleotide deletions at recombined joints. This 
conclusion agrees with the primary function of hTdTS to add random nucleotides and not 
to promote nucleotide deletions (although hTdT long isoforms may catalyze nucleotide 
deletions due to 3' to 5' exonuclease activity). Second, an average of 1.5 P-additions was 
observed per recombined joint for all experimental conditions (Table 3.3). These two 
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parameters served as internal controls for the recombination assay and were found to be 
independent ofhTdTS. 
The number of random N-additions was analyzed among the three hTdTS variants 
and compared to WT hTdTS transfections. This analysis provides a measure for TdT's 
polymerase activity and allows for comparison among polymorphic forms of the enzyme. 
WT hTdTS demonstrated the greatest activity through the addition of 3 nucleotides on 
average per recombined joint (Table 3.4). Three of the 48 recovered joints from control 
transfections (lack TdT expression) each contained one N-addition. This type of activity 
can be attributed to the action of polymerase µ that possess both template dependent and 
template independent polymerase activity. In fact, TdT knockout mice were shown to 
have template independent additions at nearly 5% of their V(D)J junctions. It is thought 
that random additions are beneficial for annealing of the coding ends during non-
homologous end jointing due to 1 or 2 nucleotides of terminal microhomology ( 45, 52, 
55). 
A445T hTdTS demonstrated in vivo polymerase activity comparable to WT 
hTdTS. The recombination assay revealed no significant difference in the number of N-
containing joints compared to WT hTdTS (78 versus 73%, Table 3.4). A445T 
recombined joint were GC-rich, as were the WT hTdTS joints. An even distribution was 
observed between the occurrences of 1-4 N-additions per A445T recombined joint 
(Figure 3.21 ). Finally, the mean length of arbitrary CDR region in the presence of A445T 
was not significantly different from that of WT hTdTS (27 .68 versus 28 bases, p-value 
0.4719, Figure 3.22). Therefore, I conclude that A445T SNP does not to alter hTdTS 
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polymerase activity in vivo despite its location within the incoming dNTP-binding site of 
the polymerase. 
The proportion of N-containing recombined joints revealed a significant 
difference for L397S SNP. About 73% of WT hTdTS joints contained N-additions, 
versus only 23% of L397S hTdTS (p-value <0.0001) (Table 3.4). Figure 3.22 depicts the 
lengths of arbitrary CDR regions of recombined joints. The L397S variant generated 
significantly shorter CDR regions compared to WT hTdTS (25.56 versus 28 bases), 
suggesting less overall additions of non-temp lated nucleotide and subsequent diversity at 
the junction region. As detailed earlier, L397S position is located within unstructured 
Loop 1 region that is thought to prevent double stranded DNA primer substrate from 
diffusing into the active site of TdT (Figure 4.3). It is possible that non-polar leucine to 
polar serine amino acid change forms new intra-molecular polar contacts within the 
Loop 1 region, rendering it less flexible. This in turn may decrease the efficiency of DNA 
primer substrate diffusion into the active site, thus resulting in lower frequency of N-
containing joints. 
R431 C variant that was found to be inactive in vitro, however demonstrated N-
addition ability in the in vivo recombination assay. However, R431 C was the least active 
polymerase adding an average of only 1.38 nucleotides per joint. Only about 23% of 
R431 C recombined joints contained N-additions versus 73% of WT joints (p-value 
<0.0001) (Table 3.4). Most of R431C joints had a single nucleotide addition compared to 
WT hTdTS joints (Figure 3.21). In fact, over 70% of the R431C joints that contained N 
additions, contained 1 N-addition while WT hTdTS demonstrated somewhat even 
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distribution between 2, 3 and 4 N-additions per joint. Referring back to Figure 4.2, it is 
plausible that an essential salt bridge between amine group of arginine and catalytic 
aspartate residues (namely D343 and D434) was disrupted, causing loss of stability at the 
active site. In vitro, this mutation turned out to be deleterious for the polymerase, while in 
vivo it resulted in the least active polymerase out of all assayed. The amimo acid change 
did not eliminate polymerase activity all together, however. Potentially, the R431 C 
variant was having difficulty initiating the polymerase reaction in terms of coordination 
of cations in addition to the polymerization reaction since significantly short N-additions 
were observed. In addition, significantly shorter arbitrary CDR region were generated in 
R431C experiments versus WT hTdTS (26.32 versus 28 bases, p-value <0.0001) (Figure 
3.22). The type of nucleotide added by hTdTS was also investigated in terms of AT 
versus GC content. As detailed earlier, TdT shows preferential addition of GC bases to 
V(D)J junctions in vivo (1, 2). Indeed, WT hTdTS recombined joints contained mostly 
GC bases (77%, Table 3.4). Surprisingly, the abundance of AT bases in R431C 
recombined joints was greater than GC bases (about 73% AT versus 27% GC bases). 
This result demonstrated a clear switch in terms of dNTP preference by R431 C. The 
specific SNP is not located in the dNTP binding site of hTdTS, thus it is difficult to 
speculate the reason behind the switch. However, it was clearly demonstrated that R431 C 
SNP has a profound effect on polymerase activity, both in vitro and in vivo. 
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4.8 Implications ofhTdTS SNPs on adaptive immune diversity 
Both L397S and R431C SNPs of hTdTS demonstrated low polymerase activities 
compared to WT hTdTS in vitro and in vivo assays. Decreased polymerase activity in 
tum affects junctional diversity at V(D)J junctions of antigen receptors of B and T cells. 
As TdT is partially responsible for antigen receptor diversity allowing recognition of 
broad pathogens by the adaptive immunity, its diminished activity may impair the 
development of a diverse antigen receptor repertoire. Failure to recognize invading 
pathogens lowers the chances of the immune system to promote an adequate response to 
fight the infection. Thus, it is plausible to hypothesize that otherwise healthy individuals 
homozygous for these hTdTS SNPs may encounter difficulty in mounting an adaptive 
immune response due to the lack of a specific high affinity antigen receptors. This may 
promote susceptibility for pathogens and subsequently increase the risk of infection. 
The specific role of TdT in autoimmune models remains controversial. Absence 
ofTdT has been shown to correlate with decreased severity of autoimmune diseases, such 
as lupus and diabetes (57-59). In fact, TdT-deficiency has been linked to decreased 
number of autoantibody producing cells. This deficiency may provide a protective role 
against autoimmunity due to lower polyreactivity towards self-antigens and reduction in 
autoantibody affinities. Researchers speculate that this autoimmune protection is the 
reason for the delayed onset of TdT activity during fetal development (57-60). The 
junctional diversity brought on by TdT is thought to produce pathogenic high affinity 
lymphocytes that protect individuals from foreign pathogens. Thus, autoimmune-prone 
individuals homozygous for the investigated SNPs (L397S and R43 l C) may experience 
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symptom relief associated with autoimmunity and potentially control the disease. It is 
likely that TdT represents one form of activity involved in autoimmunity, as TdT 
generates B and T cell receptors that are not-self. Other factors influemcing onset of 
autoimmunity and its progression remain unknown. However, TdT suppression 
represents a new therapeutic avenue to manage autoimmune-related disorders. 
It is now evident that single nucleotide polymorphisms, present in all individuals, 
contribute to individual phenotypes, susceptibility to disease or even cause a disease. 
Studies focused on understanding genetic diversity among individuals, such as this, will 
provide information on the variation seen within a population as well as allow researchers 
to explore personalized medicine to tailor individual genetic backgrounds. 
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Conclusion 
In this thesis, the in vitro and in vivo functional polymerase activities of few 
single nucleotide polymorphisms of hTdTS were investigated. The aim was to 
characterize the possible effects of SNPs on the diversity of V(D)J joints during 
recombination process of B and T cell receptors. A445T and L397S variants were 
observed to affect TdT polymerization reactions in vitro, while R4Jl C SNP demonstrated 
no polymerase activity whatsoever. Analysis of the in vivo activity was done via 
extrachromosomal V(D)J recombination assay. L397S SNP resulted in highest 
recombination efficiency out the three assayed variants. In addition, L397S substitution 
resulted in low in vivo polymerase activity that may have been caused by loss of 
flexibility of the unstructured Loopl region. In vivo R43 l C hTdTS demonstrated lowest 
activity in terms of N-additions. The proportion of N-containing joints and the number of 
nucleotide additions per recombined joint were significantly lower compared to WT 
enzyme. This may be attributed to disruption of an essential salt bridges caused by the 
aID:ino acid substitution within the catalytic site of the polymerase. It is evident that 
hTdTS SNPs revealed variable effects on both the in vitro and the in vivo TdT activities. 
Thus, homozygous individual for these SNPs may alter the V(D)J junctional diversity at 
B and T cell receptor and subsequently affect the adaptive immune response. Evidence of 
TdT's connection to autoimmunity has sparked an interest to investigate the role of the 
polymerase and its therapeutic potential in immune-related diseases. 
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Appendix A: Complete list ofhTdT variant 1 SNPs categorized according to hTdT mRNA position, base change, amino acid 
position and change, the chemical nature of amino acid change and the type of mutation. Chosen SNPs for the study are 
highlighted in bold. Adapted from NCBI SNP database. 
mRNA Base Amino Amino Chemical nature of Type of 
acid acid SNPID position change position change amino acid change mutation 
1 rs144113836 180 CtoG 4 Pro to Ala No change; non-polar to non-polar Missense 
2 rs199671984 197 GtoC 9 Leu to Phe No change; non-polar to non-polar Missense 
3 rsl44375473 203 TtoC 11 Pro to Pro No change Synonymous 
4 rs148791733 216 CtoT 16 Pro to Ser Non-polar to polar Missense 
5 rs 183314099 219 CtoT 17 Argto Trp Positively charged to non-polar Missense 
6 rs188914324 245 CtoT 25 Ser to Ser No change Synonymous 
7 rs 142422958 259 TtoC 30 Ile to Thr Non-polar to ,polar Mis sense 
8 rsl 12589253 279 GtoA 37 Val to Ile No change; non-polar to non-polar Missense 
9 rsl39248550 301 TtoC 44 Met to Thr Non-polar to polar Missense 
10 rs201054340 311 CtoT 47 Thr to Thr No change Synonymous 
11 rs144026779 313 GtoA 48 Arg to His No change; positively charged to Missense positively charged 
12 rsl44017257 348 GtoC 60 Glyto Arg Non-polar to positively charged Missense 
13 rs7081385 392 CtoT 74 Ile to Ile No change Synonymous 
-14 rs36-126211 439 - CtoT 90 Ahfto Val No change; iion~polaflo non-polar -··rviissense 
15 rs150564632 455 CtoT 95 Val to Val No change Synonymous 
16 rs20183 5 844 471 CtoT 101 Leu to .Phe No change; non-polar to non-.polar Mis_s.ense 
17 rs143503401 476 CtoT 102 Leu to Leu No change Synonymous 
18 rs6584066 504 AtoG 112 Argto Gly Positively charged to non-polar Missense 
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19 rs148898308 511 GtoA 114 Gly to Glu Non-polar to negatively charged Missense 
-I--.> 
00 
~·~ .. "' ... 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
-t·...J 
\0 
rs61758435 
rs 150972091 
rsl41660410 
rsl47054012 
rs201827729 
rsl383 l 7908 
rs34111381 
rs150189459 
rs 138972209 
rs 181822026 
rs 112342086 
rsl 83180123 
rs149429691 
rs140275341 
rs144787508 
rs201883920 
rsl39656736 
rs 141822346 
rs20043 l 503 
rs41291616 
rs61729855 
- -
rs77358696 
rs34175187 
rs200138780 
rsl81202846 
rs202209727 
557 AtoG 
587 etoA 
588 etoA 
589 etoT 
590 GtoA 
622 etoT 
665 etoT 
733 TtoA 
756 Ttoe 
773 GtoA 
827 etoT 
872 Ttoe 
888 GtoT 
893 AtoG 
902 AtoG 
921 etoT 
924 Ttoe 
932 Ttoe · 
975 AtoT 
1008 GtoC 
1010 etoA 
1046 Atoe 
1091 Atoe 
1127 etoG 
1144 AtoT 
1217 CtoA 
129 Argto Arg No change Synonymous 
139 Pro to Pro No change Synonymous 
140 Pro to Thr Non-polar to polar Missense 
140 Pro to Leu No change; non-polar to non-polar Missense 
140 Pro to Pro No change Synonymous 
151 Ser to Phe Polar to non-polar Missense 
165 Asn to Asn No change Synonymous 
188 eys to Tyr No change; polar to polar Missense 
196 Ser to Pro Polar to non-polar Mis sense 
201 Leu to Leu No change Synonymous 
219 Ser to Ser No change Synonymous 
234 Ser to Ser No change Synonymous 
240 Val to Leu No change; non-polar to non-polar Mis sense 
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244 Glu to Glu No change Synonymous 
251 Leu to Phe No change; non-polaf- to non-polar Missense 
252 Phe to Leu No change; non-polar to non-polar Missense 
254 Ser to Ser No change Synonymous 
269 Met to Leu No change; non-polar to non-polar Missense 
280 Asp to His Negatively charged to positively Missense 
char2ed 
280 Asp t~. Glu No change; negatively charged to Missense 
negatively charged 
292 Glyto Gly No change Synonymous 
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Arg to His No change; positively charged to Mis sense positively charged 
Ar_g to Cys Positively charged to polar Missense 
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Argto Trp ·Positively charged to non-polar Missense 
His to Tyr Positively charge,d to polar Missense 
Argto Gln Positively charged to polar Missense 
Ile to Phe No change; non-polar to non-polar Missense 
Glyto Glu Polar to negatively charged Missense 
Ile to Phe No change; non-polar to non-polar Missense 
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Figure 1: Coomassie stained 12% SDS-PAGE gels containing His-tag purification 
samples of D280H, R431 C, L397S, A445T, R460Q and T450S hTdTS protein variants. 
Crude lysate (CL) fraction was collected after cell lysis. Flow-through (FT) fraction was 
collected after incubation of crude lysate with the nickel resin. The wash (W) fractions 
were collected to test for removal of non-specific nickel resin binding. The elution (E) 
fraction depicts single protein band at around 58kDa, corresponding to hTdTS. 
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Appendix C: Raw data of in vivo V(D)J extrachromosomal recombination assay. 
Table 1: Summary of in vivo V(D)J recombination assay depicting 8 independent HEK293T cell transfection results. Bacterial 
counts of ampicillin resistant (AMP) and chloramphenicol and ampicillin resistant (CAM/AMP) colonies are shown along with 
number of picked double-resistant colonies and the number of true recombined plasmids obtained following colony PCR and 
plasmid sequencing. 
TF 
# 
1 
2 
3 
VJ 
VJ 
Experimental 
Condition 
Control 
WT* 
A445T 
L397S 
Control 
WT 
A445T 
L397S 
R431C 
Control 
WT 
A445T 
L397S 
R431C 
Volume 
Plated 
100µ1 
100µ1 
100µ1 
100µ1 
100µ1 
100µ1 
100µ1 
100µ1 
100µ1 
100µ1 
100µ1 
UlOµl 
100µ1 
100µ1 
AMP Plates 
Number of 
Colonies 
200X 400X 
Dilution Dilution 
207 111 
2 1 
32 39 
238 124 
TNTC 768 
TNTC 800 
TNTC 560 
TNTC 868 
TNTC 652 
--
TNTC 1 ig 
TNTC 130 
TNTC TNTC 
TNTC TNTC 
320 197 
CAM/AMP Plates Total# Number of Number of 
Number of Colonies Picked True True 
CAMI Recombine Recombined Volume 
Plate Plate Plate AMP d Plasmids Plasmids Plated (colony A B c Colonies (sequencing) PCR) 
450µ1 0 2 - 2 0 0 
450µ1 0 0 - 0 0 0 
450µ1 1 0 - 1 0 0 
450µ1 10 7 - 17 5 5 
300µ1 4 9 3 16 4 1 
300µ1 4 3 1 . 8 2 2 
300µ1 3 2 3 8 4 3 
300µ1 3 9 4 16 11 11 
300µ1 3 5 4 12 10 6 
~50µ1 151 250 - 27 15 14 
450µ1 13 12 - 30 16 15 
4~0:µ1 16 7 - 23 15 13 
450µ1 67 101 - 31 15 15 
450µ1 6 14 - 22 9 9 
~ 
AMP Plates c;~AMP Plates Total# Number of Number of 
Number of Number of c;olonies Picked True True TF Experimental c;olonies c;~ Recombined Recombined Volume Volume # c;ondition Plate Plate Plate AMP Plasmids Plasmids Plated lOOX 500X Plated (colony A B c; c;olonies (sequencing) Dilution Dilution Pc;R) 
c;ontrol 100µ1 780 468 300µ1 30 43 42 18 11 11 
WT 100µ1 451 105 300µ1 1 2 6 9 4 4 
4 A445T 100µ1 342 107 300µ1 4 4 2 10 7 5 
L397S 100µ1 936 394 300µ1 14 34 19 30 19 19 
R43lc; 100µ1 290 88 300µ1 8 5 3 16 11 10 
c;ontrol 100µ1 860 351 300µ1 25 28 55 15 7 7 
WT 100µ1 285 59 300µ1 18 2 2 15 4 4 
5 A445T 100µ1 425 136 300µ1 0 3 3 6 0 0 
L397S 100µ1 760 255 300µ1 29 9 22 15 10 9 
R43lc; 100µ1 227 79 300µ1 6 0 2 8 0 0 
c;ontrol 100µ1 960 401 300µ1 71 79 61 30 16 14 
WT 100µ1 452 226 300µ1 0 5 6 11 7 6 
6 A445T 100µ1 607 60 300µ1 3 2 7 12 8 7 
L397S 100µ1 712 289 300µ1 23 22 26 50 35 29 
:• R43lc; 100µ1 97 174 300µ1 2 2 3 7 2 2 
c;ontrol 100µ1 TNTc; 447 300µ1 114 91 57 30 13 11 
WT 100µ1 511 430 JOOµl 30 24 17 45 18 16 
7 A445T 100µ1 520 83 300µ1 14 27 28 60 34 33 
L397S 100µ1 TNTc; 792 300µ1 131 110 81 30 16 13 
R4Jic; 100µ1 648 259 300µ1 17 13 14 45 12 10 
-w 
~ 
AMP Plates CAMI AMP Plates Total# Number of Number of 
Number of Number of Colonies Picked True True TF Experimental Colonies CAMI Recombined Recombined Volume Volume # Condition Plate Plate Plate AMP Plasmids Plasmids Plated lOOX 500X Plated (colony A B c Colonies (sequencing) Dilution Dilution PCR) 
., 
Control 100µ1 TNTC 504 300µ1 22 29 17 24 14 11 
WT 100µ1 736 237 300µ1 5 7 4 16 13 13 
8 A445T 100µ1 1068 288 300µ1 2 10 8 20 14 12 
L397S * 100µ1 332 133 .. 300µ1 2 1 4 7 4 4 
R431C 100µ1 448 114 300µ1 6 4 1 11 6 6 
Experimental conditions of HEK293T cell transfections; 
Control = transfection with substrate pGG5 l plasmid + pEBG-hRAG 1 + pEBG-hRAG2 expressing vectors 
WT= transfection with wild type hTdTS pcDNA expressing vector+ substrate pGG5 l plasmfd + pEBG-hRAG 1 + pEBG-
hRAG2 expressing vectors 
A445T = transfection with A445T hTdTS pcDNA expressing vector+ substrate pGG5 l plasmid+ pEBG-hRAG 1 + pEBG-
hRAG2 expressing vectors 
L397S = transfection with L397S hTdTS pcDNA expressing vector+ substrate pGG5 l plasmid + pEBG-hRAG 1 + pEBG-
hRAG2 expressing vectors 
R43 l C = transfection with R43 l C hTdTS pcDNA expressing vector+ substrate pGG5 l plasmid+ pEBG-hRAG 1 + pEBG-
hRAG2 expressing vectors 
* The bacterial transformation via electroporation of those transfection conditions marked by a star (*) has arched, indicated by 
a popping sound, thus reducing transformation efficiency due to uneven electrical current applied. 
** TNCT: Too numerous to count. 
I.;.) 
VI 
Table 2: Calculating recombination frequency values (R-value) of 8 independent HEK.293T cell transfections. Bacterial counts 
of ampicillin resistant and chloramphenicol and ampicillin resistant colonies are shown· for 1 ml of undiluted transformation 
mixture. The mean R-value and standard deviation are calculated from 8 independent HEK.293T cell transfections. 
VJ 
°' 
TF# 
. ' 
1 
2 
3 
4 
5 
6 
7 
8 
1 
2 
3 
4 
5 
6 
7 
8 
.. · .. );,.·. 
' 
Control 
. . i ~t\ ' 
·. 
444000 
307200 
47200 
2340000 
1755000 
2005000 
2235000 
2520000 
2 
18 
446 
128 
120 
234 
291 
76 
WThTdTS A445T hTdTS L397S hTdTS R431C hTdTS 
• ; A l!IJIJ'.iJ:illifl r.~$..isl@!lt ~<!l<U!i~ . . .. i 
' 
--- 15600 49600 ---
320000 224000 347200 260800 
52000 TNCT TNCT 78800 
525000 535000 1970000 440000 
295000 680000 1275000 395000 
1130000 300000 1445000 485000 
2150000· 415000 3960000 1295000 
1185000 40000 6,5000 570000 
ChloramphenlcQl and ampicillin resistant colonies . -
---
I 19 ---
9 9 18 13 
28 26 187 22 
10 11 74 18 
24 7 67 9 
12 13 79 8 
79 60 358 49 
18 22 8 12 
TF# Control WThTdTS A445ThTdTS L397S hTdTS R431C hTdTS 
.- ... ;_""::~·~-· ;'. .. ~ ... _. : · .... -... 
,, . . ':R-v4lui!_ (%) ·:. ·. · :»·~ · . ,-.:. " -~ ~- ... ·"·~· .r.' 
1 0.00045045 
--- I 0.006410256 0.038306452 * 
2 0.005859375 0.0028125 0.004017857 0.005184332 0.004984663 
3 I 0.944915254 * 0.053846154 * 0.027918782 * 
4 I 0.0054 70085 0.001904762 0.002056075 0.003756345 0.004090909 
5 I 0.006837607 0.008135593 0.001029412 0.005254902 0.002278481 
6 I 0.011670823 0.00106194 7 0.004333333 0.005467128 0.001649485 
7 I 0.013020134 0.003674419 0.014457831 * 0.009040404 0.003783784 
8 I 0.003015873 0.001518987 0.05500000 * 0.001203008 0.002105263 
Mean R-value (%) I 0.00662 0.00318 0.00357 0.00498 0.00315 
Standard deviation I 0.00446 0.0026 0.0021 0.00255 0.00132 
*Values marked with a star(*) were disregarded in mean R-value and standard deviation calculations, due to their significant 
deviation from other values. The bacterial transformations associated with these values were arched, indicated by a popping 
· · sound, thus reducing transformation efficiency due to uneven electrical current applied .. -
**Dashed lines(---): value is not available due to arched bacterial transfonnation. 
*** TNCT: Too numerous to count. 
****The R-values calculated in this table are represented on a scatter-plot graph in Results section, Figure 3.19. Number of 
ampicillin resistant colonies was calculated using the lower dilution available; either 400X or 500X. Sample calculation is 
shown below. 
-w 
......:l 
Sample calculation of R-value (%) 
R-value (%) = 
The total number of AMP + CAM resistant colonies in a 
specific volume of undiluted transformation sample 
The total number of AMP resistant colonies in the same 
volume of undiluted transformation sample 
Sample calculation from Control TF # 1 (Appendix C, Table 1 ); 
# AMP resistant colonies in 400X diluted transformation sample = 111 
#AMP resistant colonies in lml of undiluted transformation sample= 44,400 
# CAM+AMP resistant colonies in 900µ1 undiluted transformation sample= 2 
# CAMI AMP resistant colonies in 1 ml of undiluted transformation sample = 2 
[(2xl 000µ1)/900µ1=2] 
R-value (%) = (2/44,400) * 100 % = 0.0045045 % 
x 100% 
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Table 3: Total number of unique substrate pGG51 plasmid sequences obtained in 8 
independent mammalian cell transfections in in vivo extrachromosomal V(D)J 
recombination assay. 
Control 
* TF stands for HEK293T cell transfection number. 
** The number of repeated sequences generated within the same transfection, shown in 
brackets, were excluded from the joint analysis. 
Experimental conditions ofHEK293T cell transfections; 
Control = transfection with substrate pGG51 plasmid + pEBG-hRAG 1 + pEBG-hRAG2 
expressing vectors 
WT hTdTS = transfection with wild type hTdTS pcDNA expressing vector+ substrate 
pGG51 plasmid+ pEBG-hRAG 1 + pEBG-hRAG2 expressing vectors 
A445T hTdTS = transfection with A445T hTdTS pcDNA expressing vector+ substrate 
pGG51 plasmid + pEBG-hRAG 1 + pEBG-hRAG2 expressing vectors 
L397S hTdTS = transfection with L397S hTdTS pcDNA expressing vector+ substrate 
pGG51 plasmid + pEBG-hRAG I+ pEBG-hRAG2 expressing vectors 
R431 C hTdTS = transfection with R431 C hTdTS pcDNA expressing vector+ substrate 
pGG51 plasmid + pEBG-hRAG 1 + pEBG-hRAG2 expressing vectors 
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Appendix D: Analysis of all obtained recombined substrate pGG51 plasmid joint sequences from in vivo V(D)J recombination 
-
:;f· ${lJQ.P+• 
Germline 
1 2-Cl 
2 2-C2 
3 3-Cl 
4 3-C2 
5 3-C3 
6 3-C4 
7 ·:· :-r 3-CS 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
~ 
0 
3-C6 
3-C7 
3-C8 
3-C9 
3-ClO 
3-Cll 
4-Cl 
4-C2 
4-C3 
4-C4 
4-CS 
4-C6 
4-C7 
4-C8 
4-C9 
4-ClO 
5~ f1~~g ~e.9'~0-P ~ ~ 
.. 
~~ 3 I. ~~~plti.Jlg; .,J;@g,;pii. 
TGGCTGCAGGTCGAC GGATCCCCGGGGATC 
TGGCTGCAGGTCG-- -GATCCCCGGGGATC 
TGGCTGCAGGTCGAC G ---TCCCCGGGGATC 
TGGCTGCAGGTCGAC GT -----CCCGGGGATC 
TGGCTGCAGGTCGAC GT ----CCCCGGGGATC 
TGGCTGCAGG----- c -GATCCCCGGGGATC 
TGGCTGCAGGT---- --ATCCCCGGGGATC 
TGGCTGCAGGTC--- ---TCCCCGGGGATC 
TGGCTGCAGGTCG-- ----CCCCGGGGATC 
TGGCTGCAGGTC--- -----CCCGGGGATC 
TGGCTGCAGGTCGAC -GATCCCCGGGGATC 
TGGCTGCAGGTCGAC G ' ---TCCCCGGGGATC 
TGGCTGCAG------ --ATCCCCGGGGATC 
TGGCTGCAGGTCG-- -GATCCCCGGGGATC 
TGGCTGCAGGTC--- -----CCCGGGGATC 
TGGCTGCAGGTCGAC GT --ATCCCCGGGGATC 
TGGCTGCAGG----- -GATCCCCGGGGATC 
TGGCTGCAGGTC--- -----CCCGGGGATC 
TGGCTGCAGGTCGAC GT ----CCGCGGGGATC 
TGGCTGCAGG----- c -GATCCCCGGGGATC 
TGGCTGCAGGT---- -GATCCCCGGGGATC 
-
TGGCTGCAGGTCGAC G ---TCCCCGGGGATC 
TGGCTGCAGGTCGAC GT -GATCCCCGGGGATC 
TGGCTGCAGG----- --ATCCCCGGGGATC 
- ~--. $~,+.~ : '· 
> §.! -,_f+§~~~g ~~g~Q_,~.' .•,·J.?.: .. ' .. ·.Ji. '· ·,c ··.·--~ - ~I ~:i~~g ·. E@.g~9p 
. 
24 5-Cl TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
25 5-C2 TGGCTGCAGGTCG-- -GATCCCCGGGGATC 
26 5-C3 TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
27 5-C4 TGGCTGCAGG----- --ATCCCCGGGGATC 
28 6-Cl TGGCTGCAGGTC--- -----CCCGGGGATC 
29 6-C2 TGGCTGCAGGTCGAC GT ----CCCCGGGGATC 
30 6-C3 TGGCTGCAG------ --ATCCCCGGGGATC 
31 6-C4 TGGCTGCAGGT---- --ATCCCCGGGGATC 
32 6-C5 TGGCTGCAGGT---- -GATCCCCGGGGATC 
33 6-C6 TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
34 6-C7 TGGCTGCAGGTCGAC G ---TCCCCGGGGATC 
35 6-CB TGGCTGCAGG----- --ATCCCCGGGGATC 
36 7-Cl TGGCTGCAGGTC--- ----CCCCGGGGATC 
6 
37 7-C2 TGGCTGCAGGTCGAC ----CCCCGGGGATC 
38 7-C3 TGGCTGCAGGTCGAC G ---TCCCCGGGGATC 
39 7-C4 TGGCTGCAGGTCGAC GT ----CCCCGGGGATC 
40 7-CS TGGCTGCAGGTC--- -----CCCGGGGATC 
41 7-C6 TGGCTGCAGGTCGAC GGATCCCCGGGGATC 
42 7-C7 TGGCTGCAGGTCG-- GGATCCCCGGGGATC 
43 7-CB TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
44 8-Cl TGGCTGC:AGGTC--- .... - - -----GCGGGGATC 
45 8-C2 TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
46 8-C3 TGGCTGCAGGTCG-- -GATCCCCGGGGATC 
- - - ~ ._ -. -
47 8-C4 TGGCTGCAGGTGGA- ---TCCCCGGGGATC 
48 8-CS TGGCTGCAGGTCGAC G ---TCCCCGGGGATC 
-.,i::.. 
-
:· ··$tg?1• 5 '·. :;·~~-D~~pg:,· J;"S9~P-~ ~ . M . .. ' . . ·.~. ·-· 31, ·. ·~+tP~~g<~~g~,9.:il ,_, 
1 2-Wl TGGCTGCAGGTCGAC G GTTCTT --ATCCCCGGGGATC 
2 2-W2 TGGCTGCAGG----- CTT GGATCCCCGGGGATC 
3 3-Wl TGGCTGCAGGTCG-- cc ---TCCCCGGGGATC 
4 3-W2 TGGCTGCAGG----- --ATCCCCGGGGATC 
5 3-W3 TGGCTGCAGGT---- --ATCCCCGGGGATC 
6 3-W4 TGGCTGCAGGTCGAC AAGA ----CCCCGGGGATC 
7 3-WS TGGCTGCAGGTCG-- GGGGTCTG GGATCCCCGGGGATC 
8 3-W6 TGGCTGCAGGTCGAC GT GG ---TCCCCGGGGATC 
9 3-W7 TGGCTGCAGGTCGAC GT CGAA -----CCCGGGGATC 
10 3-W8 TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
11 3-W9 TGGCTGCAGGTCG-- GGATCCCCGGGGATC 
12 3-WlO TGGCTGCAGGTCG-- G GGATCCCCGGGGATC 
13 3-Wll TGGCTGCAGGTCGA- AGG ----CCCCGGGGATC 
14 3-Wl2 TGGCTGCAGGTCGA- AGG ---TCCCCGGGGATC 
15 3-Wl3 TGGCTGCAGG----- GCCC -GATCCCCGGGGATC 
16 3-Wl4 TGGCTGCAGGTCGAC GT AA -GATCCCCGGGGATC 
17 3-WlS TGGCTGCAG------ ATC --ATCCCCGGGGATC 
18 4-Wl TGGCTGCAGGTCGA- GG -----CCCGGGGATC 
19 4-W2 TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
20 4-W3 TGGCTGCAGG----- CCGC -GATCCCCGGGGATC 
:- 21 4--W4 TGGCTGCAGGTCG-- -GATCCCCGGGGATC 
22 5-Wl TGGCTGCAGGTCG-- GCCTT --ATCCCCGGGGATC 
23 5-W2 TGGCTGCAGG----- cc -GATCCCCGGG . .GATC 
24 5-W3 TGGCTGCAGG----- CGAT -GATCCCCGGGGATC 
2.5 5-W4 TGGCTGCAGGTCGA- --ATCCCCGGGGATC 
-~ 
N 
. ·~a. .. mR+~. -· · . 
26 
27 
28 
29 
30 
31 
32 
33 
34 
~ . .;. 
. 35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
+:i-
v.> 
6-Wl 
6-W2 
6-W3 
6-W4 
6-W5 
7-Wl 
7-W2 
7-W3 
7-W4 
7-W5 
7-W6 
7-W7 
7-WB 
7-W9 
7-WlO 
7-Wll 
7-Wl2 
7-Wl3 
7-Wl4 
7-Wl5 
8-Wl 
8-W2 
8-W3 
8-W4 
8-W5 
. ~' fJ~~~~J).9··~@9~91,l 
TGGCTGCAGGTCGAC 
TGGCTGCAGGTCGAC 
TGGCTGCAGGT----
TGGCTGCAGGTC---
TGGCTGCAGGTCG--
TGGCTGCAGGTCGAC 
TGGCTGCAGG-----
TGGCTGCAGGTCG--
TGGCTGCAGGTCGAC 
TGGCTGCAGG-----
TGGCTGCAGG-----
TGGCTGCAGGTCG--
TGGCTGCAGG-----
TGGCTGCAGG-----
TGGCTGCAGGTCGAC 
TGGCTGCAGGT----
TGGCTGCAGGTCG--
TGGCTGCAGG-----
TGGCTGCAGG-----
TGGCTGCAGGTCGAC 
TGGCT_GCAGG-----
TGGCTGCAGGTC---
TGGCTGCAGGTCG--
TGGCTGCAGGTCG--
TGGCTGCAGG-----
... ·. f .. ~- o' f. 3' ~~~Q.~~:g9·~~9~9p ·. 
cc ---ATCCCCGGGGAT 
G cc ----CCCCGGGGATC 
GGGT --ATCCCCGGGGATC 
c -GATCCCCGGGGATC 
-GATCCCCGGGGATC 
AAAGGGG ----CCCCGGGGATC 
CT cc GGATCCCCGGGGATC 
TA GGATCCCCGGGGATC 
AC ----CCCCGGGGATC 
cc cc GGATCCCCGGGGATC 
cc GGATCCCCGGGGATC 
-GATCCCCGGGGATC 
CG GGATCCCCGGGGATC 
. 
CCT GGATCCCCGGGGATc~· 
--GATCCCGGGGATC 
AGG ---TCCCCGGGGATC 
CGGAA -----CCCGGGGATC 
CCTT --ATCCCCGGGGATC 
CACT -GATCCCCGGGGATC 
GT ATC -GATCCCCGGGGATC 
cc GGATCGGGGGGGATC 
-----CCCGGGGATC 
T GGATCCCCGGGGATC 
GGATCCCCGGGGATC .. 
CCT -GATCCCCGGGGATC 
· · ;" §ets+~ . . 
51 
52 
53 
54 
~5" 
56 
57 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
~ 
~ 
8-W6 
8-W7 
8-W8 
8-W9 
8-WlO 
8-Wll 
8-W12 
2-Al 
2-A2 
2-A3 
3-Al 
3-A2 
3-A3 
3-A4 
3-A5 
3-A6 
3-A7 
3-A8 
3-A9 
3-AlO 
3-All 
4-Al 
4-A2 
4-A3 
4-A4 
. . ~' -fJ..AAJs~:gig., ;''19~Q~· 
TGGCTGCAGGT----
TGGCTGCAGGT----
TGGCTGCAGGT----
TGGCTGCAGGTC---
TGGCTGCAGG-----
TGGCTGCAGGTCGA-
TGGCTGCAGGTGGA-
TGGCTGCAGGTCG--
TGGCTGCAGGTCG--
TGGCTGCAGGTCG--
TGGCTGCAGGTCGAC 
TGGCTGCAGG-----
TGGCTGCAGG-----
TGGCTGCAGGTCGA-
TGGCTGCAGGTCGAC 
TGGCTGCAGGT----
TGGCTGCAGGTCGAC 
TGGCTGCAGGTCGAC 
TGGCTGCAGGTCGAC 
TGGCTGCAGG-----
TGGCTGCAGGTCG--
TGGCTGCAGG-----
TGGCTGCAGGTCGAC 
TGGCTGCAGGTCG--
TGGCTGCAGGTCG--
\' 
,,·-.:·· 
.. · I? " . li . "' "" ·~· f ~· • • · ~· 1-: ;+~:i~g , 1;.~gi,on . 
GG GGATCCCCGGGGATC 
T ---TCCCCGGGGATC 
TCT GGATCCCCGGGGATC 
CAT --ATCCCCGGGGATC 
cc --ATCCCCGGGGATC 
A ------CCGGGGATC 
---TCCCCGGGGATC 
----CCCCGGGGATC 
GGG -----CCCGGGGATC 
---CCCCCGGGGATC 
G AG GGATCCCCGGGGATC 
cc -GATCCCCGGGGATC 
CCTT 
' 
--ATCCCCGGGGATC 
A ----CCCCGGGGATC 
G G GGATCCCCGGGGATC 
T GGATCCCCGGGGATC 
GT GGG -----CCCGGGGATC 
AGGG -----CCCGGGGATC 
GT AGGG ----CCCCGGGGATC 
cc GGATCCCCGGGGATC 
-GATCCCCGGGGATC 
cc GGATCCCCGGGGATC 
----~CCCGGG~~:r'C 
.J 
GA --ATCCCCGGGGATC 
cc cc -GATCCCCGGGGATC 
. . . . . . ~-@J.P.P~~ 
_- ~ '· :.. i:+~pg ~@9;$?P: · P. f;t: p 3' t+.~;ng-_;-~g~9n 
19 6-Al TGGCTGCAGGTCG-- -GATCCCCGGGGATC 
20 6-A2 TGGCTGCAGGTCG-- GG ----CCCCGGGGATC 
21 6-A3 TGGCTGCAGGTC--- -GATCCCCGGGGATC 
22 6-A4 TGGCTGCAGGTCGAC GT AAC ----CCCCGGGGATC 
23 6-A5 TGGCTGCAGGTCGAC G c -GATCCCCGGGGATC 
24 6-A6 TGGCTGCAGGTC--- -----CCCGGGGATC 
25 6-A7 TGGCTGCAGGTCGA- GAG ----CCCCGGGGATC 
26 7-Al TGGCTGCAGGT---- G GGATCCCCGGGGATC 
27 7-A2 TGGCTGCAGGT---- TC -GATCCCCGGGGATC 
28 7-A3 TGGCTGCAGG----- GCAT --ATCCCCGGGGATC 
29 7-A4 TGGCTGCAG------ CC CCC -GATCCCCGGGGATC 
30 7-A5 TGGCTGCAGGT---- T --ATCCCCGGGGATC 
31 7-A6 TGGCTGCAGGT---- TCCT --ATCCCCGGGGATC 
-32 7-A7 TGGCTGCAGGTCG-- cc -GATCCCCGGGGATC 
33 7-A8 TGGCTGCAG------ TT cc GGATCCCCGGGGATC 
34 7-A9 TGGCTGCAGGTCGAC G GGATCCCCGGGGATC 
35 7-AlO TGGCTGCAGG----- cc cc -GATCCCCGGGGATC 
36 7-All TGGCTGCAGGTC--- cc ----CCCCGGGGATC 
37 7-Al2 TGGCTGCAGGTC--- T GGATCCCCGGGGATC 
38 7-Al3 TGGCTGCAGGTCG-- CCG GGATCCCCGGGGATC 
39 7-A14 TGGCTGCAGGT---- T -GA'I'-CCCCGGGGATC 
40 7-A15 TGGCTGCAGGTCG-- cc cc --ATCCCCGGGGATC 
41 7-A16 TGGCTGCAGGTCG-- CCC -GATCCCCGGGGATC 
42 7-A17 TGGCTGCAGG----- GC -GATCCCCGGGGATC 
43 7-Al8 TGGCTGCAGGTCGAC G G ----CCCCGGGGATC 
-~ 
Vl 
·s~1e 5' f~cu*.l:-P.9 z:~giop. p N. p 3' f1~ng ~egiQn 
44 7-A19 TGGCTGCAGG----- CCC -GATCCCCGGGGATC 
45 7-A20 TGGCTGCAGGT---- ATT --ATCCCCGGGGATC 
46 7-A21 TGGCTGCAGGTCG-- c -GATCCCCGGGGATC 
47 7-A22 TGGCTGCAGGTCG-- GC --ATCCCCGGGGATC 
48 7-A23 TGGCTGCAGG----- GG GGATCCCCGGGGATC 
49 7-A24 TGGCTGC-------- cc GGATCCCCGGGGATC 
50 7-A25 TGGCTGCAGGTCG-- -GATCCCCGGGGATC 
51 7-A26 TGGCTGCAGGTCG-- c cc GGATCCCCGGGGATC 
52 7-A27 TGGCTGCAGGTCG-- cc GGATCCCCGGGGATC 
53 7-A28 TGGCTGCAGGTCGAC GGAA ----CCCCGGGGATC 
54 7-A29 TGGCTGCAGG----- cc -GATCCCCGGGGATC 
55 8-Al TGGCTGCAGGTCG-- TTT -GATCCCCGGGGATC 
56 8-A2 TGGCTGCAGGTCGAC G ---TCCCCGGGGATC 
57 8-A3 TGGCTGCAGGTCG-- GG ----CCCCGGGGATC 
58 8-A4 TGGCTGCAGGTCG-- GAG -----CCCGGGGATC 
59 8-A5 TGGCTGCAGGTCG-- TC -GATCCCCGGGGATC 
60 8-A6 TGGCTGC-------- CGCC -GATCCCCGGGGATC 
61 8-A7 TGGCTGCAG------ c -GATCCCCGGGGATC 
62 8-A8 TGGCTGCAGGTCGAC G GAG ----CCCCGGGGATC 
63 8-A9 TGGCTGCAGGT---- T -GATCCCCGGGGATC 
64 8-AlO TGGCTGCAGGTCG-- GC -GATCCCCGGGGATC 
65 8-All TGGCTGCAGGT---- T -GATCCCCGGGGATC 
1 1-Ll TGGCTGCAGGTCGAC GT -----CCCGGGGATC 
2 l-L2 TGGCTGCAGGTCG-- -GATCCCCGGGGATC 
3 1-L3 TGGCTGCAGG----- c GGATCCCCGGGGATC 
-~ 
0\ 
Sample 5' flanking region p N p 3' flanking region 
4 1-L4 TGGCTGCAGGT---- ----CCCCGGGGATC 
5 2-Ll TGGCTGCAGGTCGAC AC -GATCCCCGGGGATC 
6 2-L2 TGGCTGCAGGTC--- -----CCCGGGGATC 
7 2-L3 TGGCTGCAGGT---- A --ATCCCCGGGGATC 
8 2-L4 TGGCTGCAGGTC--- --ATCCCCGGGGATC 
9 2-L5 TGGCTGCAGGTCGAC -GATCCCCGGGGATC 
10 2-L6 TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
11 2-L7 TGGCTGCAGGTCGAC G AAA ----CCCCGGGGATC 
12 3-Ll CCTTGCCAGGTCGA- ACGTAA -----CCCGGGGATC 
13 3-L2 TGGCTGCAGGTCGA- GT -GATCCCCGGGGATC 
14 3-L3 TGGCTGCAGGTCG-- -GATCCCCGGGGATC 
15 3-L4 TGGCTGCAG------ --ATCCCCGGGGATC 
16 3-LS TGGCTGCAGG----- c -GATCCCCGGGGATC 
6 
17 3-L6 TGGCTGCAGGTC--- -----CCCGGGGATC 
18 3-L7 TGGCTGCAG------ --ATCCCCGGGGATC 
19 3-L8 TGGCTGCAGGT---- --ATCCCCGGGGATC 
20 3-L9 TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
21 3-LlO TGGCTGCAGGTCGAC GT ----CCCCGGGGATC 
22 4-Ll TGGCTGCAGG----- c GGATCCCCGGGGATC 
23 4-L2 TGGCTGCAG------ ------CCGGGGATC 
24 4-L3 TGGCTGCAG------ TTT -GATCCCCGGGGATC 
25 4-L4 TGGCTGCAGGT---- GA ----CCCCGGGGATC 
26 4-L5 TGGCTGCAGGTCGAC G ---TCCCCGGGGATC 
27 4-L6 TGGCTGCAGGTC--- ----CCCCGGGGATC 
28 4-L7 TGGCTGCAGGTC--- c GGATCCCCGGGGATC 
-~ 
.....J 
· .· · ~cu;q.ple 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
.i::.. 
00 
4-L8 
4-L9 
4-LlO 
4-Lll 
4-Ll2 
5-Ll 
5-L2 
5-L3 
5-L4 
5-L5 
5-L6 
5-L8 
6-Ll 
6-L2 
6-L3 
6-L4 
6-L5 
6-L6 
6-L7 
6-L8 
6-L9 
6-LlO 
6-Lll 
6-Ll2 
6-Ll3 
5' fl~~.R9' ~~g~9,n . . f . ·)I .p 3'· ·t'+~q. ~@9'~9Jl 
TGGCTGCAGGTCG-- GG ----CCCCGGGGATC 
TGGCTGCAGGT---- -GATCCCCGGGGATC 
TGGCTGCAGGTCG-- -GATCCCCGGGGATC 
TGGCTGCAGGTC--- -----CCCGGGGATC 
TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
TGGCTGCAGGTC--- ----CCCCGGGGATC 
TGGCTGCAGGTCG-- -GATCCCCGGGGATC 
TGGCTGCAGGTC--- -----CCCGGGGATC 
TGGCTGCAGGT---- GGATCCCCGGGGATC 
TGGCTGCAGG----- c -GATCCCCGGGGATC 
TGGCTGCAGGT---- -GATCCCCGGGGATC 
TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
TGGCTGCAGGTCG-- cc GGATCCCCGGGGATC 
TGGCTGCAGG----- c --ATCCCCGGGGATC 
TGGCTGCAGGT---- ---TCCCCGGGGATC 
TGGCTGCAGGT---- --ATCCCCGGGGATC 
TGGCTGCAGGTCG-- -GATCCCCGGGGATC 
TGGCTGCAGG----- cc --ATCCCCGGGGATC 
TGGCTGCAGG----- -GATCCCCGGGGATC 
TGGCTGCAGGTCGAC ----CCCCGGGGATC 
TGGCTGCAGGTC--- -----CCCGGGGATC 
TGGCTGCAGGTCGAC GT ----CCCCGGGGATC 
TGGCTGCAGG----- --ATCCCCGGGGATC 
TGGCTGCAG------ TT --ATCCCCGGGGATC -~ 
TGGCTGCAGGTCG-- ---TCCCCGGGGATC 
· · <'. Sqiple ·. ? ! . ~~-~qq: ;'_~g~.g~ . ~ ~- ... , .. -~ ~( ~ . 1:-~g·. ~e.g~q~ . .. . ~"' -. ·.~; .... ~ ~ .. 
54 6-L14 TGGCTGCAGGTC--- -----CCCGGGGATC 
55 6-L15 TGGCTGCAGGTCGAC ---TCCCCGGGGATC 
56 6-L16 TGGCTGCAGGTC--- --ATCCCCGGGGATC 
57 6-L17 TGGCTGCAGG----- cc GGATCCCCGGGGATC 
58 6-L18 TGGCTGCAGGTC--- --ATCCCCGGGGATC 
59 6-L19 TGGCTGCAGGTCGAC A ----CCCCGGGGATC 
60 6-L20 TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
61 6-L21 TGGCTGCAGGTCGAC G ---TCCCCGGGGATC 
62 7-Ll TGGCTGCAGGTCGAC G ---TCCCCGGGGATC 
63 7-L2 TGGCTGCAGGTCG-- -GATCCCCGGGGATC 
64 7-L3 TGGCTGCAGGTCGAC -GATCCCCGGGGATC 
65 7-L4 TGGCTGCAGG----- GC -GATCCCCGGGGATC 
66 7-L5 TGGCTGCAGGT---- -GATCCCCGGGGATC 
67 7-L6 TGGCTGCAGGTC--- -----CCCGGGGATC 
68 7-L7 TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
69 8-Ll TGGCTGCAGGTCGAC G GA ----CCCCGGGGATC 
70 8-L2 TGGCTGCAGGTCGAC G ---TCCCCGGGGATC 
71 8-L3 TGGCTGCAGGTC--- --ATCCCCGGGGATC 
72 8-L4 TGGCTGCAGGT---- --ATCCCCGGGGATC 
1 2-Rl TGGCTGCAGG----- -GATCCCCGGGGATC 
2 2-R2 TGGCTGCAGGTCGAC ----CCCCGGGGATC 
3 2-R3 TGGCTGCAGGTC--- ----CCCCGGGGATC 
4 2-R4 TGGCTGCAGGTCGAC G -".--TCCCCGGGGATC 
5 2-R5 TGGCTGCAGGTCGA- ---TCCCCGGGGATC ... 
6 3-Rl TGGCTGCAGGTCGAC GT ----CCCCGGGGATC 
-~ 
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7 3-R2 TGGCTGCAGGTCG-- ---TCCCCGGGGATC 
8 3-R3 TGGCTGCAGG----- c -GATCCCCGGGGATC 
9 3-R4 CTTGCCAAGGTCG-- GTT ---TCCCCGGGGATC 
10 3-R5 TGGCTGCAGGTCGAC ----CCCCGGGGATC 
11 3-R6 TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
12 4-Rl TGGCTGCAGGTCG-- T GGATCCCCGGGGATC 
13 4-R2 TGGCTGCAGGTCGAC GT AA ----CCCCGGGGATC 
14 4-R3 TGGCTGCAGGTCGAC GT G ---TCCCCGGGGATC 
15 4-R4 TGGCTGCAGGTCGAC ----CCCCGGGGATC 
i6 4-R5 
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TGGCTGCAGG----- --ATCCCCGGGGATC 
17 4-R6 TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
18 6-Rl TGGCTGCAGGTCGAC G A ----CCCCGGGGATC 
19 6-R2 TGGCTGCAGGTCG-- GGATCCCCGGGGATC 
20 7-Rl TGGCTGCAGG----- -GATCCCCGGGGATC 
21 7-R2 TGGCTGCAGGTCGAC c GGATCCCCGGGGATC 
22 7-R3 TG6CTGCAGGTC--- T -GATCCCCGGGGATC 
23 7-R4 TGGCTGCAGGTCGAC -GATCCCCGGGGATC 
24 7-R5 TGGCTGCAGG----- --ATCCCCGGGGATC 
25 7-R6 TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
26 7-R7 TGGCTGCAGGTC--- -----CCCGGGGATC 
27 7-R8 TGGCTGCAGGTCGAC ----CCCCGGGGATC 
28 7-R9 TGGCTGCAGGTC--- -----CCCGGGGATC 
29 8-Rl TGGCTGCAGGTCGAC G ---TCCCCGGGGATC 
30 8-R2 TGGCTGCAGGT---- -GATCCCCGGGGATC 
31 8-R3 TGGCTGCAGGTCGA- ---TCCCCGGGGATC 
-V'I 
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32 8-R4 TGGCTGCAGG----- cc GGATCCCCGGGGATC 
33 8-RS TGGCTGCAGGTCG-- GGATCCCCGGGGATC 
34 8-R6 TGGCTGCAGGTCGA- A ----CCCCGGGGATC 
-
*The sequences were generated from 8 independent HEK.293T cell transfections. 
Germline sequence of non-recombined substrate recombination pGG51 plasmid, showing sequence at the 5' end of 12-RSS 
flanking region and the 3' end of 23-RSS flanking region. 
Sample name; transfection number- hTdTS variant transfection. 
Each dash(-) represents a single nucleotide deletion. P stands for P-nucleotide additions either from the 5' or the 3' flanking 
region. 
N stands for N-nucleotide additions. 
**Experimental conditions are as follows; 
C= transfection with substrate pGG51 plasmid + pEBG-hRAG 1 + pEBG-hRAG2 expressing vectors 
W= transfection with wild type hTdTS pcDNA expressing vector+ substrate pGG51 plasmid+ pEBG-hRAG 1 + pEBG-
hRAG2 expressing vectors 
A = transfection with A445T hTdTS pcDNA expressing vector+ substrate pGG51 plasmid+ pEBG-hRAG 1 + pEBG-hRAG2 
expressing vectors 
L = transfection with L397S hTdTS pcDNA expressing vector+ substrate pGG51 plasmid + pEBG-hRAG 1 + pEBG-hRAG2 
expressing vectors 
R = transfection with R431 C hTdTS pcDNA expressing vector+ substrate pGG51 plasmid + pEBG-hRAG 1 + pEBG-hRAG2 
expressing vectors 
***Assignment of P-additions was considered prior to N-additions. 
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